data_2mzn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.239 0.525 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.554 HG22 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' H ' HD11 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.575 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HG ' HG21 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.419 HD13 HD23 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.7 OUTLIER -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.524 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD23 HD13 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HB2' HD21 ' A' ' 115' ' ' LEU . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.703 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.423 ' HB1' ' HD1' ' A' ' 167' ' ' HIS . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.8 OUTLIER -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.49 ' H ' HG13 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD13 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.423 ' HD1' ' HB1' ' A' ' 118' ' ' ALA . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.703 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.666 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.454 ' HG2' HG23 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.422 HG11 HG13 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.598 0.237 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.543 HG21 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.595 HD12 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.599 ' HZ2' ' HB3' ' A' ' 126' ' ' LYS . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.54 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.502 HG22 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.458 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HD1' HD12 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.451 ' HB3' HD23 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.666 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 120.603 0.239 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG21 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo . . . . . 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.612 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 40.1 p-80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD11 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.484 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG21 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.597 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD22 ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD11 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.439 ' HB3' HG23 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.494 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.578 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' HB ' ' HG2' ' A' ' 81' ' ' GLU . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.458 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.847 0.355 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.443 HD21 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.494 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.458 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.447 ' HG3' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.421 HD21 ' HE1' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.498 HH11 HG22 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HB3' ' HZ1' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.532 ' HZ1' ' HB3' ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.549 ' HG3' HG23 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.668 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.673 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.568 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.659 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.549 HG23 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD13 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 148' ' ' MET . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.446 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.628 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 121.133 0.492 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.428 HG11 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.547 HD21 ' HA ' ' A' ' 107' ' ' GLN . 11.8 m120 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.547 ' HA ' HD21 ' A' ' 101' ' ' ASN . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.428 ' HB ' HG11 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.576 HD22 ' HB1' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.518 ' HB2' HD21 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.576 ' HB1' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 119' ' ' LEU . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 171' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.454 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.409 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.504 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.542 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.619 ' HB3' HG21 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD13 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG23 ' HB1' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HZ1' ' A' ' 99' ' ' LYS . 58.9 Cg_endo . . . . . 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 25.7 pttm . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.395 0.14 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.526 ' HZ1' ' HD3' ' A' ' 89' ' ' PRO . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.457 HD22 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.499 ' H ' ' NE2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.479 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.612 ' HB2' HD21 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 171' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.533 HG12 HG11 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.467 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.433 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.404 ' HB1' HG23 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.619 HG21 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.521 HD22 ' HE1' ' A' ' 148' ' ' MET . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.601 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.533 HG11 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HB3' HD23 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 148' ' ' MET . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 HG23 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' HA3' ' HA2' ' A' ' 109' ' ' GLY . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.501 HG11 HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HD3' ' HZ1' ' A' ' 99' ' ' LYS . 92.0 Cg_endo . . . . . 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 120.491 0.186 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.523 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.548 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.587 HD22 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 23.8 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG23 HG11 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.475 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.509 HD21 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.509 HG12 HD21 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.529 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.57 ' HE1' ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.493 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.414 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.6 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.429 ' HG2' HD23 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' N ' ' HE2' ' A' ' 148' ' ' MET . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG23 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.514 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.598 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.721 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.522 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.525 ' HA ' ' HE2' ' A' ' 144' ' ' MET . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.525 ' HE2' ' HA ' ' A' ' 138' ' ' ALA . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.57 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.475 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.721 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.716 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.447 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 HD13 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG21 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB3' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB3' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 127' ' ' LEU . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.56 ' HB2' HG21 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.473 HG21 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.462 ' HG3' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.427 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 148' ' ' MET . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 144' ' ' MET . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.177 0.513 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 144' ' ' MET . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.563 ' HB2' HD22 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.551 ' HE1' HG12 ' A' ' 134' ' ' VAL . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.651 ' HE3' ' HB2' ' A' ' 63' ' ' LEU . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB3' HD23 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' H ' ' HE2' ' A' ' 148' ' ' MET . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.537 ' HB ' HG21 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.428 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.523 ' HG ' HG23 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.498 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo . . . . . 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.684 0.278 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.523 HG23 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.51 HG13 HG21 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 18.3 m120 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB2' HG23 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' HB2' HD22 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.562 ' HG3' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.433 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 156' ' ' ASN . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.51 HG21 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.433 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.519 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.755 0.312 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' HG2' ' A' ' 144' ' ' MET . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.612 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.491 ' HB ' HG21 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG21 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.616 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.61 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 167' ' ' HIS . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 HD22 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.612 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.45 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.46 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.436 ' O ' HG21 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HA ' ' CE1' ' A' ' 167' ' ' HIS . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 164' ' ' LEU . 2.2 p80 -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.502 0.191 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 ' HE2' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 89' ' ' PRO . 29.0 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . 92.0 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.703 0.287 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.589 ' HB1' ' HE2' ' A' ' 110' ' ' HIS . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.451 HG11 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.589 ' HE2' ' HB1' ' A' ' 97' ' ' ALA . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.612 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.454 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 77' ' ' VAL . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' HG21 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.51 ' HE2' HD21 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.584 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.456 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.585 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.745 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.439 ' HB2' HE22 ' A' ' 107' ' ' GLN . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.526 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.55 ' HG3' HG23 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.621 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 5.0 pp0? -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.447 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.588 ' HA ' HD12 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.469 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' HE3' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.404 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.453 ' HE3' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.567 ' HE2' ' HA ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.416 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.567 ' HA ' ' HE2' ' A' ' 148' ' ' MET . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.538 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.472 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.933 0.397 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HA ' ' HB1' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.517 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.628 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.468 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.426 ' ND2' HD22 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD22 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 HD23 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' ' HB3' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.464 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.523 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.496 HD21 ' HE3' ' A' ' 148' ' ' MET . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 145' ' ' PRO . 29.2 m170 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.495 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.539 HG22 HG13 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.535 ' HG2' HG23 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.7 OUTLIER -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HD22 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.443 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 66' ' ' HIS . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.52 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.668 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.495 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.54 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.455 ' HD1' ' HB2' ' A' ' 169' ' ' PHE . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.743 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HA ' HD22 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.449 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.574 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' HB ' ' A' ' 130' ' ' ILE . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 16.4 ptpt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.437 ' HB ' HD23 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.449 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.685 ' HG3' HD21 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.685 HD21 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.602 HG13 HG21 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.447 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.489 ' HG2' HD13 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.544 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 130' ' ' ILE . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.602 HG21 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.507 ' H ' HD13 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.699 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.604 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.602 HD13 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG12 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG2' HG23 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.526 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.696 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 15.9 ptpt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 111.238 0.088 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD22 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB3' HD23 ' A' ' 111' ' ' LEU . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.696 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 119' ' ' LEU . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.485 HG23 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 77' ' ' VAL . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.526 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.76 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD13 ' HE2' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.482 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 8.0 t30 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.552 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.175 0.512 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.61 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.687 ' HB3' HD23 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HA ' HD11 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 144' ' ' MET . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 142' ' ' PHE . 41.2 t30 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.512 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HE2' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.416 ' OD1' ' HG3' ' A' ' 155' ' ' GLU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.408 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.54 ' HD2' ' HB2' ' A' ' 169' ' ' PHE . 42.4 t60 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.511 HD23 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 p -64.81 -29.51 70.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.091 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.84 -20.73 66.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.554 0.742 . . . . 0.0 111.197 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -97.39 -56.55 2.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 110.53 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.26 -39.63 20.62 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.89 -30.97 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.636 . . . . 0.0 109.322 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.12 103.02 0.7 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.782 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m -144.33 149.69 36.6 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.073 0.949 . . . . 0.0 108.729 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.554 HG22 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' H ' HD11 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.575 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HG ' HG21 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.9 -4.66 8.89 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -177.07 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.001 0.92 . . . . 0.0 110.492 -168.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -53.79 103.17 0.35 Allowed Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 125.101 1.36 . . . . 0.0 112.23 -167.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.88 -52.43 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.749 2.299 . . . . 0.0 113.681 -169.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -84.27 -18.7 35.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.929 0.492 . . . . 0.0 110.698 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.01 67.79 0.74 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? -70.56 -18.39 62.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.419 HD13 HD23 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.7 OUTLIER -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.524 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD23 HD13 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HB2' HD21 ' A' ' 115' ' ' LEU . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.703 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.423 ' HB1' ' HD1' ' A' ' 167' ' ' HIS . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.8 OUTLIER -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.49 ' H ' HG13 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD13 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.423 ' HD1' ' HB1' ' A' ' 118' ' ' ALA . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.703 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.0 m -64.47 -19.43 65.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.941 0.896 . . . . 0.0 112.974 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.74 -41.51 83.31 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.41 0.624 . . . . 0.0 109.921 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.2 -7.06 59.46 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.982 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -131.09 37.25 3.77 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.951 0.9 . . . . 0.0 109.715 -171.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.6 -28.21 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -97.55 132.87 42.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.737 0.815 . . . . 0.0 109.759 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m -77.06 128.24 34.11 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.666 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.454 ' HG2' HG23 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.422 HG11 HG13 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.34 -7.44 4.99 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.41 13.07 0.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 122.412 0.285 . . . . 0.0 111.634 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 10.2 m120 -107.24 100.2 31.74 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.227 0.611 . . . . 0.0 109.867 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.56 -44.59 4.3 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.755 2.304 . . . . 0.0 113.352 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -88.22 -32.01 18.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.108 0.563 . . . . 0.0 111.848 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -101.0 88.83 3.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.31 0.644 . . . . 0.0 110.707 -172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.49 -19.07 56.46 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.543 HG21 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.595 HD12 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.599 ' HZ2' ' HB3' ' A' ' 126' ' ' LYS . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.54 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.502 HG22 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.458 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.595 ' HD1' HD12 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.451 ' HB3' HD23 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.666 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.3 m -64.01 -18.16 64.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.51 0.724 . . . . 0.0 112.006 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.01 -49.72 76.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 110.568 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.38 -27.45 19.33 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.658 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 69.15 5.52 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.399 0.618 . . . . 0.0 109.661 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.63 7.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.916 0.886 . . . . 0.0 112.302 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.41 145.03 48.33 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.921 0.391 . . . . 0.0 110.41 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m -68.03 107.37 2.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.579 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG21 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -100.71 -0.7 0.62 Allowed 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -132.17 -56.51 0.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.058 0.845 . . . . 0.0 112.788 -167.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 1.9 m-20 -79.71 99.76 0.51 Allowed Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 124.338 1.055 . . . . 0.0 110.493 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.41 -47.17 14.98 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.858 2.372 . . . . 0.0 113.313 -166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -82.23 -31.99 29.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.41 0.684 . . . . 0.0 110.418 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 29.3 t70 -90.72 47.62 1.44 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.277 1.031 . . . . 0.0 109.163 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -71.69 -13.1 61.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.038 0.935 . . . . 0.0 113.324 -171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.612 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 40.1 p-80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD11 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.484 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG21 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.597 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD22 ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD11 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -67.55 -23.6 65.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.869 0.468 . . . . 0.0 111.892 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -75.46 -33.54 60.86 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.356 0.662 . . . . 0.0 111.205 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.77 -54.47 4.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.491 0.717 . . . . 0.0 110.965 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.45 73.64 10.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.01 -27.66 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.552 0.741 . . . . 0.0 111.334 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.62 132.55 36.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.112 0.565 . . . . 0.0 110.309 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m -80.71 104.75 11.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.439 ' HB3' HG23 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.494 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.578 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' HB ' ' HG2' ' A' ' 81' ' ' GLU . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.458 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo -81.11 -8.92 12.97 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -164.21 -42.49 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.111 0.964 . . . . 0.0 109.038 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.38 101.39 0.25 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 125.231 1.412 . . . . 0.0 112.684 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.23 -15.02 6.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.365 2.043 . . . . 0.0 112.256 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -83.1 -30.8 27.66 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.149 0.979 . . . . 0.0 109.629 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -126.63 98.48 5.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.82 -13.67 61.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.26 0.624 . . . . 0.0 110.487 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.443 HD21 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.494 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.458 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.447 ' HG3' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.421 HD21 ' HE1' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.498 HH11 HG22 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HB3' ' HZ1' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.532 ' HZ1' ' HB3' ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -67.31 -35.28 79.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.276 1.03 . . . . 0.0 112.292 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -67.46 -18.32 65.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.294 0.638 . . . . 0.0 111.677 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -84.21 -34.23 23.96 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.344 0.658 . . . . 0.0 110.083 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -74.38 -14.5 60.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.178 0.591 . . . . 0.0 112.254 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.1 9.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -89.88 150.25 22.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 111.451 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -123.32 106.6 10.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.571 1.148 . . . . 0.0 108.273 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.549 ' HG3' HG23 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.78 -3.07 6.45 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -164.91 -38.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.9 0.48 . . . . 0.0 110.936 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 14.2 m120 -67.01 102.0 0.34 Allowed Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 124.214 1.006 . . . . 0.0 111.37 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.07 -35.34 3.14 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.172 1.915 . . . . 0.0 113.169 -170.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -81.32 -41.12 22.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.967 0.507 . . . . 0.0 109.802 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.9 m-20 -85.41 68.66 10.54 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.103 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -29.18 68.25 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.808 176.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.668 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.673 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.568 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.659 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.549 HG23 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD13 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 148' ' ' MET . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.446 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.628 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 CA-C-O 120.235 -0.203 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 p -63.75 -37.15 86.28 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.36 -36.14 81.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.176 0.591 . . . . 0.0 110.779 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.45 -23.87 27.66 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.73 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.8 -32.67 27.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.939 0.895 . . . . 0.0 111.71 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.37 0.1 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.184 0.594 . . . . 0.0 112.522 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.51 102.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m -82.08 141.7 32.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.912 0.885 . . . . 0.0 111.688 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.71 -10.22 17.05 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -76.25 -35.67 58.86 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -108.26 97.5 22.55 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 0.0 110.893 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.38 -25.04 7.27 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.375 2.05 . . . . 0.0 112.424 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -85.27 -5.57 59.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.693 0.797 . . . . 0.0 111.413 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 93.06 3.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.113 0.565 . . . . 0.0 109.663 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -67.34 -31.65 72.05 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.019 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.428 HG11 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.547 HD21 ' HA ' ' A' ' 107' ' ' GLN . 11.8 m120 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.547 ' HA ' HD21 ' A' ' 101' ' ' ASN . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.428 ' HB ' HG11 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.576 HD22 ' HB1' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.518 ' HB2' HD21 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.576 ' HB1' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 119' ' ' LEU . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 171' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.454 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.409 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.504 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.542 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 68.5 m -68.9 -5.48 21.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 112.142 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.12 -38.86 92.59 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.576 1.15 . . . . 0.0 109.752 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.36 -39.16 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.38 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 31.1 mt-10 -80.7 23.24 0.54 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.084 0.954 . . . . 0.0 111.871 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -75.36 -29.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.937 -0.477 . . . . 0.0 111.438 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -88.39 134.84 33.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.316 0.646 . . . . 0.0 111.574 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -76.15 103.51 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.977 0.911 . . . . 0.0 109.622 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.619 ' HB3' HG21 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD13 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG23 ' HB1' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HZ1' ' A' ' 99' ' ' LYS . 58.9 Cg_endo -69.35 -21.75 34.96 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -83.98 -23.11 31.19 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 25.7 m-80 -108.61 98.56 29.14 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.474 0.71 . . . . 0.0 112.279 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.19 -39.39 3.04 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.96 -34.94 19.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.706 0.803 . . . . 0.0 111.382 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 7.9 m-20 -87.92 63.46 7.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 25.7 pttm -75.07 -9.4 58.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.961 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.526 ' HZ1' ' HD3' ' A' ' 89' ' ' PRO . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.457 HD22 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.499 ' H ' ' NE2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.479 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.612 ' HB2' HD21 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 171' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.533 HG12 HG11 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.467 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.433 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.404 ' HB1' HG23 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.619 HG21 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.521 HD22 ' HE1' ' A' ' 148' ' ' MET . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.601 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.533 HG11 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HB3' HD23 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m -85.55 -23.97 27.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 0.0 112.704 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.75 -37.84 88.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 120.866 0.365 . . . . 0.0 111.939 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.34 -8.93 56.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.734 0.814 . . . . 0.0 112.786 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -136.58 27.86 3.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.851 0.86 . . . . 0.0 110.681 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.49 -28.13 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 122.659 0.384 . . . . 0.0 110.942 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.61 124.57 28.31 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.716 0.806 . . . . 0.0 110.228 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m -85.09 137.79 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 109.593 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 148' ' ' MET . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 HG23 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' HA3' ' HA2' ' A' ' 109' ' ' GLY . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.501 HG11 HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HD3' ' HZ1' ' A' ' 99' ' ' LYS . 92.0 Cg_endo -75.44 -18.8 17.53 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -91.57 -24.71 19.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.994 0.918 . . . . 0.0 110.362 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 47.6 m-80 -106.76 97.19 16.38 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.339 0.656 . . . . 0.0 110.8 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.22 -39.76 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.382 2.055 . . . . 0.0 113.042 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.16 -34.15 26.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.454 0.702 . . . . 0.0 110.596 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.5 m-20 -80.32 75.63 7.14 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 166.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -75.99 -9.82 58.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.671 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.523 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.548 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.587 HD22 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 23.8 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG23 HG11 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.475 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.509 HD21 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.509 HG12 HD21 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.529 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.57 ' HE1' ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.493 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.414 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.6 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.429 ' HG2' HD23 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.8 p -72.95 -9.46 58.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.72 0.808 . . . . 0.0 112.211 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.18 -52.8 64.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.147 0.498 . . . . 0.0 109.763 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.12 -14.91 40.01 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.254 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -127.18 92.39 3.51 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.186 0.517 . . . . 0.0 111.322 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.07 3.69 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.98 0.912 . . . . 0.0 109.402 165.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.68 117.99 23.02 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.244 1.018 . . . . 0.0 111.006 -168.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -86.41 132.92 33.83 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 165.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' N ' ' HE2' ' A' ' 148' ' ' MET . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG23 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.514 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -86.36 -11.44 6.12 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -140.35 -53.35 0.51 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.282 1.033 . . . . 0.0 110.74 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -53.72 108.67 1.18 Allowed Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.99 1.316 . . . . 0.0 113.145 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.24 -52.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.33 2.02 . . . . 0.0 112.868 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -85.81 -25.05 26.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.172 0.989 . . . . 0.0 110.792 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -107.95 40.16 1.79 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.377 1.071 . . . . 0.0 108.346 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -63.37 -27.53 69.37 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.137 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.598 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.721 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.522 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.525 ' HA ' ' HE2' ' A' ' 144' ' ' MET . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.525 ' HE2' ' HA ' ' A' ' 138' ' ' ALA . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.57 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.475 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.721 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.716 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 CA-C-O 119.688 -0.507 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -60.78 -43.5 97.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 0.0 112.055 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.83 -37.11 78.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.743 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.36 -45.15 61.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.491 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.56 16.87 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.85 -29.46 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.978 0.511 . . . . 0.0 110.846 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.87 148.15 25.94 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -111.12 166.62 10.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 109.201 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.447 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 HD13 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG21 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 -23.34 20.95 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.71 -22.09 34.61 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.225 0.61 . . . . 0.0 110.672 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.606 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 16.8 m-80 -99.52 93.91 2.58 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.56 -52.75 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.997 1.798 . . . . 0.0 113.223 -168.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -87.44 -30.6 20.56 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.11 0.564 . . . . 0.0 110.543 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 13.6 t70 -76.7 77.37 3.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.017 0.913 . . . . 0.0 109.395 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.22 -12.85 60.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.928 1.291 . . . . 0.0 112.284 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB3' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB3' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 127' ' ' LEU . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' HB2' HG21 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.473 HG21 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.462 ' HG3' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.427 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 26.4 p -64.66 -23.09 67.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.064 0.946 . . . . 0.0 112.817 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.3 -44.28 95.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.03 0.932 . . . . 0.0 110.57 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -85.49 -18.76 32.57 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.012 0.925 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 6.7 tp10 -80.54 0.31 34.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.674 1.189 . . . . 0.0 111.992 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.0 -17.96 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.134 0.574 . . . . 0.0 112.265 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -102.84 127.92 49.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.84 0.856 . . . . 0.0 109.973 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -78.64 118.32 20.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 148' ' ' MET . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 144' ' ' MET . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -88.84 -15.75 2.53 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -162.48 24.86 0.1 Allowed 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -167.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 15.2 m120 -109.13 96.76 22.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.341 171.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.27 -40.07 85.18 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.582 . . . . 0.0 113.406 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -90.54 -43.82 9.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.29 0.636 . . . . 0.0 111.548 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.3 m-20 -87.77 78.9 8.31 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.128 0.49 . . . . 0.0 112.111 -168.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 0.5 OUTLIER -68.37 -23.15 64.64 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 170.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 144' ' ' MET . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.563 ' HB2' HD22 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.551 ' HE1' HG12 ' A' ' 134' ' ' VAL . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.651 ' HE3' ' HB2' ' A' ' 63' ' ' LEU . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB3' HD23 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -58.56 -36.04 73.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.127 0.971 . . . . 0.0 112.917 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.89 -35.94 82.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.087 0.555 . . . . 0.0 111.186 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -76.26 -31.77 58.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.814 0.845 . . . . 0.0 110.659 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -96.57 17.23 16.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.477 1.111 . . . . 0.0 111.978 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.58 -24.8 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.666 0.386 . . . . 0.0 111.029 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.49 102.26 2.18 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.263 0.625 . . . . 0.0 109.717 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m -85.91 131.32 34.32 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.829 0.852 . . . . 0.0 109.804 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' H ' ' HE2' ' A' ' 148' ' ' MET . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.537 ' HB ' HG21 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.428 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 ' HG ' HG23 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.498 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo -75.58 -11.4 20.44 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -79.16 -22.93 44.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.98 0.512 . . . . 0.0 110.358 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 6.2 m-20 -108.04 95.61 15.62 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.462 0.705 . . . . 0.0 109.864 175.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.27 -34.0 3.07 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.464 2.11 . . . . 0.0 112.453 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -80.09 -32.85 39.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.487 1.115 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 25.2 t70 -102.76 93.37 5.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.259 0.552 . . . . 0.0 109.725 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.44 -15.17 60.91 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.917 0.887 . . . . 0.0 110.857 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.523 HG23 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.51 HG13 HG21 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 18.3 m120 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB2' HG23 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' HB2' HD22 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.562 ' HG3' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.433 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 156' ' ' ASN . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.51 HG21 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.433 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.519 ' HA ' ' HE1' ' A' ' 148' ' ' MET . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.6 p -75.23 -16.55 60.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.704 0.802 . . . . 0.0 112.038 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -80.7 -30.71 36.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.005 0.922 . . . . 0.0 110.697 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.46 -55.12 4.04 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.855 0.862 . . . . 0.0 109.251 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -89.28 63.72 6.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.897 1.279 . . . . 0.0 108.821 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.29 -38.0 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.267 0.627 . . . . 0.0 111.097 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.48 142.39 50.09 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.934 0.893 . . . . 0.0 108.824 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m -64.4 136.52 57.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.601 0.76 . . . . 0.0 110.703 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' HG2' ' A' ' 144' ' ' MET . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.612 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.491 ' HB ' HG21 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG21 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -86.29 -8.54 7.5 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -95.6 -35.04 11.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.897 0.879 . . . . 0.0 110.553 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -103.17 104.76 42.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.917 0.887 . . . . 0.0 110.532 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.47 -36.16 12.09 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.671 2.248 . . . . 0.0 112.267 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -82.48 -34.19 28.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.572 0.749 . . . . 0.0 111.091 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.83 59.85 0.74 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.817 0.818 . . . . 0.0 109.551 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.47 -22.82 65.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.024 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.616 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.61 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 167' ' ' HIS . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 HD22 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.612 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.45 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.46 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.436 ' O ' HG21 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HA ' ' CE1' ' A' ' 167' ' ' HIS . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 164' ' ' LEU . 2.2 p80 -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 CA-C-O 119.585 -0.564 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.409 ' O ' HG12 ' A' ' 55' ' ' VAL . 21.7 m -57.23 -40.39 77.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.319 1.048 . . . . 0.0 113.262 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.78 -32.94 60.75 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.154 0.582 . . . . 0.0 111.979 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.25 -7.55 24.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.416 1.087 . . . . 0.0 110.853 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.84 -9.76 15.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.014 0.925 . . . . 0.0 111.769 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 51' ' ' SER . 15.6 m -81.0 20.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -98.68 146.17 26.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.884 0.874 . . . . 0.0 109.366 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -67.36 119.68 12.6 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.079 0.552 . . . . 0.0 110.579 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 ' HE2' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 89' ' ' PRO . 29.0 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . 92.0 Cg_endo -82.99 -39.47 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -169.2 17.98 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.563 0.745 . . . . 0.0 110.506 -172.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 17.9 m120 -104.79 98.78 16.04 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 123.792 0.837 . . . . 0.0 109.457 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.67 -44.59 25.47 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.457 2.771 . . . . 0.0 114.189 -166.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.77 -21.85 26.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.179 0.592 . . . . 0.0 111.026 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 97' ' ' ALA . 28.0 m-20 -93.93 64.77 3.43 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 109.761 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.35 -24.94 63.06 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.575 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.589 ' HB1' ' HE2' ' A' ' 110' ' ' HIS . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.451 HG11 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.589 ' HE2' ' HB1' ' A' ' 97' ' ' ALA . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.612 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.454 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 77' ' ' VAL . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' HG21 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.51 ' HE2' HD21 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.584 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.456 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.585 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.745 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 41.1 p -54.34 -25.34 23.52 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.36 1.064 . . . . 0.0 113.698 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.37 -55.4 35.21 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.209 1.003 . . . . 0.0 111.305 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -5.47 48.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.108 0.563 . . . . 0.0 111.415 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 28.6 tt0 -90.96 21.81 3.99 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.517 0.727 . . . . 0.0 110.878 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.34 -4.09 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.792 0.837 . . . . 0.0 112.222 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.1 109.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.763 0.825 . . . . 0.0 111.589 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -105.15 117.71 34.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.494 1.118 . . . . 0.0 108.767 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.439 ' HB2' HE22 ' A' ' 107' ' ' GLN . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.526 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.55 ' HG3' HG23 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -104.31 4.27 0.31 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -158.28 -44.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -58.5 103.02 0.33 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 124.648 1.179 . . . . 0.0 111.451 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.56 -44.85 12.8 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.154 2.569 . . . . 0.0 113.902 -163.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -89.25 -44.88 9.95 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.181 0.593 . . . . 0.0 110.89 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.05 85.25 6.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 -168.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -75.6 -14.8 60.4 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.295 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.621 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 5.0 pp0? -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.447 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.588 ' HA ' HD12 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.469 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' HE3' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.404 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.453 ' HE3' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.567 ' HE2' ' HA ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.416 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.567 ' HA ' ' HE2' ' A' ' 148' ' ' MET . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 p -74.56 -12.83 60.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.036 0.935 . . . . 0.0 111.844 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.17 -28.84 69.08 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.196 0.599 . . . . 0.0 111.049 174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -68.4 -16.37 63.89 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 0.0 111.527 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 49.0 mt-10 -109.22 16.1 22.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.35 1.06 . . . . 0.0 111.727 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.85 0.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.95 129.44 56.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.109 0.964 . . . . 0.0 108.822 169.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -76.48 116.11 16.86 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.538 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.472 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -85.16 -6.81 9.27 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.0 -32.22 30.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.306 0.643 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -98.66 105.58 31.36 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.629 0.771 . . . . 0.0 109.353 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -48.72 4.64 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.816 2.344 . . . . 0.0 113.193 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -78.72 -31.61 46.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.466 0.706 . . . . 0.0 111.987 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -80.25 79.95 6.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.261 0.553 . . . . 0.0 110.176 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.6 -21.07 60.43 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.309 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HA ' ' HB1' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.517 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.628 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB2' HD21 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.426 ' ND2' HD22 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD22 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 HD23 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' ' HB3' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.464 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.523 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.496 HD21 ' HE3' ' A' ' 148' ' ' MET . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -63.14 -28.28 69.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.222 1.009 . . . . 0.0 111.632 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -65.71 -34.22 77.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.704 1.201 . . . . 0.0 111.399 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.08 -27.96 27.9 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.896 0.878 . . . . 0.0 110.075 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -91.94 17.48 9.2 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.657 -174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.03 -32.52 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.67 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 100.9 4.38 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m -73.1 136.2 44.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.577 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 145' ' ' PRO . 29.2 m170 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.495 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.539 HG22 HG13 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.535 ' HG2' HG23 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -86.14 3.58 6.88 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -160.81 -50.51 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.497 0.719 . . . . 0.0 111.069 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -46.73 100.57 0.24 Allowed Pre-proline 0 N--CA 1.495 1.788 0 C-N-CA 125.041 1.336 . . . . 0.0 113.4 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.3 -34.5 27.1 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.44 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.74 -45.68 10.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.93 80.1 8.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -71.76 -14.66 62.06 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.7 OUTLIER -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HD22 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.443 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 66' ' ' HIS . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.52 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.668 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.495 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.54 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.455 ' HD1' ' HB2' ' A' ' 169' ' ' PHE . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.743 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.0 m -74.72 1.76 11.61 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.581 0.752 . . . . 0.0 112.548 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.6 -36.33 18.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.8 -60.06 1.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 111.83 -172.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.551 ' HB2' ' HZ2' ' A' ' 153' ' ' LYS . 16.3 pt-20 -85.7 15.79 4.46 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -162.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.15 -26.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.572 0.349 . . . . 0.0 111.085 172.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -87.15 109.14 19.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.51 0.724 . . . . 0.0 109.898 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m -74.66 123.56 25.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HA ' HD22 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.449 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.574 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' HB ' ' A' ' 130' ' ' ILE . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.98 -19.29 13.98 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -72.96 -36.25 67.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.778 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 42.0 m-80 -102.78 98.43 11.24 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.058 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.32 -50.57 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.7 2.267 . . . . 0.0 113.267 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -87.2 -31.2 20.46 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.23 0.612 . . . . 0.0 110.832 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.778 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 14.3 t70 -74.81 85.19 2.18 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 16.4 ptpt -74.04 -14.5 61.02 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.989 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.437 ' HB ' HD23 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.685 ' HG3' HD21 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.685 HD21 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.602 HG13 HG21 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.447 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.489 ' HG2' HD13 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.544 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 130' ' ' ILE . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.551 ' HZ2' ' HB2' ' A' ' 54' ' ' GLU . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.602 HG21 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.507 ' H ' HD13 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.699 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -71.68 -25.05 61.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.967 0.907 . . . . 0.0 111.504 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.4 -29.95 69.59 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.453 0.701 . . . . 0.0 112.103 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.47 -16.17 61.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.475 0.71 . . . . 0.0 111.813 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.2 48.75 1.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.632 0.773 . . . . 0.0 110.545 -172.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.92 -13.94 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.669 0.388 . . . . 0.0 111.494 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -107.77 129.35 55.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.302 1.041 . . . . 0.0 109.766 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -82.73 132.5 35.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.604 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.602 HD13 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG12 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG2' HG23 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.526 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 -17.76 13.62 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -78.78 -41.83 29.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -107.53 99.49 29.02 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.022 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.65 -31.3 2.03 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.358 2.039 . . . . 0.0 112.951 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.97 -41.81 41.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.293 0.637 . . . . 0.0 110.222 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.32 95.89 9.36 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.696 ' HG3' ' HB3' ' A' ' 120' ' ' ALA . 15.9 ptpt -76.2 -17.3 59.59 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.238 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD22 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB3' HD23 ' A' ' 111' ' ' LEU . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.696 ' HB3' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 119' ' ' LEU . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.485 HG23 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 77' ' ' VAL . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.526 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.76 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.2 p -55.1 -48.11 74.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.678 1.191 . . . . 0.0 113.14 -171.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.38 -21.89 55.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 0.0 112.081 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.43 -43.61 17.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.371 0.669 . . . . 0.0 111.161 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.75 28.63 1.29 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.304 0.642 . . . . 0.0 111.89 -171.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.14 -21.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.218 0.607 . . . . 0.0 110.465 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.87 125.57 29.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.381 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -77.05 148.11 36.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD13 ' HE2' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.482 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 8.0 t30 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.552 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.07 -14.8 18.76 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.39 -42.99 9.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.512 0.725 . . . . 0.0 110.263 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 6.0 m-20 -84.85 107.71 12.53 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.039 0.936 . . . . 0.0 110.455 -175.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.25 -51.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.58 2.186 . . . . 0.0 113.681 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -87.81 -24.61 23.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.253 0.621 . . . . 0.0 111.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.7 m-20 -85.56 58.58 5.12 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.34 1.067 . . . . 0.0 108.824 168.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -77.44 -15.16 59.48 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.662 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.61 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.687 ' HB3' HD23 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HA ' HD11 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 144' ' ' MET . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 142' ' ' PHE . 41.2 t30 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.512 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HE2' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.416 ' OD1' ' HG3' ' A' ' 155' ' ' GLU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.408 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.54 ' HD2' ' HB2' ' A' ' 169' ' ' PHE . 42.4 t60 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.511 HD23 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.239 0.525 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.454 ' H ' HD13 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' HD22 ' A' ' 102' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.599 HD22 ' HG3' ' A' ' 81' ' ' GLU . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD22 HD12 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HG3' HG21 ' A' ' 68' ' ' VAL . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.52 ' HG2' HD11 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.551 HH21 HG23 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.546 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 138' ' ' ALA . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.461 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.598 0.237 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.551 HG22 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.591 ' HD1' HD13 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 120.603 0.239 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG22 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo . . . . . 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.641 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 30.4 p80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.654 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.579 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.443 ' HB3' HG22 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.515 HG12 HD22 ' A' ' 102' ' ' ASN . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.477 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.847 0.355 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.515 HD22 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.547 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 170' ' ' LYS . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 137' ' ' GLY . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.507 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD23 ' HE3' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.502 HH11 HG21 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 156' ' ' ASN . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.724 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.586 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.682 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 99' ' ' LYS . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.724 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.667 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 134' ' ' VAL . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.445 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 167' ' ' HIS . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.633 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 121.133 0.492 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' HG13 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG13 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HB2' HD22 ' A' ' 115' ' ' LEU . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 160' ' ' VAL . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.501 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.664 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.595 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 25.7 pttm . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.395 0.14 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' HD21 ' A' ' 101' ' ' ASN . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.482 HD21 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.488 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.595 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.578 HG12 HG13 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.432 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' GLY . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.416 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.607 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' HD22 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 171' ' ' LEU . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' TYR . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 74' ' ' THR . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 120.491 0.186 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 76.2 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD23 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.546 HG12 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.583 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.416 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.447 ' HG2' HD22 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 111' ' ' LEU . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG22 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.608 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.488 HG12 HG23 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.525 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.742 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.646 HG12 HG13 ' A' ' 160' ' ' VAL . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE1' HG11 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.177 0.513 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.619 HD13 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.545 ' HB2' HD22 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.619 ' SD ' HD13 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' A' ' 123' ' ' MET . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.587 HD21 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 136' ' ' PHE . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.571 HD22 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.533 ' HB ' HG22 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo . . . . . 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.684 0.278 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.532 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.543 HG22 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 35.4 m-80 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' A' ' 138' ' ' ALA . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.449 HD21 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.571 ' HG3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.447 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.755 0.312 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 70' ' ' LEU . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 103' ' ' VAL . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.655 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 169' ' ' PHE . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 130' ' ' ILE . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 167' ' ' HIS . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 163' ' ' GLN . 0.5 OUTLIER -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.541 ' H ' HD21 ' A' ' 119' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.502 0.191 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.6 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.703 0.287 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.569 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 137' ' ' GLY . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.423 ' HE2' ' H ' ' A' ' 140' ' ' ASN . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' H ' ' HE2' ' A' ' 136' ' ' PHE . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.471 HD23 ' HE3' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.462 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.462 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.6 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.569 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.685 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG13 HD22 ' A' ' 102' ' ' ASN . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.572 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 82' ' ' MET . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' HD22 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.619 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.519 ' HE3' ' HB3' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.546 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.933 0.397 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.444 ' ND2' HD21 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.444 HD21 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HD22 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 137' ' ' GLY . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.576 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' ' HB1' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 111' ' ' LEU . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.559 ' HG2' HG22 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.682 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.544 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.522 HG21 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.539 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.749 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.539 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.603 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 16.4 ptpt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HB ' HD22 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.453 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.572 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HG3' HD22 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.667 HG13 HG23 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' HD11 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.543 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' HG21 ' A' ' 160' ' ' VAL . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 158' ' ' LYS . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.553 ' H ' HD12 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.63 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.515 ' HB3' HG22 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.695 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.9 ptpt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 111.238 0.088 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.543 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.596 HG21 HD11 ' A' ' 130' ' ' ILE . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.596 HD11 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 137' ' ' GLY . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.63 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.538 ' HG2' HD22 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.531 HD13 ' HE3' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 23.2 t-20 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 103' ' ' VAL . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' HG2' ' A' ' 123' ' ' MET . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.175 0.512 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.7 p30 -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.652 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HB2' HD23 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 87' ' ' ARG . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 156' ' ' ASN . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.531 ' HE3' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.458 HD23 ' HE3' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 127' ' ' LEU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.604 HG11 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HB3' HD22 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.507 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 p -64.81 -29.51 70.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.091 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.84 -20.73 66.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.554 0.742 . . . . 0.0 111.197 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -97.39 -56.55 2.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 110.53 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.26 -39.63 20.62 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.89 -30.97 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.636 . . . . 0.0 109.322 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.12 103.02 0.7 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.782 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m -144.33 149.69 36.6 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.073 0.949 . . . . 0.0 108.729 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.454 ' H ' HD13 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' HD22 ' A' ' 102' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.9 -4.66 8.89 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -177.07 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.001 0.92 . . . . 0.0 110.492 -168.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -53.79 103.17 0.35 Allowed Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 125.101 1.36 . . . . 0.0 112.23 -167.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.88 -52.43 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.749 2.299 . . . . 0.0 113.681 -169.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -84.27 -18.7 35.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.929 0.492 . . . . 0.0 110.698 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.01 67.79 0.74 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? -70.56 -18.39 62.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.599 HD22 ' HG3' ' A' ' 81' ' ' GLU . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD22 HD12 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HG3' HG21 ' A' ' 68' ' ' VAL . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.52 ' HG2' HD11 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.551 HH21 HG23 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.0 m -64.47 -19.43 65.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.941 0.896 . . . . 0.0 112.974 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.74 -41.51 83.31 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.41 0.624 . . . . 0.0 109.921 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.2 -7.06 59.46 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.982 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -131.09 37.25 3.77 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.951 0.9 . . . . 0.0 109.715 -171.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.6 -28.21 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -97.55 132.87 42.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.737 0.815 . . . . 0.0 109.759 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m -77.06 128.24 34.11 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.546 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 138' ' ' ALA . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.461 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.34 -7.44 4.99 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.41 13.07 0.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 122.412 0.285 . . . . 0.0 111.634 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 10.2 m120 -107.24 100.2 31.74 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.227 0.611 . . . . 0.0 109.867 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.56 -44.59 4.3 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.755 2.304 . . . . 0.0 113.352 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -88.22 -32.01 18.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.108 0.563 . . . . 0.0 111.848 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -101.0 88.83 3.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.31 0.644 . . . . 0.0 110.707 -172.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.49 -19.07 56.46 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.551 HG22 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.591 ' HD1' HD13 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.3 m -64.01 -18.16 64.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.51 0.724 . . . . 0.0 112.006 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.01 -49.72 76.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 110.568 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.38 -27.45 19.33 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.658 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 69.15 5.52 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.399 0.618 . . . . 0.0 109.661 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.63 7.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.916 0.886 . . . . 0.0 112.302 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.41 145.03 48.33 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.921 0.391 . . . . 0.0 110.41 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m -68.03 107.37 2.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.579 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG22 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -100.71 -0.7 0.62 Allowed 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -132.17 -56.51 0.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.058 0.845 . . . . 0.0 112.788 -167.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 1.9 m-20 -79.71 99.76 0.51 Allowed Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 124.338 1.055 . . . . 0.0 110.493 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.41 -47.17 14.98 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.858 2.372 . . . . 0.0 113.313 -166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -82.23 -31.99 29.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.41 0.684 . . . . 0.0 110.418 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 29.3 t70 -90.72 47.62 1.44 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.277 1.031 . . . . 0.0 109.163 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -71.69 -13.1 61.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.038 0.935 . . . . 0.0 113.324 -171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.641 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 30.4 p80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.654 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.579 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -67.55 -23.6 65.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.869 0.468 . . . . 0.0 111.892 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -75.46 -33.54 60.86 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.356 0.662 . . . . 0.0 111.205 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.77 -54.47 4.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.491 0.717 . . . . 0.0 110.965 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.45 73.64 10.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.01 -27.66 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.552 0.741 . . . . 0.0 111.334 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.62 132.55 36.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.112 0.565 . . . . 0.0 110.309 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m -80.71 104.75 11.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.443 ' HB3' HG22 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.515 HG12 HD22 ' A' ' 102' ' ' ASN . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.477 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo -81.11 -8.92 12.97 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -164.21 -42.49 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.111 0.964 . . . . 0.0 109.038 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.38 101.39 0.25 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 125.231 1.412 . . . . 0.0 112.684 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.23 -15.02 6.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.365 2.043 . . . . 0.0 112.256 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -83.1 -30.8 27.66 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.149 0.979 . . . . 0.0 109.629 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -126.63 98.48 5.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.82 -13.67 61.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.26 0.624 . . . . 0.0 110.487 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.515 HD22 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.547 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 170' ' ' LYS . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 137' ' ' GLY . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.507 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD23 ' HE3' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.502 HH11 HG21 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 156' ' ' ASN . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -67.31 -35.28 79.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.276 1.03 . . . . 0.0 112.292 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -67.46 -18.32 65.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.294 0.638 . . . . 0.0 111.677 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -84.21 -34.23 23.96 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.344 0.658 . . . . 0.0 110.083 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -74.38 -14.5 60.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.178 0.591 . . . . 0.0 112.254 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.1 9.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -89.88 150.25 22.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 111.451 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -123.32 106.6 10.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.571 1.148 . . . . 0.0 108.273 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.724 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.586 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.78 -3.07 6.45 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -164.91 -38.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.9 0.48 . . . . 0.0 110.936 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 14.2 m120 -67.01 102.0 0.34 Allowed Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 124.214 1.006 . . . . 0.0 111.37 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.07 -35.34 3.14 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.172 1.915 . . . . 0.0 113.169 -170.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -81.32 -41.12 22.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.967 0.507 . . . . 0.0 109.802 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.9 m-20 -85.41 68.66 10.54 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.103 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.84 -29.18 68.25 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.808 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.682 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 99' ' ' LYS . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.724 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.667 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 134' ' ' VAL . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.445 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 167' ' ' HIS . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.633 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 CA-C-O 120.235 -0.203 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 p -63.75 -37.15 86.28 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.36 -36.14 81.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.176 0.591 . . . . 0.0 110.779 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.45 -23.87 27.66 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.73 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.8 -32.67 27.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.939 0.895 . . . . 0.0 111.71 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.37 0.1 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.184 0.594 . . . . 0.0 112.522 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.51 102.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m -82.08 141.7 32.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.912 0.885 . . . . 0.0 111.688 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' HG13 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG13 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.71 -10.22 17.05 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -76.25 -35.67 58.86 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 2.9 m-20 -108.26 97.5 22.55 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 0.0 110.893 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.38 -25.04 7.27 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.375 2.05 . . . . 0.0 112.424 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -85.27 -5.57 59.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.693 0.797 . . . . 0.0 111.413 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 16.7 m-20 -122.93 93.06 3.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.113 0.565 . . . . 0.0 109.663 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -67.34 -31.65 72.05 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.019 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HB2' HD22 ' A' ' 115' ' ' LEU . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 160' ' ' VAL . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.501 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 68.5 m -68.9 -5.48 21.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 112.142 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.12 -38.86 92.59 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.576 1.15 . . . . 0.0 109.752 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.36 -39.16 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.38 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 31.1 mt-10 -80.7 23.24 0.54 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.084 0.954 . . . . 0.0 111.871 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -75.36 -29.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.937 -0.477 . . . . 0.0 111.438 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -88.39 134.84 33.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.316 0.646 . . . . 0.0 111.574 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -76.15 103.51 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.977 0.911 . . . . 0.0 109.622 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.664 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.35 -21.75 34.96 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -83.98 -23.11 31.19 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 25.7 m-80 -108.61 98.56 29.14 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.474 0.71 . . . . 0.0 112.279 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.19 -39.39 3.04 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.96 -34.94 19.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.706 0.803 . . . . 0.0 111.382 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 7.9 m-20 -87.92 63.46 7.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.595 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 25.7 pttm -75.07 -9.4 58.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.961 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' HD21 ' A' ' 101' ' ' ASN . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.482 HD21 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.488 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.595 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.578 HG12 HG13 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.432 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' GLY . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.607 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' HD22 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m -85.55 -23.97 27.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 0.0 112.704 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.75 -37.84 88.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 120.866 0.365 . . . . 0.0 111.939 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.34 -8.93 56.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.734 0.814 . . . . 0.0 112.786 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -136.58 27.86 3.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.851 0.86 . . . . 0.0 110.681 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.49 -28.13 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 122.659 0.384 . . . . 0.0 110.942 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.61 124.57 28.31 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.716 0.806 . . . . 0.0 110.228 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m -85.09 137.79 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 109.593 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 171' ' ' LEU . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' TYR . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 74' ' ' THR . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.44 -18.8 17.53 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -91.57 -24.71 19.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.994 0.918 . . . . 0.0 110.362 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 47.6 m-80 -106.76 97.19 16.38 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.339 0.656 . . . . 0.0 110.8 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.22 -39.76 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.382 2.055 . . . . 0.0 113.042 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.16 -34.15 26.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.454 0.702 . . . . 0.0 110.596 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.5 m-20 -80.32 75.63 7.14 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 166.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -75.99 -9.82 58.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.671 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 76.2 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD23 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.546 HG12 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.583 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.416 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.447 ' HG2' HD22 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 111' ' ' LEU . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.8 p -72.95 -9.46 58.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.72 0.808 . . . . 0.0 112.211 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.18 -52.8 64.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.147 0.498 . . . . 0.0 109.763 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.12 -14.91 40.01 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.254 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -127.18 92.39 3.51 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.186 0.517 . . . . 0.0 111.322 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.07 3.69 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.98 0.912 . . . . 0.0 109.402 165.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.68 117.99 23.02 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.244 1.018 . . . . 0.0 111.006 -168.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -86.41 132.92 33.83 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 165.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG22 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -86.36 -11.44 6.12 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -140.35 -53.35 0.51 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.282 1.033 . . . . 0.0 110.74 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -53.72 108.67 1.18 Allowed Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.99 1.316 . . . . 0.0 113.145 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.24 -52.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.33 2.02 . . . . 0.0 112.868 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -85.81 -25.05 26.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.172 0.989 . . . . 0.0 110.792 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -107.95 40.16 1.79 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.377 1.071 . . . . 0.0 108.346 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -63.37 -27.53 69.37 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.137 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.608 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.488 HG12 HG23 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.525 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.742 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 CA-C-O 119.688 -0.507 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -60.78 -43.5 97.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 0.0 112.055 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.83 -37.11 78.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.743 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.36 -45.15 61.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.491 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.56 16.87 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.85 -29.46 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.978 0.511 . . . . 0.0 110.846 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.87 148.15 25.94 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -111.12 166.62 10.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 109.201 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 -23.34 20.95 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.71 -22.09 34.61 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.225 0.61 . . . . 0.0 110.672 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 16.8 m-80 -99.52 93.91 2.58 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.56 -52.75 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.997 1.798 . . . . 0.0 113.223 -168.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -87.44 -30.6 20.56 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.11 0.564 . . . . 0.0 110.543 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 13.6 t70 -76.7 77.37 3.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.017 0.913 . . . . 0.0 109.395 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.22 -12.85 60.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.928 1.291 . . . . 0.0 112.284 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.646 HG12 HG13 ' A' ' 160' ' ' VAL . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE1' HG11 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 26.4 p -64.66 -23.09 67.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.064 0.946 . . . . 0.0 112.817 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.3 -44.28 95.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.03 0.932 . . . . 0.0 110.57 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -85.49 -18.76 32.57 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.012 0.925 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 6.7 tp10 -80.54 0.31 34.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.674 1.189 . . . . 0.0 111.992 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.0 -17.96 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.134 0.574 . . . . 0.0 112.265 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -102.84 127.92 49.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.84 0.856 . . . . 0.0 109.973 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -78.64 118.32 20.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -88.84 -15.75 2.53 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -162.48 24.86 0.1 Allowed 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -167.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 15.2 m120 -109.13 96.76 22.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.341 171.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.27 -40.07 85.18 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.582 . . . . 0.0 113.406 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -90.54 -43.82 9.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.29 0.636 . . . . 0.0 111.548 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.3 m-20 -87.77 78.9 8.31 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.128 0.49 . . . . 0.0 112.111 -168.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -23.15 64.64 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 170.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.619 HD13 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.545 ' HB2' HD22 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.619 ' SD ' HD13 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' A' ' 123' ' ' MET . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.587 HD21 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 136' ' ' PHE . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -58.56 -36.04 73.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.127 0.971 . . . . 0.0 112.917 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.89 -35.94 82.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.087 0.555 . . . . 0.0 111.186 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -76.26 -31.77 58.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.814 0.845 . . . . 0.0 110.659 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -96.57 17.23 16.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.477 1.111 . . . . 0.0 111.978 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.58 -24.8 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.666 0.386 . . . . 0.0 111.029 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.49 102.26 2.18 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.263 0.625 . . . . 0.0 109.717 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m -85.91 131.32 34.32 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.829 0.852 . . . . 0.0 109.804 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.571 HD22 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.533 ' HB ' HG22 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo -75.58 -11.4 20.44 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -79.16 -22.93 44.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.98 0.512 . . . . 0.0 110.358 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 6.2 m-20 -108.04 95.61 15.62 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.462 0.705 . . . . 0.0 109.864 175.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.27 -34.0 3.07 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.464 2.11 . . . . 0.0 112.453 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -80.09 -32.85 39.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.487 1.115 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 25.2 t70 -102.76 93.37 5.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.259 0.552 . . . . 0.0 109.725 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.44 -15.17 60.91 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.917 0.887 . . . . 0.0 110.857 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.532 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.543 HG22 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 35.4 m-80 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' A' ' 138' ' ' ALA . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.449 HD21 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.571 ' HG3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.447 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.6 p -75.23 -16.55 60.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.704 0.802 . . . . 0.0 112.038 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -80.7 -30.71 36.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.005 0.922 . . . . 0.0 110.697 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.46 -55.12 4.04 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.855 0.862 . . . . 0.0 109.251 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -89.28 63.72 6.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.897 1.279 . . . . 0.0 108.821 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.29 -38.0 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.267 0.627 . . . . 0.0 111.097 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.48 142.39 50.09 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.934 0.893 . . . . 0.0 108.824 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m -64.4 136.52 57.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.601 0.76 . . . . 0.0 110.703 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 70' ' ' LEU . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 103' ' ' VAL . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -86.29 -8.54 7.5 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -95.6 -35.04 11.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.897 0.879 . . . . 0.0 110.553 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -103.17 104.76 42.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.917 0.887 . . . . 0.0 110.532 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.47 -36.16 12.09 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.671 2.248 . . . . 0.0 112.267 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -82.48 -34.19 28.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.572 0.749 . . . . 0.0 111.091 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.83 59.85 0.74 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.817 0.818 . . . . 0.0 109.551 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.47 -22.82 65.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.024 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.655 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 169' ' ' PHE . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 130' ' ' ILE . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 167' ' ' HIS . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 163' ' ' GLN . 0.5 OUTLIER -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.541 ' H ' HD21 ' A' ' 119' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 CA-C-O 119.585 -0.564 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 55' ' ' VAL . 21.7 m -57.23 -40.39 77.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.319 1.048 . . . . 0.0 113.262 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.78 -32.94 60.75 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.154 0.582 . . . . 0.0 111.979 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.25 -7.55 24.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.416 1.087 . . . . 0.0 110.853 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 39.9 tt0 -108.84 -9.76 15.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.014 0.925 . . . . 0.0 111.769 -174.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' SER . 15.6 m -81.0 20.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -98.68 146.17 26.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.884 0.874 . . . . 0.0 109.366 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -67.36 119.68 12.6 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.079 0.552 . . . . 0.0 110.579 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.6 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.99 -39.47 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -169.2 17.98 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.563 0.745 . . . . 0.0 110.506 -172.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 17.9 m120 -104.79 98.78 16.04 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 123.792 0.837 . . . . 0.0 109.457 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.67 -44.59 25.47 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.457 2.771 . . . . 0.0 114.189 -166.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.77 -21.85 26.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.179 0.592 . . . . 0.0 111.026 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 28.0 m-20 -93.93 64.77 3.43 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 109.761 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.35 -24.94 63.06 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.575 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.569 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 137' ' ' GLY . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.423 ' HE2' ' H ' ' A' ' 140' ' ' ASN . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' H ' ' HE2' ' A' ' 136' ' ' PHE . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.471 HD23 ' HE3' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.462 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.462 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.6 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.569 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.685 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 41.1 p -54.34 -25.34 23.52 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.36 1.064 . . . . 0.0 113.698 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.37 -55.4 35.21 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.209 1.003 . . . . 0.0 111.305 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -5.47 48.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.108 0.563 . . . . 0.0 111.415 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 28.6 tt0 -90.96 21.81 3.99 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.517 0.727 . . . . 0.0 110.878 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.34 -4.09 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.792 0.837 . . . . 0.0 112.222 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.1 109.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.763 0.825 . . . . 0.0 111.589 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -105.15 117.71 34.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.494 1.118 . . . . 0.0 108.767 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG13 HD22 ' A' ' 102' ' ' ASN . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.572 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -104.31 4.27 0.31 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -158.28 -44.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -58.5 103.02 0.33 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 124.648 1.179 . . . . 0.0 111.451 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.56 -44.85 12.8 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.154 2.569 . . . . 0.0 113.902 -163.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -89.25 -44.88 9.95 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.181 0.593 . . . . 0.0 110.89 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.05 85.25 6.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 -168.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -75.6 -14.8 60.4 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.295 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 82' ' ' MET . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 0.0 OUTLIER -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' HD22 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.619 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.519 ' HE3' ' HB3' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 p -74.56 -12.83 60.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.036 0.935 . . . . 0.0 111.844 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.17 -28.84 69.08 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.196 0.599 . . . . 0.0 111.049 174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -68.4 -16.37 63.89 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 0.0 111.527 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 49.0 mt-10 -109.22 16.1 22.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.35 1.06 . . . . 0.0 111.727 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.85 0.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.95 129.44 56.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.109 0.964 . . . . 0.0 108.822 169.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -76.48 116.11 16.86 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.546 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -85.16 -6.81 9.27 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.0 -32.22 30.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.306 0.643 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -98.66 105.58 31.36 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.629 0.771 . . . . 0.0 109.353 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -48.72 4.64 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.816 2.344 . . . . 0.0 113.193 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -78.72 -31.61 46.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.466 0.706 . . . . 0.0 111.987 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -80.25 79.95 6.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.261 0.553 . . . . 0.0 110.176 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.6 -21.07 60.43 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.309 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.444 ' ND2' HD21 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.444 HD21 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HD22 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 137' ' ' GLY . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.576 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' ' HB1' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 111' ' ' LEU . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -63.14 -28.28 69.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.222 1.009 . . . . 0.0 111.632 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -65.71 -34.22 77.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.704 1.201 . . . . 0.0 111.399 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.08 -27.96 27.9 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.896 0.878 . . . . 0.0 110.075 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -91.94 17.48 9.2 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.657 -174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.03 -32.52 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.67 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 100.9 4.38 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m -73.1 136.2 44.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.577 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.559 ' HG2' HG22 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -86.14 3.58 6.88 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -160.81 -50.51 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.497 0.719 . . . . 0.0 111.069 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -46.73 100.57 0.24 Allowed Pre-proline 0 N--CA 1.495 1.788 0 C-N-CA 125.041 1.336 . . . . 0.0 113.4 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.3 -34.5 27.1 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.44 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.74 -45.68 10.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.93 80.1 8.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -71.76 -14.66 62.06 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.682 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.544 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.522 HG21 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.539 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.749 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.539 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.0 m -74.72 1.76 11.61 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.581 0.752 . . . . 0.0 112.548 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.6 -36.33 18.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.8 -60.06 1.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 111.83 -172.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -85.7 15.79 4.46 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -162.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.15 -26.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.572 0.349 . . . . 0.0 111.085 172.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -87.15 109.14 19.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.51 0.724 . . . . 0.0 109.898 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m -74.66 123.56 25.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.603 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.98 -19.29 13.98 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -72.96 -36.25 67.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 42.0 m-80 -102.78 98.43 11.24 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.058 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.32 -50.57 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.7 2.267 . . . . 0.0 113.267 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -87.2 -31.2 20.46 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.23 0.612 . . . . 0.0 110.832 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 14.3 t70 -74.81 85.19 2.18 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 16.4 ptpt -74.04 -14.5 61.02 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.989 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HB ' HD22 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.453 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.572 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HG3' HD22 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.667 HG13 HG23 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' HD11 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.543 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' HG21 ' A' ' 160' ' ' VAL . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 158' ' ' LYS . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.553 ' H ' HD12 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -71.68 -25.05 61.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.967 0.907 . . . . 0.0 111.504 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.4 -29.95 69.59 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.453 0.701 . . . . 0.0 112.103 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.47 -16.17 61.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.475 0.71 . . . . 0.0 111.813 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 48.7 mt-10 -95.2 48.75 1.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.632 0.773 . . . . 0.0 110.545 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.92 -13.94 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.669 0.388 . . . . 0.0 111.494 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -107.77 129.35 55.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.302 1.041 . . . . 0.0 109.766 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -82.73 132.5 35.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.63 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.515 ' HB3' HG22 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 -17.76 13.62 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -78.78 -41.83 29.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -107.53 99.49 29.02 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.022 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.65 -31.3 2.03 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.358 2.039 . . . . 0.0 112.951 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.97 -41.81 41.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.293 0.637 . . . . 0.0 110.222 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.32 95.89 9.36 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.695 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.9 ptpt -76.2 -17.3 59.59 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.238 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.543 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.596 HG21 HD11 ' A' ' 130' ' ' ILE . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.596 HD11 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 137' ' ' GLY . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.63 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.538 ' HG2' HD22 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.2 p -55.1 -48.11 74.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.678 1.191 . . . . 0.0 113.14 -171.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.38 -21.89 55.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 0.0 112.081 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.43 -43.61 17.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.371 0.669 . . . . 0.0 111.161 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.75 28.63 1.29 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.304 0.642 . . . . 0.0 111.89 -171.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.14 -21.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.218 0.607 . . . . 0.0 110.465 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.87 125.57 29.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.381 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -77.05 148.11 36.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.531 HD13 ' HE3' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 23.2 t-20 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 103' ' ' VAL . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' HG2' ' A' ' 123' ' ' MET . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.07 -14.8 18.76 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.39 -42.99 9.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.512 0.725 . . . . 0.0 110.263 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 6.0 m-20 -84.85 107.71 12.53 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.039 0.936 . . . . 0.0 110.455 -175.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.25 -51.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.58 2.186 . . . . 0.0 113.681 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -87.81 -24.61 23.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.253 0.621 . . . . 0.0 111.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.7 m-20 -85.56 58.58 5.12 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.34 1.067 . . . . 0.0 108.824 168.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -77.44 -15.16 59.48 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.662 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.7 p30 -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.652 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HB2' HD23 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 87' ' ' ARG . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 156' ' ' ASN . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.531 ' HE3' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.458 HD23 ' HE3' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 127' ' ' LEU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.604 HG11 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HB3' HD22 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.507 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.239 0.525 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.454 ' H ' HD13 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' HD22 ' A' ' 102' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.599 HD22 ' HG3' ' A' ' 81' ' ' GLU . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.515 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD22 HD12 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HG3' HG21 ' A' ' 68' ' ' VAL . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.52 ' HG2' HD11 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.551 HH21 HG23 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.546 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 138' ' ' ALA . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.461 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.598 0.237 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.551 HG22 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.591 ' HD1' HD13 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 120.603 0.239 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG22 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo . . . . . 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.641 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 40.1 p-80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.654 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.579 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.443 ' HB3' HG22 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.515 HG12 HD22 ' A' ' 102' ' ' ASN . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.477 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.847 0.355 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.515 HD22 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.547 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 170' ' ' LYS . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 137' ' ' GLY . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.507 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD23 ' HE3' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.502 HH11 HG21 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 156' ' ' ASN . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.724 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.586 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.682 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 99' ' ' LYS . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.724 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.667 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 134' ' ' VAL . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.445 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 167' ' ' HIS . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.633 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 121.133 0.492 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' HG13 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG13 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.584 HD22 ' HA ' ' A' ' 107' ' ' GLN . 11.8 m120 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.584 ' HA ' HD22 ' A' ' 101' ' ' ASN . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HB2' HD22 ' A' ' 115' ' ' LEU . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 160' ' ' VAL . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.501 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.664 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.595 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 25.7 pttm . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.395 0.14 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' HD21 ' A' ' 101' ' ' ASN . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.482 HD21 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.572 ' H ' ' NE2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.488 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.595 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.578 HG12 HG13 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.432 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' GLY . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.416 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.607 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' HD22 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 171' ' ' LEU . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' TYR . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 74' ' ' THR . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 120.491 0.186 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 23.8 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD23 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.546 HG12 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.583 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.416 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.447 ' HG2' HD22 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 111' ' ' LEU . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG22 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.608 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.488 HG12 HG23 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.525 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.742 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.646 HG12 HG13 ' A' ' 160' ' ' VAL . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE1' HG11 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.177 0.513 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.619 HD13 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.545 ' HB2' HD22 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.619 ' SD ' HD13 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' A' ' 123' ' ' MET . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.587 HD21 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 136' ' ' PHE . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.571 HD22 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.533 ' HB ' HG22 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo . . . . . 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.684 0.278 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.532 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.543 HG22 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 18.3 m120 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' A' ' 138' ' ' ALA . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.449 HD21 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.571 ' HG3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.447 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG2' HD22 ' A' ' 156' ' ' ASN . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.57 HD22 ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.755 0.312 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 70' ' ' LEU . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 103' ' ' VAL . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.655 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 169' ' ' PHE . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 167' ' ' HIS . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 130' ' ' ILE . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.537 ' HA ' ' CE1' ' A' ' 167' ' ' HIS . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 164' ' ' LEU . 2.2 p80 -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.541 ' H ' HD21 ' A' ' 119' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.502 0.191 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.6 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 89' ' ' PRO . 29.0 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.445 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . 92.0 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.703 0.287 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.569 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 137' ' ' GLY . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.423 ' HE2' ' H ' ' A' ' 140' ' ' ASN . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' H ' ' HE2' ' A' ' 136' ' ' PHE . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.471 HD23 ' HE3' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.462 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.462 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.6 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.569 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.685 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.491 ' HB2' HE22 ' A' ' 107' ' ' GLN . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG13 HD22 ' A' ' 102' ' ' ASN . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.572 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 82' ' ' MET . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 5.0 pp0? -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' HD22 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.619 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.519 ' HE3' ' HB3' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.546 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 120.933 0.397 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.444 ' ND2' HD21 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.444 HD21 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HD22 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 137' ' ' GLY . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.576 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' ' HB1' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 111' ' ' LEU . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.559 ' HG2' HG22 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.682 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.544 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.522 HG21 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.539 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.749 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.539 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.603 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 16.4 ptpt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HB ' HD22 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.453 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.572 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HG3' HD22 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.667 HG13 HG23 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' HD11 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.543 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' HG21 ' A' ' 160' ' ' VAL . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 158' ' ' LYS . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.553 ' H ' HD12 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.63 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.515 ' HB3' HG22 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.695 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.9 ptpt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 111.238 0.088 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.543 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.596 HG21 HD11 ' A' ' 130' ' ' ILE . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.596 HD11 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 137' ' ' GLY . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.63 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.538 ' HG2' HD22 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.531 HD13 ' HE3' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 8.0 t30 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 103' ' ' VAL . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' HG2' ' A' ' 123' ' ' MET . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.175 0.512 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.652 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HB2' HD23 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 87' ' ' ARG . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 156' ' ' ASN . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 142' ' ' PHE . 41.2 t30 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.516 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.531 ' HE3' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.458 HD23 ' HE3' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 127' ' ' LEU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.604 HG11 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 169' ' ' PHE . 42.4 t60 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HB3' HD22 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.507 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 p -64.81 -29.51 70.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.091 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.84 -20.73 66.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.554 0.742 . . . . 0.0 111.197 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -97.39 -56.55 2.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 110.53 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.26 -39.63 20.62 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.89 -30.97 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.636 . . . . 0.0 109.322 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.12 103.02 0.7 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.782 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.6 m -144.33 149.69 36.6 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.073 0.949 . . . . 0.0 108.729 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 157' ' ' ARG . 16.6 m -94.33 160.34 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -77.48 125.51 29.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.772 0.429 . . . . 0.0 110.056 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.66 -43.1 23.4 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.921 0.888 . . . . 0.0 108.925 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.13 -161.32 28.45 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.885 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -113.07 139.31 48.81 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.378 0.671 . . . . 0.0 109.193 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD22 ' HD3' ' A' ' 170' ' ' LYS . 38.2 mt -111.89 146.06 38.42 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 108.434 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -105.88 128.2 53.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.35 0.66 . . . . 0.0 109.357 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.52 -175.93 14.27 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.454 ' H ' HD13 ' A' ' 171' ' ' LEU . 23.7 p-80 -150.58 100.44 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.824 0.849 . . . . 0.0 109.412 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 171' ' ' LEU . 16.8 t -78.38 111.79 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.59 0.356 . . . . 0.0 111.149 -170.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 112' ' ' LYS . 27.4 m -79.26 -25.61 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.355 0.662 . . . . 0.0 111.411 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -16.81 71.36 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 115.186 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 144' ' ' MET . 68.0 mt -52.69 -52.29 56.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.077 0.951 . . . . 0.0 112.539 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.62 3.61 4.82 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.89 0.876 . . . . 0.0 112.926 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -55.44 -58.61 7.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.871 0.869 . . . . 0.0 110.664 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -114.48 -67.23 1.01 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.068 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 76' ' ' VAL . 26.3 p -122.88 -46.41 2.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 66.75 37.83 92.65 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.62 0.575 . . . . 0.0 112.879 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 74' ' ' THR . 33.0 m -125.77 137.25 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 110.197 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 29.1 m -143.59 177.69 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.296 1.038 . . . . 0.0 109.537 172.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 33.0 t30 -69.18 148.89 49.24 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -51.68 -32.3 29.27 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.751 1.22 . . . . 0.0 112.889 -171.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -133.57 63.41 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.267 0.556 . . . . 0.0 109.551 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' HD22 ' A' ' 102' ' ' ASN . 8.9 mm-40 -72.3 174.95 6.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.971 0.891 . . . . 0.0 112.714 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 66.0 mtt -136.46 125.67 24.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.33 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 26.5 m -109.26 134.36 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.651 0.739 . . . . 0.0 111.059 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -99.48 124.1 44.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.642 1.177 . . . . 0.0 108.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.9 mp -85.33 117.63 24.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -114.75 151.22 34.1 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -68.0 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.24 0.616 . . . . 0.0 111.188 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 95' ' ' LYS . 7.7 p-10 -54.58 121.93 36.03 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.581 0.753 . . . . 0.0 111.138 171.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.9 -4.66 8.89 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.812 2.342 . . . . 0.0 112.664 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -177.07 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.001 0.92 . . . . 0.0 110.492 -168.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -53.79 103.17 0.35 Allowed Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 125.101 1.36 . . . . 0.0 112.23 -167.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.88 -52.43 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.749 2.299 . . . . 0.0 113.681 -169.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -84.27 -18.7 35.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.929 0.492 . . . . 0.0 110.698 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.01 67.79 0.74 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 88' ' ' ASP . 9.4 ptmm? -70.56 -18.39 62.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.294 0.569 . . . . 0.0 110.618 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.2 p30 -67.27 -33.33 75.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.091 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.92 104.95 0.51 Allowed 'General case' 0 C--N 1.36 1.044 0 O-C-N 124.194 0.934 . . . . 0.0 111.293 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 111' ' ' LEU . 65.1 mt -81.31 116.4 25.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.744 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -86.72 108.27 18.6 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.178 177.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 85' ' ' LEU . 54.0 t -91.6 135.87 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -138.79 130.8 28.05 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.894 1.277 . . . . 0.0 108.351 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.599 HD22 ' HG3' ' A' ' 81' ' ' GLU . 34.2 p-10 -80.6 167.38 20.14 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.746 0.248 . . . . 0.0 110.502 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.36 -9.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.928 0.491 . . . . 0.0 111.868 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -72.62 -27.28 62.05 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.031 0.532 . . . . 0.0 110.217 168.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.92 13.83 15.12 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 114.122 0.409 . . . . 0.0 114.122 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.515 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -96.59 125.32 40.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.039 0.936 . . . . 0.0 109.235 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.06 60.43 4.86 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.401 0.68 . . . . 0.0 109.429 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.41 -35.9 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.091 0.957 . . . . 0.0 111.807 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.12 157.87 21.65 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.784 -0.189 . . . . 0.0 113.269 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -165.74 136.56 3.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.64 0.776 . . . . 0.0 109.041 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD22 HD12 ' A' ' 98' ' ' ILE . 9.9 mp -79.31 163.1 25.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.827 0.851 . . . . 0.0 110.404 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HG3' HG21 ' A' ' 68' ' ' VAL . 45.7 mtmt -85.29 164.61 17.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 164.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.96 -25.23 67.49 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.634 0.584 . . . . 0.0 112.047 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.9 -52.37 17.63 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.201 0.6 . . . . 0.0 110.293 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.7 mm? -65.28 -53.86 37.84 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.449 0.699 . . . . 0.0 109.649 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -60.51 -29.05 68.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.527 1.131 . . . . 0.0 112.1 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.3 -25.08 59.81 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.21 -58.34 2.62 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.275 0.56 . . . . 0.0 109.667 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.76 -19.35 64.91 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.4 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.86 -36.88 70.56 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 112.613 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.93 -41.66 67.58 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.52 -30.49 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.208 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.0 tpp -76.77 -59.48 2.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.669 1.188 . . . . 0.0 110.724 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.47 -42.89 95.64 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.952 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -90.2 -2.83 58.09 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.414 -177.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 52.74 43.85 30.89 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.788 1.235 . . . . 0.0 111.775 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.65 -37.77 87.46 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.523 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 151' ' ' TRP . . . -154.62 166.59 32.89 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 64.2 mm-40 -102.34 129.79 48.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.529 0.732 . . . . 0.0 109.2 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.02 100.33 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 117.18 34.29 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.98 149.28 19.29 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 60.6 t -140.81 137.4 35.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.957 1.303 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 137' ' ' GLY . 60.1 t -114.82 91.33 25.59 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 0.0 110.112 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.22 -15.56 14.33 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.327 2.018 . . . . 0.0 112.257 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.7 -31.29 70.27 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 75.54 4.15 74.24 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.16 62.27 2.27 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.672 0.789 . . . . 0.0 110.924 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -65.05 -33.37 75.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.598 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -118.47 146.75 44.26 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.811 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . . . -66.49 -20.33 66.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.844 0.858 . . . . 0.0 111.167 175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.04 -179.85 4.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 111.528 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 123.95 22.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.305 0.642 . . . . 0.0 111.589 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.52 ' HG2' HD11 ' A' ' 70' ' ' LEU . 21.6 ptt? -119.99 157.71 52.09 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 124.218 1.007 . . . . 0.0 109.289 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.77 128.75 24.1 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.467 2.111 . . . . 0.0 112.282 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.2 tp -104.25 145.42 30.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.624 0.769 . . . . 0.0 109.112 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -112.74 105.35 13.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.23 111.8 24.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.76 113.2 20.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -94.85 126.38 40.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.083 -169.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 61.2 m95 -115.96 168.49 10.03 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.915 1.286 . . . . 0.0 108.592 176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.25 177.36 35.21 Favored Glycine 0 N--CA 1.473 1.104 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -116.61 153.57 32.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.419 0.61 . . . . 0.0 110.753 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.05 -44.31 51.55 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.755 1.222 . . . . 0.0 112.363 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -53.93 -41.79 68.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -92.75 -18.36 23.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.51 0.724 . . . . 0.0 111.856 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.551 HH21 HG23 ' A' ' 58' ' ' VAL . 23.3 mmt180 -51.57 -39.82 58.57 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.814 0.846 . . . . 0.0 112.372 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.17 -55.01 39.03 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.601 0.563 . . . . 0.0 111.024 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.16 95.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.486 0.714 . . . . 0.0 111.983 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.94 -58.12 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.412 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -60.92 -36.27 78.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.535 0.734 . . . . 0.0 110.798 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.37 -48.86 75.98 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.597 0.561 . . . . 0.0 110.092 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -66.61 -36.54 82.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.967 0.907 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.43 -43.18 86.37 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.312 0.645 . . . . 0.0 111.627 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -29.1 31.62 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.845 0.458 . . . . 0.0 112.108 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -69.6 -54.81 12.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.822 0.449 . . . . 0.0 110.444 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -79.83 -37.15 35.67 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.39 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.17 31.3 55.47 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.165 -0.471 . . . . 0.0 113.706 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 75.2 m-85 -128.08 131.48 49.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.42 0.688 . . . . 0.0 111.05 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HD3' HD22 ' A' ' 63' ' ' LEU . 62.2 mttp -136.02 128.75 30.89 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.298 1.039 . . . . 0.0 110.035 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 67' ' ' VAL . 18.0 tp . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.722 1.209 . . . . 0.0 108.619 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.0 m -64.47 -19.43 65.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.941 0.896 . . . . 0.0 112.974 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.74 -41.51 83.31 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.41 0.624 . . . . 0.0 109.921 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.2 -7.06 59.46 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.982 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -131.09 37.25 3.77 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.951 0.9 . . . . 0.0 109.715 -171.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.6 -28.21 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.818 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -97.55 132.87 42.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.737 0.815 . . . . 0.0 109.759 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 m -77.06 128.24 34.11 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.19 150.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.092 0.472 . . . . 0.0 111.132 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.4 tp -83.05 109.67 17.32 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -69.69 -35.6 75.24 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.36 -161.02 31.39 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.273 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.2 p -121.94 134.84 54.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.708 0.803 . . . . 0.0 110.773 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 96.2 mt -97.04 161.16 13.95 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 109.51 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -147.64 11.65 0.99 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -165.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -70.36 172.12 42.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 -171.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -103.63 134.64 46.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.37 0.668 . . . . 0.0 112.181 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.8 116.1 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 110.525 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -90.1 -12.36 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.947 0.899 . . . . 0.0 110.468 168.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.08 -14.91 57.57 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 124.64 1.114 . . . . 0.0 115.862 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.546 HD11 ' HG2' ' A' ' 144' ' ' MET . 82.4 mt -54.26 -21.5 9.32 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -85.57 8.15 20.45 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.896 0.478 . . . . 0.0 112.151 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -60.69 -67.38 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.974 0.509 . . . . 0.0 111.044 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -115.74 -69.4 0.86 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.4 p -124.69 -45.72 1.9 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.845 0.858 . . . . 0.0 109.698 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.47 -20.13 4.38 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.327 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.31 129.12 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.753 0.821 . . . . 0.0 109.388 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 138' ' ' ALA . 11.6 m -137.65 -173.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.888 0.875 . . . . 0.0 110.577 -173.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.17 152.7 36.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.18 -30.0 68.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.783 0.433 . . . . 0.0 112.111 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.11 29.49 7.94 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.409 0.684 . . . . 0.0 109.662 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 10.3 tp10 -55.43 149.41 13.4 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.872 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.461 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.8 mtt -120.08 134.54 55.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 108' ' ' VAL . 35.4 m -125.55 175.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.017 0.927 . . . . 0.0 110.776 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.14 140.79 23.48 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.645 0.778 . . . . 0.0 109.513 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 111' ' ' LEU . 7.9 mp -94.8 130.61 41.29 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.314 0.645 . . . . 0.0 109.745 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -130.66 151.07 51.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.075 1.35 . . . . 0.0 108.617 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -68.24 -170.77 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.874 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 7.0 p-10 -55.36 112.99 4.79 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.459 1.104 . . . . 0.0 111.655 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.34 -7.44 4.99 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.41 2.074 . . . . 0.0 113.182 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.41 13.07 0.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 122.412 0.285 . . . . 0.0 111.634 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 10.2 m120 -107.24 100.2 31.74 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.227 0.611 . . . . 0.0 109.867 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.56 -44.59 4.3 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.755 2.304 . . . . 0.0 113.352 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -88.22 -32.01 18.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.108 0.563 . . . . 0.0 111.848 -175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -101.0 88.83 3.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.31 0.644 . . . . 0.0 110.707 -172.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.49 -19.07 56.46 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.133 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.32 -0.75 38.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 0.0 110.815 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 104.95 3.03 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.4 mt -110.89 108.0 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.51 135.46 34.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.299 0.639 . . . . 0.0 109.958 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.551 HG22 ' HG ' ' A' ' 85' ' ' LEU . 38.8 t -102.72 127.29 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.465 0.706 . . . . 0.0 109.416 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -125.03 147.34 49.0 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.435 0.694 . . . . 0.0 109.566 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -81.75 179.38 7.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 82' ' ' MET . 27.4 m -60.31 -29.95 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.16 -32.32 63.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.711 0.404 . . . . 0.0 110.592 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.8 -0.59 23.08 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.493 -0.615 . . . . 0.0 114.069 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.72 139.72 58.39 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.331 0.652 . . . . 0.0 110.195 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.27 88.58 3.11 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 83' ' ' VAL . 3.9 p -71.77 -40.62 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.395 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.2 -170.67 20.36 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -157.46 127.61 6.28 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 108.017 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.6 tt -68.15 136.9 54.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.708 1.203 . . . . 0.0 109.939 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mmmt -59.76 118.3 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.62 1.168 . . . . 0.0 110.342 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -57.57 -28.1 63.26 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.305 0.642 . . . . 0.0 111.989 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.32 -37.27 86.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.312 1.045 . . . . 0.0 111.312 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' HD1' ' A' ' 169' ' ' PHE . 2.9 mm? -86.67 -35.82 19.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.773 0.829 . . . . 0.0 109.079 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -60.08 -18.24 45.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.674 1.19 . . . . 0.0 112.399 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.08 -28.08 40.24 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 120.146 -0.252 . . . . 0.0 113.134 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.3 -47.89 6.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.104 0.961 . . . . 0.0 110.439 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 3.9 mm? -63.65 -19.57 64.99 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.934 0.894 . . . . 0.0 112.296 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.7 -33.8 76.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.541 0.736 . . . . 0.0 110.906 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.91 -36.88 75.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.353 0.661 . . . . 0.0 110.562 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.0 mp -66.79 -43.32 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.227 0.537 . . . . 0.0 110.063 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 57.2 tpp -74.91 -43.7 52.8 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.231 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.92 -55.3 5.25 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.545 0.738 . . . . 0.0 111.293 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -76.9 -4.67 45.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.042 0.537 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? 61.47 41.74 12.3 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 124.274 1.03 . . . . 0.0 111.968 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.63 -39.6 88.84 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.751 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.21 169.73 7.65 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.792 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -95.75 146.27 24.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.772 1.229 . . . . 0.0 109.449 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.19 102.23 13.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -84.74 147.82 26.69 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -135.01 163.4 24.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 112.601 -0.199 . . . . 0.0 112.601 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 82' ' ' MET . 98.1 t -147.29 134.28 13.72 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 C-N-CA 125.55 1.54 . . . . 0.0 108.007 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 29.3 t -107.74 91.63 7.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 108.859 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.56 -11.24 17.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.561 2.174 . . . . 0.0 111.298 168.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.82 -23.4 59.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.37 1.068 . . . . 0.0 111.285 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 80.43 -8.38 53.94 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.966 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 54.7 38.74 30.58 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 -173.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.71 -20.47 65.27 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.555 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.18 132.55 33.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.265 1.026 . . . . 0.0 109.61 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.09 -21.56 33.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.302 0.572 . . . . 0.0 109.502 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -77.32 -177.0 4.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.477 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 m -71.39 136.65 47.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.749 0.42 . . . . 0.0 110.848 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.546 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -134.5 160.9 66.7 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.64 168.32 23.02 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.709 1.606 . . . . 0.0 111.747 164.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.0 tp -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -111.45 106.41 15.3 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 27.5 mtm -115.42 148.64 39.13 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.211 1.004 . . . . 0.0 109.718 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -114.43 128.71 56.48 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 160' ' ' VAL . 30.8 t80 -95.8 112.42 24.15 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.641 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -114.69 132.74 56.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.45 -132.49 1.51 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -139.2 162.65 34.45 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.1 0.476 . . . . 0.0 110.874 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 tp10 -68.1 -37.29 81.0 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.249 -163.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.33 -39.46 71.34 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.917 0.389 . . . . 0.0 111.06 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -80.69 -9.91 59.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.499 0.72 . . . . 0.0 112.132 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 154' ' ' GLU . 31.8 mtt180 -48.75 -46.3 40.9 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 123.387 0.43 . . . . 0.0 110.552 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -64.53 -40.6 95.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.157 0.583 . . . . 0.0 111.704 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.19 78.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.987 0.515 . . . . 0.0 111.567 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 5.8 p -74.37 -40.97 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.467 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.9 t -59.16 -45.56 90.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.198 0.599 . . . . 0.0 110.351 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.07 -53.78 54.48 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.54 -39.63 70.81 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.125 0.891 . . . . 0.0 112.371 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 170' ' ' LYS . 90.4 mt -64.56 -54.78 26.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.236 0.614 . . . . 0.0 110.938 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -75.26 -32.01 60.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 0.0 112.053 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.12 -47.41 51.41 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.998 0.919 . . . . 0.0 110.371 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.69 -29.78 64.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.657 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.82 27.18 65.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.371 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.591 ' HD1' HD13 ' A' ' 115' ' ' LEU . 71.8 m-85 -142.54 137.79 30.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.982 0.913 . . . . 0.0 110.016 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 164' ' ' LEU . 6.5 ptpp? -159.9 154.43 24.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.996 0.918 . . . . 0.0 109.975 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 7.4 tt . . . . . 0 C--O 1.252 1.23 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.3 m -64.01 -18.16 64.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.51 0.724 . . . . 0.0 112.006 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.01 -49.72 76.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 110.568 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.38 -27.45 19.33 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.658 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 69.15 5.52 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.399 0.618 . . . . 0.0 109.661 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.63 7.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.916 0.886 . . . . 0.0 112.302 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.41 145.03 48.33 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.921 0.391 . . . . 0.0 110.41 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 38.6 m -68.03 107.37 2.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.579 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.43 157.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.573 0.749 . . . . 0.0 110.219 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.1 tp -83.2 120.27 25.6 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.064 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -88.61 -47.28 8.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.18 -167.45 38.67 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.212 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 32.7 p -144.2 134.28 24.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 110.005 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 82.1 mt -92.87 164.84 13.18 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.022 . . . . 0.0 111.293 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -152.31 93.88 1.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.47 -172.05 13.0 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.512 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.89 126.9 44.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.918 0.487 . . . . 0.0 110.634 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 t -94.01 116.43 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.481 0.713 . . . . 0.0 109.277 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -90.37 -20.12 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.6 -16.5 67.75 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.091 -0.959 . . . . 0.0 114.333 -172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 144' ' ' MET . 55.0 mt -43.4 -42.09 4.52 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 125.47 1.508 . . . . 0.0 113.346 -173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -65.66 7.26 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.457 1.103 . . . . 0.0 113.706 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -52.48 -67.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.147 1.379 . . . . 0.0 111.262 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.47 -66.67 1.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -124.28 -45.41 1.97 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.827 0.451 . . . . 0.0 111.616 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.32 -19.06 45.69 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.93 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -81.17 145.22 9.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 122.893 0.477 . . . . 0.0 110.451 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.73 -174.07 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.052 0.941 . . . . 0.0 109.711 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.87 150.54 45.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.968 0.507 . . . . 0.0 110.666 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -43.01 -50.92 5.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.272 1.429 . . . . 0.0 111.627 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.4 70.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 134' ' ' VAL . 12.1 tp10 -71.86 154.61 41.14 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.531 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.463 ' HG2' HG22 ' A' ' 133' ' ' VAL . 88.6 mtp -129.29 118.62 22.59 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 164.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 33.4 m -103.26 171.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.596 0.758 . . . . 0.0 109.875 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.75 17.18 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.754 0.822 . . . . 0.0 108.863 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.94 125.05 30.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.107 0.563 . . . . 0.0 109.545 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -116.31 149.29 39.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 108.221 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.818 0.281 . . . . 0.0 110.591 172.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.51 123.44 85.66 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 122.419 0.287 . . . . 0.0 110.67 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -100.71 -0.7 0.62 Allowed 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 123.694 2.929 . . . . 0.0 114.853 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -132.17 -56.51 0.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.058 0.845 . . . . 0.0 112.788 -167.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 1.9 m-20 -79.71 99.76 0.51 Allowed Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 124.338 1.055 . . . . 0.0 110.493 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.41 -47.17 14.98 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.858 2.372 . . . . 0.0 113.313 -166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -82.23 -31.99 29.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.41 0.684 . . . . 0.0 110.418 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 29.3 t70 -90.72 47.62 1.44 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.277 1.031 . . . . 0.0 109.163 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -71.69 -13.1 61.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.038 0.935 . . . . 0.0 113.324 -171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -80.16 -1.23 39.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.944 0.498 . . . . 0.0 111.147 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.45 103.74 3.02 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.6 mt -91.2 107.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.22 122.37 30.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.047 0.539 . . . . 0.0 110.326 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.9 113.54 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.075 0.95 . . . . 0.0 110.169 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -112.23 136.25 51.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 12.9 p-10 -76.28 179.18 5.93 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.152 0.433 . . . . 0.0 110.778 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.08 -28.5 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.212 0.605 . . . . 0.0 112.198 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.36 -26.4 42.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.246 0.618 . . . . 0.0 111.011 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.7 -15.12 11.49 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.46 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -61.89 116.02 4.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.465 0.706 . . . . 0.0 111.148 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -65.25 105.32 1.09 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.397 0.618 . . . . 0.0 109.986 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.31 -38.62 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.548 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.57 -150.89 8.5 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.945 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.641 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 40.1 p-80 -143.48 171.1 14.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.536 0.734 . . . . 0.0 110.676 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 171' ' ' LEU . 6.4 tp -90.48 152.57 20.89 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 109.284 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB2' HD23 ' A' ' 115' ' ' LEU . 30.4 mmmt -64.8 134.08 53.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -67.47 -24.5 65.61 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.76 0.824 . . . . 0.0 112.33 -172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.41 -53.01 40.56 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.512 0.725 . . . . 0.0 109.492 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.93 -39.01 72.91 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.009 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.32 -20.46 65.51 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.057 . . . . 0.0 110.824 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.24 -23.2 32.46 Favored Glycine 0 C--N 1.354 1.531 0 C-N-CA 123.029 0.347 . . . . 0.0 113.342 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.36 -56.15 2.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.301 0.64 . . . . 0.0 110.189 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.1 mp -62.05 -21.78 65.21 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.08 -28.15 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.203 0.601 . . . . 0.0 111.315 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.63 -30.0 36.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.76 0.824 . . . . 0.0 111.265 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 160' ' ' VAL . 3.0 mp -70.78 -36.41 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.6 tpp -68.89 -45.05 71.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.199 0.999 . . . . 0.0 110.348 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.33 -55.67 12.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.738 -176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.36 -14.8 59.65 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.029 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 62.92 51.44 2.91 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.201 1.001 . . . . 0.0 111.076 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 74.5 mt -76.77 -28.88 55.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.063 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.3 153.98 18.47 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.367 0.667 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -94.56 106.47 18.45 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -92.61 116.11 32.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HB3' ' HZ3' ' A' ' 151' ' ' TRP . 27.0 tt0 -135.3 129.97 34.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.934 0.494 . . . . 0.0 109.787 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -101.45 165.83 18.26 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.846 0.716 . . . . 0.0 113.106 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 82' ' ' MET . 95.9 t -136.51 127.74 42.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 125.257 1.423 . . . . 0.0 107.57 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 31.4 t -108.65 92.64 10.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.51 0.724 . . . . 0.0 109.263 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.52 -9.3 16.09 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.703 2.269 . . . . 0.0 111.391 169.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -70.82 -26.03 63.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.839 1.256 . . . . 0.0 111.208 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 77.83 -7.27 43.26 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.619 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.48 78.91 0.17 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.566 1.146 . . . . 0.0 111.22 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.48 17.56 4.46 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.48 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -165.07 150.42 9.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.897 0.879 . . . . 0.0 109.651 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.4 -20.17 44.59 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.576 0.75 . . . . 0.0 111.918 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -75.55 177.85 6.43 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.541 0.737 . . . . 0.0 109.949 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.6 m -66.38 126.48 28.93 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.188 0.995 . . . . 0.0 112.263 -168.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.654 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.0 ptt? -121.05 162.56 34.72 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.25 1.02 . . . . 0.0 109.158 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 170.86 18.91 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.583 2.188 . . . . 0.0 113.281 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 51.8 tp -157.56 139.17 13.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 108.988 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -107.1 109.66 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.15 0.58 . . . . 0.0 109.742 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.579 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.2 OUTLIER -102.89 164.49 11.59 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.6 m -142.59 143.09 32.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.028 0.531 . . . . 0.0 110.502 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -96.86 118.72 33.91 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 110.205 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 9.6 m-90 -116.09 132.86 56.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 167.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.64 -135.73 1.87 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -147.31 165.1 31.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.464 0.705 . . . . 0.0 109.385 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 38.9 mt-10 -66.3 -34.15 77.33 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -165.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.36 -32.25 69.87 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.4 m-20 -84.67 -24.84 28.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.703 . . . . 0.0 111.613 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 23.0 ptt180 -69.11 -30.58 68.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.13 -39.56 94.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.107 0.963 . . . . 0.0 110.651 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.81 50.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.384 0.674 . . . . 0.0 111.936 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 122' ' ' ILE . 6.3 p -68.46 -35.38 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' A' ' 165' ' ' LYS . 24.7 t -59.61 -58.22 9.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.28 0.632 . . . . 0.0 109.337 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -43.31 -50.61 6.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.428 1.491 . . . . 0.0 111.82 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -70.13 -39.01 75.67 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 123.903 0.752 . . . . 0.0 111.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 170' ' ' LYS . 94.9 mt -71.94 -32.46 67.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.142 0.577 . . . . 0.0 111.806 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 161' ' ' SER . 4.4 mptp? -76.86 -41.45 43.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.705 0.802 . . . . 0.0 109.955 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.3 -51.23 47.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.5 1.12 . . . . 0.0 111.042 -174.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -82.62 -32.91 28.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.75 78.83 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.36 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 66.9 m-85 -94.43 132.02 39.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.266 1.026 . . . . 0.0 110.667 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 164' ' ' LEU . 17.9 ptmt -162.15 116.73 1.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.254 1.022 . . . . 0.0 109.421 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 111' ' ' LEU . 4.6 tt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -67.55 -23.6 65.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.869 0.468 . . . . 0.0 111.892 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -75.46 -33.54 60.86 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.356 0.662 . . . . 0.0 111.205 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.77 -54.47 4.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.491 0.717 . . . . 0.0 110.965 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.45 73.64 10.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.01 -27.66 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.552 0.741 . . . . 0.0 111.334 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.62 132.55 36.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.112 0.565 . . . . 0.0 110.309 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 m -80.71 104.75 11.45 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH11 ' A' ' 157' ' ' ARG . 23.6 m -96.23 167.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.221 0.609 . . . . 0.0 110.271 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 tp -68.86 118.36 11.71 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.049 0.54 . . . . 0.0 109.794 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 75.0 t80 -74.87 -46.91 33.01 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 168.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.5 166.58 19.59 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.815 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 p -110.14 131.87 54.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 117.718 0.759 . . . . 0.0 110.017 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 5.3 mp -100.15 170.27 8.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 0.0 109.427 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -161.01 43.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.905 0.482 . . . . 0.0 110.547 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.02 -174.25 33.67 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.552 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.443 ' HB3' HG22 ' A' ' 143' ' ' THR . 58.1 m80 -122.21 125.46 46.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.973 0.509 . . . . 0.0 110.628 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 143' ' ' THR . 41.6 t -88.48 125.98 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.481 0.712 . . . . 0.0 109.967 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.36 -16.38 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.06 -17.78 77.39 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.659 -171.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 83.1 mt -44.03 -44.53 7.45 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.403 1.081 . . . . 0.0 113.535 -174.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.31 -2.94 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.469 1.508 . . . . 0.0 113.897 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -61.87 -68.55 0.31 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.516 1.126 . . . . 0.0 111.163 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.35 -66.92 1.04 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -100.23 -47.46 4.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.22 0.464 . . . . 0.0 112.07 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 70' ' ' LEU . . . 72.02 2.95 54.66 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.029 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.48 149.44 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.343 1.057 . . . . 0.0 110.429 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.515 HG12 HD22 ' A' ' 102' ' ' ASN . 23.7 m -144.81 -174.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.277 1.431 . . . . 0.0 108.711 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -67.96 148.88 50.48 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.876 0.47 . . . . 0.0 110.405 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.61 -22.62 66.99 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.651 0.781 . . . . 0.0 112.715 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.16 43.73 3.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.326 1.051 . . . . 0.0 108.945 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 8.5 tp10 -69.7 156.39 39.05 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.42 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 86.7 mtp -124.54 114.85 19.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 164.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.98 159.43 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.938 0.895 . . . . 0.0 110.165 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.77 117.77 31.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.294 0.637 . . . . 0.0 110.118 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.92 111.04 15.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -108.28 147.1 31.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.178 0.991 . . . . 0.0 108.494 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 124' ' ' ASP . 14.0 ptm180 -70.08 -164.6 0.08 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.414 0.686 . . . . 0.0 111.009 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.46 111.33 2.96 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.44 0.696 . . . . 0.0 111.422 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.477 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 57.1 Cg_endo -81.11 -8.92 12.97 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.934 2.423 . . . . 0.0 113.097 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -164.21 -42.49 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.111 0.964 . . . . 0.0 109.038 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.38 101.39 0.25 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 125.231 1.412 . . . . 0.0 112.684 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.23 -15.02 6.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.365 2.043 . . . . 0.0 112.256 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -83.1 -30.8 27.66 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.149 0.979 . . . . 0.0 109.629 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -126.63 98.48 5.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.333 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.82 -13.67 61.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.26 0.624 . . . . 0.0 110.487 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 9.7 p30 -82.42 -6.8 59.51 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.68 0.792 . . . . 0.0 111.792 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.03 100.93 2.6 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 76.5 mt -103.0 106.68 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 89' ' ' PRO . 35.3 ttpt -91.79 127.12 37.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.113 0.565 . . . . 0.0 109.555 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.11 132.02 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.157 0.504 . . . . 0.0 109.826 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 18.7 m120 -112.8 157.14 21.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.054 0.942 . . . . 0.0 110.77 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.515 HD22 HG12 ' A' ' 77' ' ' VAL . 20.9 t-20 -87.0 171.01 11.07 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.314 1.045 . . . . 0.0 108.797 173.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.6 m -64.28 -23.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 123.366 0.666 . . . . 0.0 111.788 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -80.01 -7.94 59.09 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.904 0.881 . . . . 0.0 110.965 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.16 -16.72 59.87 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.235 0.445 . . . . 0.0 113.191 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -69.8 120.36 15.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.524 0.729 . . . . 0.0 109.794 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 2.4 pm0 -69.16 127.7 34.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.99 0.424 . . . . 0.0 110.262 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 t -85.51 -46.62 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.472 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.74 -149.73 6.77 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.978 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.547 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 9.1 p80 -149.7 155.67 40.58 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HG ' HD22 ' A' ' 171' ' ' LEU . 8.3 tt -72.01 145.14 48.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.567 1.147 . . . . 0.0 108.268 171.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.8 mtpt -60.5 126.56 27.92 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.741 0.416 . . . . 0.0 110.92 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -55.05 -34.64 63.73 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.653 1.181 . . . . 0.0 113.023 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.84 -47.38 69.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.461 0.704 . . . . 0.0 111.022 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 170' ' ' LYS . 3.4 mm? -69.5 -35.19 75.31 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.557 0.694 . . . . 0.0 109.767 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -18.9 41.69 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.175 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.82 -22.59 27.13 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 114.306 0.482 . . . . 0.0 114.306 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.16 -54.42 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.398 0.679 . . . . 0.0 110.228 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.5 mm? -60.27 -30.6 69.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.918 0.887 . . . . 0.0 112.94 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.12 -37.58 80.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.75 0.82 . . . . 0.0 111.551 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.33 -27.85 67.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.672 0.789 . . . . 0.0 111.027 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.3 mp -75.7 -47.7 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 78.6 mtp -70.99 -25.14 62.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.514 0.726 . . . . 0.0 111.515 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 30.6 t70 -86.14 -51.61 6.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.887 0.875 . . . . 0.0 110.661 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.99 4.1 24.02 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.737 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm 57.16 37.67 28.57 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.631 1.172 . . . . 0.0 111.383 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' A' ' 122' ' ' ILE . 92.8 mt -65.68 -58.27 6.1 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.721 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.19 171.37 17.04 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.931 0.492 . . . . 0.0 109.806 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -110.74 140.94 44.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 109.305 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.31 102.32 13.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.02 148.66 45.66 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.791 0.836 . . . . 0.0 109.587 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.29 130.95 7.73 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 65.8 t -134.74 126.64 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.078 0.951 . . . . 0.0 108.633 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 137' ' ' GLY . 2.5 t -107.57 94.06 11.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.226 0.61 . . . . 0.0 109.408 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.15 -17.96 13.07 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.219 1.946 . . . . 0.0 111.413 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.07 -30.74 69.12 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 110.54 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 81.87 -7.48 62.63 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.535 -0.592 . . . . 0.0 114.326 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.27 63.59 2.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.252 1.021 . . . . 0.0 111.241 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -87.39 21.36 2.49 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 0.0 110.747 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -149.34 124.36 10.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.075 1.35 . . . . 0.0 107.747 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.61 -23.7 60.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.887 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.35 -168.83 1.23 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.532 0.733 . . . . 0.0 110.278 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 66' ' ' HIS . 12.6 m -71.68 135.99 47.08 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.443 0.697 . . . . 0.0 112.201 -170.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.507 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -145.64 158.29 50.26 Favored Pre-proline 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 0.0 110.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.12 128.06 13.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.421 2.08 . . . . 0.0 112.877 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD23 ' HE3' ' A' ' 148' ' ' MET . 65.2 tp -110.53 145.3 38.0 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -112.83 111.39 22.12 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -101.37 162.38 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.169 0.988 . . . . 0.0 109.166 -177.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.3 m -139.04 114.93 10.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -94.76 131.34 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.697 1.199 . . . . 0.0 108.464 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -145.3 131.27 19.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.366 0.603 . . . . 0.0 111.895 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.35 45.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.974 1.273 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -72.67 172.09 11.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 118.117 0.958 . . . . 0.0 111.217 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.4 -49.03 73.42 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 124.18 0.992 . . . . 0.0 111.311 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.12 -38.09 75.82 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.534 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 19.0 m120 -78.29 -32.65 49.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.446 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.502 HH11 HG21 ' A' ' 58' ' ' VAL . 22.1 mtm180 -58.24 -45.22 88.15 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 123.833 0.708 . . . . 0.0 110.369 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -59.8 -42.57 93.73 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.876 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.91 80.67 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.712 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 156' ' ' ASN . 73.9 t -61.03 -50.44 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.773 0.829 . . . . 0.0 110.801 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.2 t -57.89 -52.25 66.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.252 1.021 . . . . 0.0 110.308 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 28.5 t70 -60.01 -41.02 91.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.729 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.3 -40.52 94.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 0.0 111.518 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 170' ' ' LYS . 92.9 mt -61.77 -41.98 98.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.979 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.91 -33.28 70.39 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.639 0.376 . . . . 0.0 111.402 176.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 55.5 mttm -59.76 -56.12 25.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.756 0.422 . . . . 0.0 111.874 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -92.46 -10.23 38.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.69 69.35 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 123.133 0.271 . . . . 0.0 113.587 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 39.6 m-85 -113.71 152.62 30.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.967 0.907 . . . . 0.0 110.669 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.9 ptpp? -174.39 144.96 0.95 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.256 1.422 . . . . 0.0 109.716 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.462 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.249 1.037 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -67.31 -35.28 79.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.276 1.03 . . . . 0.0 112.292 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -67.46 -18.32 65.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.294 0.638 . . . . 0.0 111.677 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -84.21 -34.23 23.96 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.344 0.658 . . . . 0.0 110.083 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -74.38 -14.5 60.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.178 0.591 . . . . 0.0 112.254 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.1 9.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -89.88 150.25 22.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 111.451 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -123.32 106.6 10.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.571 1.148 . . . . 0.0 108.273 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.85 152.37 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 110.048 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.41 115.68 14.22 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.737 0.815 . . . . 0.0 109.589 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -79.27 -41.27 28.52 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.693 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.88 -162.45 34.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 50.9 p -144.75 148.95 34.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.167 0.587 . . . . 0.0 111.446 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 1.7 mp -113.07 174.63 5.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.516 1.126 . . . . 0.0 108.501 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -162.36 31.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.975 0.352 . . . . 0.0 111.886 -173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -75.04 -171.7 29.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 114.5 0.56 . . . . 0.0 114.5 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -118.82 129.87 55.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.964 0.506 . . . . 0.0 111.727 -171.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.92 122.88 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.813 0.845 . . . . 0.0 110.652 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 143' ' ' THR . 28.1 m -93.38 -12.03 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.764 0.826 . . . . 0.0 110.573 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.724 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.2 -14.21 63.55 Favored Glycine 0 C--O 1.218 -0.849 0 CA-C-N 114.869 -1.06 . . . . 0.0 115.346 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 144' ' ' MET . 54.3 mt -53.59 -29.66 38.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -73.25 -8.73 57.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.938 0.895 . . . . 0.0 113.143 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.34 -67.92 0.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.504 1.122 . . . . 0.0 112.008 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -113.42 -70.41 0.81 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.5 p -126.71 -44.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.618 0.767 . . . . 0.0 109.793 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.33 1.95 86.79 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 114.546 -1.206 . . . . 0.0 113.425 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 m -81.85 136.19 23.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.593 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.63 167.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.631 1.172 . . . . 0.0 108.945 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 62.1 t30 -79.68 165.27 23.03 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -42.61 -58.33 2.33 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -167.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -119.8 29.0 7.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 0.0 109.952 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 37.1 tt0 -63.85 129.56 40.57 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 111.384 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.586 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.3 mpt? -77.65 142.33 38.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.171 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.8 m -123.21 170.97 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.547 174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.76 133.47 21.08 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.79 138.77 33.08 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.245 0.545 . . . . 0.0 110.701 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -130.69 149.04 52.52 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -70.41 -157.38 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.123 0.419 . . . . 0.0 110.151 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.97 116.1 12.35 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.295 0.638 . . . . 0.0 110.912 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.78 -3.07 6.45 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.608 2.205 . . . . 0.0 113.074 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -164.91 -38.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.9 0.48 . . . . 0.0 110.936 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 14.2 m120 -67.01 102.0 0.34 Allowed Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 124.214 1.006 . . . . 0.0 111.37 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.07 -35.34 3.14 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.172 1.915 . . . . 0.0 113.169 -170.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -81.32 -41.12 22.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.967 0.507 . . . . 0.0 109.802 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.9 m-20 -85.41 68.66 10.54 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.103 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.84 -29.18 68.25 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.808 176.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.49 -5.11 58.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.244 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.06 102.23 5.6 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.92 107.03 19.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 4.0 tppp? -86.74 116.78 25.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.52 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.4 p -96.43 127.6 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.25 0.548 . . . . 0.0 109.887 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -117.04 136.51 52.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.103 0.961 . . . . 0.0 108.611 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 44.3 p-10 -78.05 170.77 16.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.789 0.436 . . . . 0.0 110.381 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.37 -9.21 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.397 0.679 . . . . 0.0 112.744 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -79.84 -24.76 41.08 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.679 0.391 . . . . 0.0 110.476 172.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.59 37.43 4.77 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-O 121.128 0.293 . . . . 0.0 112.569 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -124.64 130.02 51.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.965 1.306 . . . . 0.0 108.65 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.682 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 20.8 pt20 -74.71 103.59 5.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.11 -45.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.187 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 99' ' ' LYS . . . 179.2 -151.24 10.04 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.811 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.724 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 13.5 p80 -136.73 152.56 50.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.827 0.451 . . . . 0.0 110.003 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.4 tt -63.48 141.21 58.85 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.9 mtpt -54.42 120.9 7.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.238 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 21.4 ptmt -55.35 -25.14 33.15 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.87 . . . . 0.0 113.015 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.52 -43.89 84.64 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.734 1.214 . . . . 0.0 111.457 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.3 mm? -96.73 -28.47 14.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.109 0.964 . . . . 0.0 110.137 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -69.63 -24.93 63.71 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.382 1.073 . . . . 0.0 112.2 -173.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.12 -31.29 76.25 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 123.502 0.501 . . . . 0.0 112.072 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.43 -51.71 10.33 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.17 0.988 . . . . 0.0 111.164 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' MET . 3.4 mm? -66.13 -22.71 66.4 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.352 0.261 . . . . 0.0 111.425 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -25.31 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.572 0.749 . . . . 0.0 111.835 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.863 0.465 . . . . 0.0 110.593 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.4 mp -77.7 -33.62 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.309 0.644 . . . . 0.0 109.772 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.667 ' SD ' HD13 ' A' ' 130' ' ' ILE . 95.6 mmm -74.07 -45.21 50.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.894 0.878 . . . . 0.0 111.07 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.93 -50.7 31.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 0.0 110.687 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.74 -2.05 45.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.988 0.515 . . . . 0.0 111.11 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 59.45 39.7 21.6 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.792 0.837 . . . . 0.0 111.327 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.1 mt -72.26 -43.94 63.57 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.988 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.27 151.12 29.67 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.908 0.483 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -88.36 111.76 22.1 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.814 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.3 mp -81.17 100.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -90.08 121.74 32.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.043 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.69 156.06 18.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 82' ' ' MET . 59.3 t -144.59 118.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.339 . . . . 0.0 107.649 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 146' ' ' LEU . 40.4 t -91.73 108.97 33.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.82 -11.89 8.81 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.362 2.041 . . . . 0.0 112.759 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -81.18 -27.74 35.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.711 0.804 . . . . 0.0 110.534 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 67.81 18.86 70.88 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.391 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.74 43.3 31.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.916 0.887 . . . . 0.0 111.543 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.3 -15.45 62.54 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.908 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -143.44 143.59 31.66 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -19.04 63.05 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.187 0.995 . . . . 0.0 112.141 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -69.22 172.27 7.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.206 0.603 . . . . 0.0 111.188 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 68' ' ' VAL . 67.6 p -68.9 138.25 54.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.343 0.657 . . . . 0.0 111.074 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 70' ' ' LEU . 25.7 ptt? -134.87 153.52 78.73 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 123.391 0.677 . . . . 0.0 110.691 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.2 136.31 40.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.366 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 134' ' ' VAL . 29.7 tp -120.71 113.74 20.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.762 1.225 . . . . 0.0 107.806 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -79.61 105.61 11.04 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 42.4 mtt -102.92 164.36 11.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.393 0.677 . . . . 0.0 109.256 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.1 m -147.59 141.47 25.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.145 0.578 . . . . 0.0 109.612 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 164' ' ' LEU . 45.8 m-85 -92.63 118.41 31.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -115.25 127.49 55.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.0 177.28 44.8 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 123.53 0.519 . . . . 0.0 111.948 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 53.3 mttm -94.6 170.97 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 110.28 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.4 -32.43 68.61 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.455 1.102 . . . . 0.0 112.0 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 153' ' ' LYS . 10.9 pt-20 -63.47 -46.38 86.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.525 1.13 . . . . 0.0 111.088 -178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.76 -11.13 25.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.421 1.088 . . . . 0.0 111.569 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -60.48 -42.85 97.12 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.786 0.835 . . . . 0.0 109.197 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -66.25 -38.15 87.18 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.56 84.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.187 0.595 . . . . 0.0 111.714 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.55 -43.81 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.828 0.851 . . . . 0.0 110.047 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -57.96 -61.15 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.384 1.053 . . . . 0.0 110.544 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -52.52 -45.72 66.41 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.436 1.085 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -64.66 -38.71 91.94 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.321 1.013 . . . . 0.0 111.522 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 167' ' ' HIS . 20.9 mt -62.7 -51.54 66.8 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.821 0.448 . . . . 0.0 111.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -26.55 66.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.397 0.279 . . . . 0.0 111.315 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.63 -56.54 6.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.605 0.762 . . . . 0.0 111.515 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.445 ' NE2' ' HA ' ' A' ' 164' ' ' LEU . 1.5 p-80 -81.86 -24.25 35.9 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.852 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.48 2.59 75.18 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 167' ' ' HIS . 89.2 m-85 -132.25 149.98 52.26 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.91 0.855 . . . . 0.0 111.128 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.27 155.96 3.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.592 1.157 . . . . 0.0 109.713 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.633 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 13.5 tp . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 CA-C-O 120.235 -0.203 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 p -63.75 -37.15 86.28 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.36 -36.14 81.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.176 0.591 . . . . 0.0 110.779 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.45 -23.87 27.66 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.73 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.8 -32.67 27.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.939 0.895 . . . . 0.0 111.71 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.37 0.1 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.184 0.594 . . . . 0.0 112.522 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.51 102.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 m -82.08 141.7 32.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.912 0.885 . . . . 0.0 111.688 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.69 138.79 52.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.08 1.352 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.0 107.44 8.2 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 150' ' ' PHE . 77.1 t80 -72.07 -37.4 69.62 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.345 0.403 . . . . 0.0 110.289 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.7 -161.2 32.11 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.354 0.409 . . . . 0.0 112.422 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.3 p -117.06 152.73 34.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.414 0.686 . . . . 0.0 111.317 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.0 mp -114.38 -176.97 3.02 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.282 1.033 . . . . 0.0 108.888 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -156.45 153.3 28.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.472 0.709 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.28 -158.63 9.49 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.759 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.5 105.25 3.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.025 0.53 . . . . 0.0 110.066 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.8 t -88.15 120.09 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.812 0.845 . . . . 0.0 111.28 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.66 -11.52 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 123.574 0.75 . . . . 0.0 110.329 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -57.47 -15.62 17.93 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.524 1.37 . . . . 0.0 116.524 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.71 -26.22 56.26 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.334 1.067 . . . . 0.0 112.34 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -81.13 3.17 24.43 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.507 0.723 . . . . 0.0 112.563 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -65.9 -70.16 0.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.644 . . . . 0.0 110.162 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.71 -68.27 0.93 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.039 0.447 . . . . 0.0 110.367 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' HG13 ' A' ' 76' ' ' VAL . 39.0 p -123.85 -44.78 2.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.629 0.771 . . . . 0.0 110.035 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.16 28.59 72.67 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.51 -176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG13 ' HB ' ' A' ' 74' ' ' THR . 31.2 m -74.14 127.09 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.446 0.641 . . . . 0.0 109.49 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -137.13 136.36 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.204 1.002 . . . . 0.0 108.575 -172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 38.1 t30 -70.74 153.64 42.59 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.204 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 1.9 m-20 -59.98 -27.89 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.089 0.955 . . . . 0.0 112.706 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -121.36 21.39 11.07 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.883 0.473 . . . . 0.0 110.925 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.2 tp10 -62.1 134.67 56.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.473 0.709 . . . . 0.0 111.297 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 86.5 mtp -102.64 138.73 39.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 28.9 m -122.49 178.77 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.822 0.849 . . . . 0.0 110.463 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.99 134.51 18.6 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.949 0.899 . . . . 0.0 109.036 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.97 116.26 23.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -128.53 130.57 47.62 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.523 0.729 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' SD ' ' A' ' 123' ' ' MET . 7.2 tmm_? -62.89 128.45 35.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -52.43 115.96 7.88 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 111.172 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.71 -10.22 17.05 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.474 2.783 . . . . 0.0 112.763 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -76.25 -35.67 58.86 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 2.9 m-20 -108.26 97.5 22.55 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 0.0 110.893 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.38 -25.04 7.27 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.375 2.05 . . . . 0.0 112.424 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -85.27 -5.57 59.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.693 0.797 . . . . 0.0 111.413 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 16.7 m-20 -122.93 93.06 3.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.113 0.565 . . . . 0.0 109.663 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -67.34 -31.65 72.05 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.019 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -70.6 -14.57 62.54 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.547 0.739 . . . . 0.0 111.461 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.04 106.91 10.23 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 65.5 mt -126.75 131.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -110.53 129.48 55.78 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.08 0.952 . . . . 0.0 109.61 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 108' ' ' VAL . 13.9 p -91.8 128.87 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.584 HD22 ' HA ' ' A' ' 107' ' ' GLN . 11.8 m120 -125.2 141.77 51.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.259 1.024 . . . . 0.0 108.675 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.0 p30 -73.92 173.94 9.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.094 0.406 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.2 -20.17 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.294 0.638 . . . . 0.0 112.538 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -71.29 -31.6 67.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.131 0.573 . . . . 0.0 110.139 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.58 -2.93 27.72 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.34 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.2 134.0 46.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.6 0.76 . . . . 0.0 110.637 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.584 ' HA ' HD22 ' A' ' 101' ' ' ASN . 5.2 pm0 -69.59 108.62 3.91 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.48 0.712 . . . . 0.0 110.065 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 100' ' ' VAL . 94.4 t -77.06 -41.95 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 172.64 -152.79 17.33 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.217 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -129.64 131.39 46.42 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 116' ' ' ALA . 4.7 tt -72.46 134.23 45.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.783 1.233 . . . . 0.0 108.619 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HB2' HD23 ' A' ' 115' ' ' LEU . 45.1 mtpt -64.74 129.49 39.97 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.505 0.503 . . . . 0.0 110.829 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 63.1 pttt -59.92 -28.54 67.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.167 0.987 . . . . 0.0 113.123 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HB2' HD22 ' A' ' 115' ' ' LEU . 34.6 mt-10 -62.88 -44.55 95.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.656 0.782 . . . . 0.0 110.66 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.8 mm? -84.2 -33.63 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.883 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -62.9 -22.77 66.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.678 173.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -52.51 -21.44 9.04 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.013 0.339 . . . . 0.0 113.454 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -94.1 -63.89 1.14 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.315 0.646 . . . . 0.0 111.008 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.7 mp -73.97 -20.5 60.33 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -164.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.96 77.51 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.39 0.676 . . . . 0.0 111.11 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.68 -44.29 82.19 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.754 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 160' ' ' VAL . 2.5 mp -63.44 -39.5 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.04 0.536 . . . . 0.0 110.56 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 45.2 ttm -72.9 -44.96 60.64 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.479 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.39 -45.26 32.54 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.263 0.625 . . . . 0.0 111.227 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -76.05 -8.61 57.38 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.742 0.817 . . . . 0.0 110.868 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 67.01 33.91 5.45 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.702 1.201 . . . . 0.0 111.386 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.9 mt -61.07 -50.55 72.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.501 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 150' ' ' PHE . . . -168.23 174.42 7.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.595 0.358 . . . . 0.0 111.518 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.55 134.47 45.84 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.08 0.952 . . . . 0.0 109.998 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.07 106.62 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.501 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 39.6 tt0 -79.19 166.75 21.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.857 0.863 . . . . 0.0 109.013 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.88 169.6 26.08 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 117.904 0.32 . . . . 0.0 112.704 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 7.7 p -166.62 133.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.811 1.244 . . . . 0.0 108.858 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 137' ' ' GLY . 14.1 t -105.36 96.02 10.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.844 0.858 . . . . 0.0 108.872 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.72 -18.28 28.78 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.969 2.446 . . . . 0.0 111.894 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -75.73 -27.16 58.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.981 0.912 . . . . 0.0 110.924 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 63.81 23.95 67.82 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.34 44.63 28.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.47 0.708 . . . . 0.0 111.2 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -63.34 -21.73 66.44 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.006 0.922 . . . . 0.0 111.121 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.95 136.03 53.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.86 -17.77 65.06 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.28 0.632 . . . . 0.0 110.901 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.92 -177.41 1.99 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.573 1.149 . . . . 0.0 111.153 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.7 m -69.76 115.72 9.33 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.326 0.65 . . . . 0.0 110.014 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.58 154.24 40.91 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 123.192 0.597 . . . . 0.0 111.651 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.92 134.36 21.49 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.669 2.246 . . . . 0.0 113.24 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -106.62 149.43 27.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 0.0 108.93 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -116.19 135.06 54.25 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -113.62 163.31 15.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.472 0.709 . . . . 0.0 109.14 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.25 114.4 13.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.841 0.857 . . . . 0.0 108.815 172.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 77.9 t80 -95.23 122.42 37.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.996 0.918 . . . . 0.0 110.101 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 27.6 p-90 -138.27 135.21 35.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.785 0.834 . . . . 0.0 110.146 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.9 -168.74 40.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.02 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.74 154.21 9.44 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.789 0.836 . . . . 0.0 112.652 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.55 -18.47 59.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.725 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.19 -42.26 26.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.099 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.79 -18.67 39.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.771 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -60.64 -38.5 85.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.184 0.516 . . . . 0.0 110.005 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -48.32 30.86 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.115 0.966 . . . . 0.0 109.868 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.28 69.92 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.709 0.803 . . . . 0.0 111.84 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 122' ' ' ILE . 70.8 t -68.84 -51.53 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 111.705 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 164' ' ' LEU . 51.0 m -60.71 -42.77 97.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.454 0.471 . . . . 0.0 111.073 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.12 -37.33 86.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.989 0.515 . . . . 0.0 110.285 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -73.53 -24.37 60.13 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.354 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 170' ' ' LYS . 65.1 mt -69.33 -41.43 76.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.771 0.829 . . . . 0.0 111.052 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -37.81 71.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.187 0.304 . . . . 0.0 110.46 172.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.53 -41.45 94.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.193 0.997 . . . . 0.0 111.258 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -79.17 -36.3 40.58 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.464 0.706 . . . . 0.0 110.586 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.71 75.25 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 41.6 m-85 -132.44 140.1 48.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.305 1.042 . . . . 0.0 110.126 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 164' ' ' LEU . 7.7 ptpp? -161.82 138.89 8.45 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 123.906 0.754 . . . . 0.0 111.444 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.646 1.978 . . . . 0.0 107.053 177.223 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 68.5 m -68.9 -5.48 21.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 112.142 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.12 -38.86 92.59 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.576 1.15 . . . . 0.0 109.752 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.36 -39.16 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.38 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 51' ' ' SER . 31.1 mt-10 -80.7 23.24 0.54 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.084 0.954 . . . . 0.0 111.871 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -75.36 -29.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.937 -0.477 . . . . 0.0 111.438 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -88.39 134.84 33.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.316 0.646 . . . . 0.0 111.574 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -76.15 103.51 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.977 0.911 . . . . 0.0 109.622 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.69 157.99 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.99 0.916 . . . . 0.0 110.977 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.51 108.1 7.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.734 0.414 . . . . 0.0 109.906 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB3' ' CD1' ' A' ' 150' ' ' PHE . 70.2 t80 -80.54 -28.73 37.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.559 173.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.58 -159.5 30.61 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.773 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.7 p -125.7 150.37 47.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.212 1.005 . . . . 0.0 109.881 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 64.6 mt -116.86 170.95 8.22 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.876 0.87 . . . . 0.0 109.191 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HA ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -155.35 151.74 28.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.289 0.636 . . . . 0.0 110.729 178.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 -161.96 19.33 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.127 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.664 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.8 m-70 -136.83 119.77 16.4 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.757 0.823 . . . . 0.0 110.654 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.69 125.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 34.5 m -87.42 -18.03 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.758 0.823 . . . . 0.0 110.745 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -56.7 -15.43 12.45 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 116.116 1.207 . . . . 0.0 116.116 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 ' SD ' ' A' ' 144' ' ' MET . 59.8 mt -56.05 -26.82 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.853 0.826 . . . . 0.0 112.857 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 5.7 ptm180 -80.96 3.61 22.33 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.394 0.678 . . . . 0.0 112.442 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.534 0.334 . . . . 0.0 111.054 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -115.89 -68.45 0.92 Allowed 'General case' 0 N--CA 1.482 1.154 0 O-C-N 122.446 -0.159 . . . . 0.0 110.717 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.8 p -123.49 -46.22 2.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.201 0.6 . . . . 0.0 110.593 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 28.97 72.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.24 135.46 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 138' ' ' ALA . 35.0 m -134.27 -175.09 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.544 0.738 . . . . 0.0 110.256 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -64.06 154.29 34.84 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.075 0.55 . . . . 0.0 110.353 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.65 -43.26 80.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.329 1.052 . . . . 0.0 111.22 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.9 37.18 3.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.401 1.08 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -51.66 139.59 20.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.153 0.981 . . . . 0.0 112.77 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.24 109.85 17.98 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.8 -177.8 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.894 0.877 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.57 135.19 10.58 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.843 0.857 . . . . 0.0 109.25 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.7 123.32 25.99 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.66 135.0 36.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.5 ptt180 -65.79 174.76 2.21 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.031 0.443 . . . . 0.0 110.481 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 12.7 t70 -68.67 120.58 76.62 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.35 -21.75 34.96 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.97 2.446 . . . . 0.0 112.94 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -83.98 -23.11 31.19 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 25.7 m-80 -108.61 98.56 29.14 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.474 0.71 . . . . 0.0 112.279 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.19 -39.39 3.04 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.96 -34.94 19.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.706 0.803 . . . . 0.0 111.382 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 7.9 m-20 -87.92 63.46 7.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.595 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 25.7 pttm -75.07 -9.4 58.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.961 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.95 -22.61 65.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.076 0.95 . . . . 0.0 111.063 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.84 105.67 10.31 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 65.8 mt -125.31 115.44 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' HD21 ' A' ' 101' ' ' ASN . 20.6 pttm -93.31 165.23 12.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.504 0.722 . . . . 0.0 109.524 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -115.23 120.11 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.482 HD21 ' HE2' ' A' ' 99' ' ' LYS . 21.2 m120 -108.67 135.88 49.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.474 1.11 . . . . 0.0 109.286 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -86.05 -168.69 2.33 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.286 0.634 . . . . 0.0 111.18 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -64.13 -25.9 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.138 0.575 . . . . 0.0 112.046 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.43 -25.61 57.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.527 0.731 . . . . 0.0 110.577 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.75 1.22 63.75 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.94 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.64 137.49 47.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.217 1.007 . . . . 0.0 110.148 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.572 ' H ' ' NE2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -77.92 114.54 16.88 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.48 -42.28 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.914 0.864 . . . . 0.0 109.188 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.42 -149.27 7.24 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.007 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.488 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 p-80 -155.44 166.36 33.78 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.519 0.676 . . . . 0.0 111.508 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 171' ' ' LEU . 6.8 mp -74.98 153.8 38.37 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.271 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' HD23 ' A' ' 115' ' ' LEU . 56.1 mtpt -73.49 144.27 46.26 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 164.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.12 -22.68 64.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.288 0.367 . . . . 0.0 111.631 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.58 -47.25 86.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.516 0.726 . . . . 0.0 110.501 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.0 mm? -77.84 -53.47 7.45 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.443 0.697 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.21 62.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.58 1.552 . . . . 0.0 113.463 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.87 61.88 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.531 0.519 . . . . 0.0 113.265 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.86 -57.08 3.93 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.257 0.623 . . . . 0.0 110.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' LEU . 2.8 mm? -58.21 -27.42 63.89 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.566 0.746 . . . . 0.0 111.858 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.595 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -51.56 -47.11 63.56 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.23 1.012 . . . . 0.0 111.803 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.57 -37.05 82.07 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.585 0.754 . . . . 0.0 111.66 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.578 HG12 HG13 ' A' ' 160' ' ' VAL . 1.9 mp -74.25 -42.81 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.017 0.927 . . . . 0.0 110.624 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 98' ' ' ILE . 87.4 mtp -75.86 -25.79 56.51 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 20.1 t70 -66.93 -61.75 1.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.559 0.744 . . . . 0.0 110.328 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD21 ' A' ' 127' ' ' LEU . 62.3 t30 -81.03 2.97 24.79 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.168 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 61.53 27.47 16.98 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.635 1.174 . . . . 0.0 111.504 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.432 HD21 ' ND2' ' A' ' 125' ' ' ASN . 96.4 mt -63.36 -38.36 90.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.82 1.248 . . . . 0.0 112.39 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.74 143.74 25.62 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.259 0.624 . . . . 0.0 110.942 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 80.9 mm-40 -90.99 105.91 18.16 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.342 1.057 . . . . 0.0 108.565 171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.32 101.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.61 161.83 27.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 109.29 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.45 147.38 18.08 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -145.13 125.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' GLY . 23.4 t -91.81 101.93 5.3 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.865 0.866 . . . . 0.0 109.169 175.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.94 -12.29 10.89 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.475 2.116 . . . . 0.0 111.729 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -77.95 -25.65 48.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.568 1.147 . . . . 0.0 110.576 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 78.01 -0.15 73.85 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.411 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 51.75 40.48 27.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.66 1.184 . . . . 0.0 111.285 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.73 -22.43 61.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -109.1 138.84 44.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.29 -20.34 55.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.918 0.887 . . . . 0.0 111.936 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.34 165.29 14.37 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.981 0.512 . . . . 0.0 110.444 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 66' ' ' HIS . 35.7 m -69.05 113.37 6.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.582 0.753 . . . . 0.0 110.121 -171.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -106.3 159.12 30.86 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.258 0.623 . . . . 0.0 110.76 -166.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.33 141.37 42.75 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.465 2.11 . . . . 0.0 112.878 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.2 tp -120.32 135.16 55.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.412 1.085 . . . . 0.0 108.37 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.27 112.07 24.31 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.607 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.3 mpt? -100.01 161.58 13.52 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.5 m -128.98 134.11 48.05 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 60' ' ' PHE . 2.6 t80 -94.17 113.41 25.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 78.5 m95 -113.1 136.69 52.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 170.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.54 3.23 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -68.27 153.94 42.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.046 0.539 . . . . 0.0 111.119 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.79 -44.18 96.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.852 0.861 . . . . 0.0 112.882 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -25.73 63.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.934 0.894 . . . . 0.0 112.15 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.4 m120 -99.16 -37.86 9.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.187 0.595 . . . . 0.0 111.942 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 ptt180 -62.18 -28.28 69.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -161.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.31 -41.14 61.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.728 0.411 . . . . 0.0 110.615 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.74 90.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.036 0.534 . . . . 0.0 110.735 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 122' ' ' ILE . 58.3 t -64.46 -56.54 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.968 0.907 . . . . 0.0 110.559 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 56.4 p -58.63 -45.77 88.54 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 124.241 0.963 . . . . 0.0 110.629 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 24.4 t70 -56.42 -40.32 74.51 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.773 0.829 . . . . 0.0 111.416 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.26 -29.3 66.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 123.778 0.674 . . . . 0.0 110.457 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 170' ' ' LYS . 74.6 mt -68.33 -29.89 68.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.635 0.374 . . . . 0.0 110.824 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -82.11 -37.17 26.71 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.856 0.462 . . . . 0.0 111.543 173.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -67.92 -47.25 69.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.136 0.574 . . . . 0.0 111.457 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.43 -30.13 59.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.167 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.13 86.8 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.745 -0.662 . . . . 0.0 113.979 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 64.9 m-85 -142.64 141.04 31.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.269 0.628 . . . . 0.0 111.032 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.498 ' HB3' HD22 ' A' ' 164' ' ' LEU . 1.4 pptp? -165.25 156.18 14.14 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.649 1.18 . . . . 0.0 110.559 171.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 111' ' ' LEU . 21.8 tp . . . . . 0 C--O 1.255 1.345 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.124 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m -85.55 -23.97 27.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 0.0 112.704 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.75 -37.84 88.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 120.866 0.365 . . . . 0.0 111.939 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.34 -8.93 56.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.734 0.814 . . . . 0.0 112.786 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -136.58 27.86 3.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.851 0.86 . . . . 0.0 110.681 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.49 -28.13 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 122.659 0.384 . . . . 0.0 110.942 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.61 124.57 28.31 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.716 0.806 . . . . 0.0 110.228 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 m -85.09 137.79 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.198 0.599 . . . . 0.0 109.593 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -95.76 152.63 3.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.11 121.55 23.74 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.588 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -79.34 -54.53 5.86 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.85 -175.58 39.21 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.31 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -112.99 137.43 51.41 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.785 0.834 . . . . 0.0 110.331 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' ' SD ' ' A' ' 148' ' ' MET . 3.1 mp -101.4 170.38 8.25 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.419 1.088 . . . . 0.0 110.226 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -150.65 135.63 17.57 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.982 168.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -151.31 -177.98 25.65 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.189 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -115.37 101.66 9.12 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.009 0.524 . . . . 0.0 111.345 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 171' ' ' LEU . 59.7 t -71.91 97.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.915 0.886 . . . . 0.0 111.046 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 112' ' ' LYS . 32.6 m -72.02 -23.47 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.7 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' TYR . . . -65.84 -14.5 60.93 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.794 -1.094 . . . . 0.0 115.72 -172.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.5 mt -52.74 -54.02 39.76 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.393 1.097 . . . . 0.0 111.092 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.2 ptm180 -68.59 -9.08 47.42 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.64 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 65.1 t80 -60.43 -57.64 11.91 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.78 0.832 . . . . 0.0 111.334 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -114.16 -69.12 0.88 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.8 t -124.4 -42.44 2.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.94 76.14 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.38 0.512 . . . . 0.0 114.38 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 74' ' ' THR . 22.7 m -130.32 146.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.601 0.76 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -155.51 168.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 0.0 110.189 173.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 41.3 t30 -71.91 150.97 43.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.19 0.996 . . . . 0.0 110.663 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -50.09 -34.18 20.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.024 1.33 . . . . 0.0 113.253 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -132.45 61.52 1.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.951 0.881 . . . . 0.0 109.667 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 78' ' ' ASN . 11.0 mm-40 -70.46 164.63 24.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.076 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.71 139.65 53.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -129.25 169.08 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.41 134.43 16.91 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.111 0.964 . . . . 0.0 109.055 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.96 133.52 33.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.122 0.569 . . . . 0.0 110.22 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.95 151.78 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.042 1.337 . . . . 0.0 107.793 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -54.81 160.28 1.97 Allowed 'General case' 0 C--O 1.249 1.04 0 C-N-CA 123.199 0.6 . . . . 0.0 110.609 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.69 121.48 82.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.44 -18.8 17.53 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.929 2.419 . . . . 0.0 112.165 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -91.57 -24.71 19.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.994 0.918 . . . . 0.0 110.362 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 47.6 m-80 -106.76 97.19 16.38 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.339 0.656 . . . . 0.0 110.8 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.22 -39.76 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.382 2.055 . . . . 0.0 113.042 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.16 -34.15 26.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.454 0.702 . . . . 0.0 110.596 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.5 m-20 -80.32 75.63 7.14 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 166.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -75.99 -9.82 58.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.671 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.6 p30 -69.68 -37.67 76.73 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 167.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.5 107.63 0.82 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -118.48 126.09 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.393 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 101' ' ' ASN . 25.2 pttm -94.18 148.39 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.106 0.562 . . . . 0.0 109.525 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 109' ' ' GLY . 86.3 t -107.07 113.06 42.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' ' 99' ' ' LYS . 60.4 m-20 -99.39 138.33 36.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.705 0.802 . . . . 0.0 108.947 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 p-10 -75.74 174.89 9.24 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.805 0.73 . . . . 0.0 109.607 172.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.85 -21.6 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.101 0.561 . . . . 0.0 111.853 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.32 -31.54 62.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.945 0.498 . . . . 0.0 110.686 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.85 38.07 2.25 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.65 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.04 141.83 46.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.999 0.92 . . . . 0.0 110.156 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 23.8 mt-30 -72.58 84.18 1.14 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.524 0.729 . . . . 0.0 110.076 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 77' ' ' VAL . 14.2 p -94.12 -13.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 100' ' ' VAL . . . -141.32 169.49 25.05 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.394 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -158.33 136.71 10.94 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.626 1.57 . . . . 0.0 108.284 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' HA ' HD23 ' A' ' 171' ' ' LEU . 10.4 mp -76.06 133.72 40.25 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.527 0.731 . . . . 0.0 109.509 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.5 mmpt? -73.13 148.98 43.4 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 162.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -56.63 -23.45 41.37 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.078 0.951 . . . . 0.0 112.676 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 115' ' ' LEU . 9.3 pt-20 -61.52 -53.2 59.54 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.674 0.79 . . . . 0.0 111.256 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -73.81 -42.32 61.09 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.873 0.844 . . . . 0.0 109.741 -177.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 96' ' ' ASN . . . -57.7 -31.45 66.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 113.483 -1.69 . . . . 0.0 112.375 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -54.65 -29.23 48.32 Favored Glycine 0 C--N 1.35 1.344 0 O-C-N 123.825 0.703 . . . . 0.0 113.69 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 119' ' ' LEU . . . -87.78 -62.41 1.5 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.623 -0.339 . . . . 0.0 110.773 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD23 HG12 ' A' ' 130' ' ' ILE . 6.1 mp -71.36 -20.28 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.72 82.03 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.758 0.423 . . . . 0.0 111.328 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.09 -36.93 85.64 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.493 0.717 . . . . 0.0 111.338 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.2 mp -66.5 -37.54 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.469 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -71.93 -34.95 69.46 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 111.345 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.55 -59.65 4.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.574 0.749 . . . . 0.0 110.761 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -88.73 0.07 56.82 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.268 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 59.12 35.96 23.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.302 1.041 . . . . 0.0 111.407 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.65 -34.91 73.43 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.129 0.972 . . . . 0.0 112.014 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -163.13 169.65 19.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.918 0.887 . . . . 0.0 109.909 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.38 127.87 52.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.257 1.023 . . . . 0.0 109.045 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.546 HG12 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -94.61 99.36 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.65 116.01 31.32 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.901 0.88 . . . . 0.0 108.681 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -99.84 174.95 27.18 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-O 120.971 0.206 . . . . 0.0 113.418 -176.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.4 132.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.055 0 C-N-CA 124.484 1.114 . . . . 0.0 108.596 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 137' ' ' GLY . 31.5 t -103.55 100.47 19.12 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.994 0.918 . . . . 0.0 109.434 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.68 -11.08 9.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.553 2.169 . . . . 0.0 113.16 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -86.72 -23.51 25.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.68 0.792 . . . . 0.0 111.775 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 62.33 25.45 66.74 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.536 0.522 . . . . 0.0 114.286 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . 59.57 87.85 0.08 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.381 1.072 . . . . 0.0 110.628 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -65.91 -35.65 81.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.853 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -136.95 173.01 12.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.454 1.102 . . . . 0.0 109.449 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.59 42.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.062 0.945 . . . . 0.0 110.492 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -73.79 -175.55 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.064 0.946 . . . . 0.0 110.791 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.3 m -71.2 123.49 22.33 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 0.0 110.845 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' ALA . 24.1 ptt? -120.08 161.86 36.42 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.745 0.818 . . . . 0.0 109.622 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.2 Cg_endo -70.29 157.66 58.67 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.113 1.876 . . . . 0.0 112.648 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 57.7 tp -137.93 156.23 48.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.015 1.326 . . . . 0.0 108.445 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -115.47 126.87 54.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.583 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 0.0 OUTLIER -119.02 167.69 11.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.387 1.075 . . . . 0.0 108.847 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -143.87 132.44 22.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.564 0.746 . . . . 0.0 109.165 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 130' ' ' ILE . 9.1 m-85 -94.9 122.22 37.31 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -115.49 128.42 55.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.2 1.0 . . . . 0.0 109.123 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.1 -162.45 34.54 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.22 162.92 12.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.364 0.666 . . . . 0.0 111.013 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 157' ' ' ARG . 37.9 mt-10 -71.0 -39.12 72.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.899 0.88 . . . . 0.0 113.244 -168.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -63.28 -31.94 73.22 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.081 0.552 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -90.02 -34.15 16.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.282 0.633 . . . . 0.0 111.335 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 154' ' ' GLU . 28.6 ptt180 -68.58 -23.9 64.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.818 0.447 . . . . 0.0 110.702 -175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -73.74 -37.97 64.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.252 0.621 . . . . 0.0 110.113 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.33 83.13 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.223 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 122' ' ' ILE . 59.2 t -57.07 -52.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.307 1.043 . . . . 0.0 110.128 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -56.8 -47.3 80.52 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.683 1.239 . . . . 0.0 110.579 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 8.3 t70 -60.13 -43.14 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.416 ' OE1' ' HD2' ' A' ' 166' ' ' LYS . 7.6 tp60 -59.11 -41.05 87.23 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 124.089 0.956 . . . . 0.0 111.372 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 170' ' ' LYS . 75.1 mt -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.346 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -25.61 58.7 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 63.5 mttm -60.6 -48.12 83.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -91.31 -38.52 12.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.112 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.43 30.98 71.03 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.515 -0.311 . . . . 0.0 112.484 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 59.1 m-85 -136.5 136.18 39.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.153 0.981 . . . . 0.0 110.383 -174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.447 ' HG2' HD22 ' A' ' 164' ' ' LEU . 34.7 mtmm -147.32 142.78 27.5 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.111 0.964 . . . . 0.0 111.221 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 111' ' ' LEU . 46.4 tp . . . . . 0 N--CA 1.487 1.378 0 C-N-CA 125.77 1.628 . . . . 0.0 108.149 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.8 p -72.95 -9.46 58.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.72 0.808 . . . . 0.0 112.211 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.18 -52.8 64.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.147 0.498 . . . . 0.0 109.763 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.12 -14.91 40.01 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.254 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -127.18 92.39 3.51 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.186 0.517 . . . . 0.0 111.322 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.07 3.69 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.98 0.912 . . . . 0.0 109.402 165.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.68 117.99 23.02 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.244 1.018 . . . . 0.0 111.006 -168.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -86.41 132.92 33.83 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 165.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.47 161.85 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.961 0.504 . . . . 0.0 110.124 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.46 107.34 6.55 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.259 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.52 -35.59 70.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.237 0.615 . . . . 0.0 109.378 170.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.71 -167.15 40.16 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.13 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 34.6 p -125.83 148.62 49.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.548 1.139 . . . . 0.0 108.949 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 170' ' ' LYS . 2.1 mp -115.19 167.73 10.57 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.239 1.016 . . . . 0.0 109.452 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.36 130.92 12.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.586 0.754 . . . . 0.0 109.619 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.78 -159.61 9.56 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' HB3' HG22 ' A' ' 143' ' ' THR . 70.2 m-70 -136.31 127.64 28.33 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.166 0.983 . . . . 0.0 110.102 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 t -85.48 104.87 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.12 0.568 . . . . 0.0 109.796 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.29 -22.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.43 0.692 . . . . 0.0 111.031 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -67.66 -16.66 68.08 Favored Glycine 0 C--O 1.21 -1.362 0 CA-C-O 118.18 -1.344 . . . . 0.0 115.31 -171.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 144' ' ' MET . 57.9 mt -45.59 -38.23 6.33 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.227 1.411 . . . . 0.0 114.444 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -73.29 7.67 2.11 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -52.05 -68.67 0.15 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 109.942 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -116.29 -69.71 0.84 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -126.79 -43.79 1.69 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.851 0.86 . . . . 0.0 110.083 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.59 57.15 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.472 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.33 133.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.381 0.61 . . . . 0.0 110.586 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 138' ' ' ALA . 12.1 p -159.06 144.9 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.438 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.6 t30 -65.87 153.34 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.331 0.652 . . . . 0.0 111.331 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 21.1 t-20 -58.77 -33.09 69.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.515 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -128.23 36.79 4.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.768 0.827 . . . . 0.0 109.199 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 10.4 tp10 -65.21 139.89 58.69 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.735 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.1 mtt -101.05 110.32 22.32 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.63 164.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 0.0 110.158 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.69 127.6 33.22 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.024 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.33 115.59 15.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -107.4 139.92 41.13 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.305 1.442 . . . . 0.0 107.496 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.95 -163.82 0.46 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.199 0.454 . . . . 0.0 110.233 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -58.15 114.82 9.44 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.422 0.689 . . . . 0.0 110.966 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -86.36 -11.44 6.12 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.062 1.841 . . . . 0.0 111.279 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -140.35 -53.35 0.51 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.282 1.033 . . . . 0.0 110.74 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -53.72 108.67 1.18 Allowed Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.99 1.316 . . . . 0.0 113.145 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.24 -52.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.33 2.02 . . . . 0.0 112.868 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -85.81 -25.05 26.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.172 0.989 . . . . 0.0 110.792 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -107.95 40.16 1.79 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.377 1.071 . . . . 0.0 108.346 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -63.37 -27.53 69.37 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.137 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -74.19 -0.1 15.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.807 0.843 . . . . 0.0 111.931 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.69 102.82 4.75 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.55 109.45 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 4.3 ttmp? -78.46 164.01 25.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.462 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.8 135.71 59.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.13 155.57 44.22 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.087 0.955 . . . . 0.0 109.03 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -88.88 -175.84 5.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.858 0.463 . . . . 0.0 109.793 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -24.3 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 122.743 0.417 . . . . 0.0 111.509 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 -18.45 59.13 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.871 0.868 . . . . 0.0 111.246 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.29 66.88 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 123.101 0.382 . . . . 0.0 113.341 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.48 126.84 29.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.16 0.984 . . . . 0.0 109.575 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -71.47 91.98 1.07 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.758 0.823 . . . . 0.0 109.224 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.14 -45.72 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.582 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.67 -151.44 8.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.69 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.608 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 7.3 p80 -159.88 159.32 32.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.308 0.643 . . . . 0.0 110.276 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.78 152.0 46.37 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.942 1.297 . . . . 0.0 110.569 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 115' ' ' LEU . 55.0 mtpt -68.22 142.57 55.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -56.12 -29.29 60.47 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.395 0.678 . . . . 0.0 111.465 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.31 -54.1 44.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.356 1.462 . . . . 0.0 111.636 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.5 mm? -77.88 -51.74 9.97 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.923 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -20.26 14.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.35 1.46 . . . . 0.0 113.399 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.13 -28.64 58.79 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 117.994 0.361 . . . . 0.0 113.578 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.79 -48.93 7.14 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.983 0.913 . . . . 0.0 110.623 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.1 mm? -65.02 -21.14 66.8 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.619 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.37 72.31 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.961 0.904 . . . . 0.0 111.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -74.21 -38.32 63.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 110.386 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.488 HG12 HG23 ' A' ' 160' ' ' VAL . 50.4 mt -74.49 -24.99 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.694 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.5 tpp -84.66 -54.75 4.51 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.592 1.157 . . . . 0.0 111.321 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.11 -41.44 74.0 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.71 0.804 . . . . 0.0 111.062 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -88.24 -11.98 45.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 0.0 110.513 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 56.43 54.46 7.54 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.302 1.041 . . . . 0.0 111.086 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.11 -34.2 75.94 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.723 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.81 159.7 32.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.231 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.06 114.69 27.52 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 108.783 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.74 108.48 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -71.28 157.32 38.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.009 0.924 . . . . 0.0 108.931 167.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -143.55 159.08 27.5 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.13 127.04 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.994 0 C-N-CA 123.119 0.568 . . . . 0.0 109.979 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 137' ' ' GLY . 35.6 t -102.21 106.37 47.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.5 1.12 . . . . 0.0 108.803 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.06 -11.03 10.07 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.724 2.283 . . . . 0.0 112.826 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.525 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 95.3 m-85 -82.99 -25.48 32.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.699 . . . . 0.0 111.648 -175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 55.28 45.88 81.45 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . 56.78 40.79 28.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.986 0.914 . . . . 0.0 111.75 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.22 -36.93 85.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.751 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -130.9 145.87 52.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.117 0.967 . . . . 0.0 109.503 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.11 66.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.119 0.968 . . . . 0.0 110.303 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.94 161.22 18.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 110.682 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 66' ' ' HIS . 93.8 m -68.68 114.15 6.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.75 0.82 . . . . 0.0 110.583 -170.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 17.8 ptp -98.24 154.17 37.77 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.439 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.24 159.53 42.95 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.609 2.206 . . . . 0.0 112.588 166.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 tp -136.48 145.01 44.66 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.204 1.002 . . . . 0.0 108.345 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -114.05 114.23 25.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -104.86 164.56 11.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 m -136.54 131.6 34.09 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 63' ' ' LEU . 1.2 t80 -96.67 115.07 26.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.35 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -116.51 130.49 56.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.549 0.74 . . . . 0.0 109.373 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.98 160.23 29.07 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -78.56 168.94 19.04 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.292 0.546 . . . . 0.0 111.17 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.27 -31.96 71.78 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.22 -38.78 65.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.744 0.818 . . . . 0.0 110.67 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.11 -33.84 56.84 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.513 0.725 . . . . 0.0 109.589 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -51.19 -41.94 60.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.375 1.87 . . . . 0.0 112.628 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -66.97 -51.54 53.88 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.414 0.686 . . . . 0.0 111.484 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.38 -35.89 71.23 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.383 0.673 . . . . 0.0 112.062 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 HG12 ' A' ' 122' ' ' ILE . 9.3 p -77.23 -28.57 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 21.1 t -62.43 -49.45 75.41 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.06 -43.56 63.87 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.799 1.24 . . . . 0.0 111.517 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.29 -40.89 98.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.549 0.74 . . . . 0.0 111.265 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.14 -27.44 57.03 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.421 0.688 . . . . 0.0 111.691 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 161' ' ' SER . 72.6 mmtt -73.41 -44.08 59.14 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.802 0.81 . . . . 0.0 109.579 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.65 -49.27 60.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.285 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 13.4 m170 -89.23 -39.11 13.75 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.82 10.79 65.1 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.193 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 65.9 m-85 -102.73 122.5 44.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.193 0.997 . . . . 0.0 109.456 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.742 ' HB2' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -149.01 136.2 20.04 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.621 0.769 . . . . 0.0 110.627 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.982 1.313 . . . . 0.0 108.889 -175.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 CA-C-O 119.688 -0.507 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -60.78 -43.5 97.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 0.0 112.055 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.83 -37.11 78.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.743 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.36 -45.15 61.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.491 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.56 16.87 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.85 -29.46 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.978 0.511 . . . . 0.0 110.846 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.87 148.15 25.94 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -111.12 166.62 10.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 109.201 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.42 148.1 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.378 0.671 . . . . 0.0 111.476 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.52 127.45 32.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.834 0.854 . . . . 0.0 109.433 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -90.47 -32.96 16.15 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.268 0.556 . . . . 0.0 110.159 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.9 -164.46 34.75 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.48 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 p -114.82 133.89 55.58 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.974 0.91 . . . . 0.0 109.891 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.8 mp -83.85 165.23 18.93 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -144.48 142.95 30.62 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.203 0.601 . . . . 0.0 110.497 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.75 -164.6 31.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.514 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 143' ' ' THR . 42.4 m170 -129.29 135.82 49.25 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.081 0.952 . . . . 0.0 111.067 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.5 t -99.41 116.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.399 1.08 . . . . 0.0 110.387 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.5 m -93.95 4.31 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.731 0.813 . . . . 0.0 109.926 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.57 64.9 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 114.942 -1.026 . . . . 0.0 115.263 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 144' ' ' MET . 50.6 mt -61.75 -28.5 69.48 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.352 0.576 . . . . 0.0 112.55 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 15.6 ptm180 -89.45 -8.92 51.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.386 0.674 . . . . 0.0 112.245 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -66.71 -68.86 0.34 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.078 0.551 . . . . 0.0 111.02 -173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -115.36 -70.29 0.81 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.602 0.239 . . . . 0.0 111.103 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -125.92 -44.42 1.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.206 0.603 . . . . 0.0 110.688 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.26 12.21 68.76 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.782 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.78 127.54 39.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.91 138.3 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 24.5 t-20 -69.17 159.23 33.37 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.822 0.449 . . . . 0.0 110.741 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -49.22 -41.84 38.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.298 1.439 . . . . 0.0 113.349 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -133.44 36.84 3.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.871 0.869 . . . . 0.0 109.832 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 11.9 tp10 -56.6 143.91 33.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.405 1.082 . . . . 0.0 112.177 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.6 mtt -105.29 122.67 46.42 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -105.64 172.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.694 0.798 . . . . 0.0 110.158 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.43 125.54 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.02 118.69 22.7 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -139.68 142.98 36.9 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 136.99 58.15 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.87 0.759 . . . . 0.0 109.581 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.02 119.72 28.72 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.422 -165.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 -23.34 20.95 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.87 2.38 . . . . 0.0 112.927 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.71 -22.09 34.61 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.225 0.61 . . . . 0.0 110.672 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 16.8 m-80 -99.52 93.91 2.58 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.56 -52.75 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.997 1.798 . . . . 0.0 113.223 -168.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -87.44 -30.6 20.56 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.11 0.564 . . . . 0.0 110.543 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 13.6 t70 -76.7 77.37 3.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.017 0.913 . . . . 0.0 109.395 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.22 -12.85 60.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.928 1.291 . . . . 0.0 112.284 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -75.13 -18.11 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.621 0.368 . . . . 0.0 110.208 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -70.6 137.17 49.76 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 167.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.77 143.84 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -129.64 139.07 51.51 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.067 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.583 HG23 ' HB ' ' A' ' 108' ' ' VAL . 24.7 m -97.0 127.69 48.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.73 143.93 43.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.632 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 156.45 26.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.612 0.765 . . . . 0.0 109.076 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.53 -9.95 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 118.038 0.381 . . . . 0.0 110.844 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -70.25 -31.9 69.5 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.333 1.053 . . . . 0.0 110.668 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.28 -16.95 11.63 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.532 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.93 151.76 41.74 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.002 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -96.52 119.66 35.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' HG23 ' A' ' 100' ' ' VAL . 85.1 t -70.46 -61.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.41 -152.98 23.46 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.756 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.453 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 81.6 t60 -109.06 137.63 46.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.168 0.587 . . . . 0.0 111.213 -161.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.04 129.09 34.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.039 1.336 . . . . 0.0 107.822 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HB2' HD23 ' A' ' 115' ' ' LEU . 31.4 mtpt -60.43 128.38 36.38 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.222 0.465 . . . . 0.0 111.673 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -55.79 -31.89 63.02 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.831 1.252 . . . . 0.0 113.568 -172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.03 -30.18 64.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.139 0.576 . . . . 0.0 111.811 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.9 mm? -92.11 -45.08 8.47 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.744 0.783 . . . . 0.0 109.715 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.59 66.88 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 125.251 1.421 . . . . 0.0 111.715 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.62 75.95 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.512 0.508 . . . . 0.0 113.489 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.3 -51.41 17.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.22 0.608 . . . . 0.0 109.71 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.23 -20.19 65.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.057 0.943 . . . . 0.0 111.805 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.5 68.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.594 1.158 . . . . 0.0 112.51 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -72.69 -38.63 67.49 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.646 HG12 HG13 ' A' ' 160' ' ' VAL . 3.2 mp -73.77 -30.8 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.084 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.69 -38.63 54.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.67 1.188 . . . . 0.0 110.197 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.49 -57.86 4.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.754 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.79 -20.17 53.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.029 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 60.49 56.19 3.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.957 0.903 . . . . 0.0 110.134 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 122' ' ' ILE . 91.7 mt -61.4 -34.97 76.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.191 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -165.21 176.59 8.3 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.616 0.766 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -97.88 117.88 33.18 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.182 . . . . 0.0 110.297 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.81 102.45 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 41.7 tt0 -71.71 161.48 30.92 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.994 0.917 . . . . 0.0 109.305 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -138.62 146.44 18.17 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 82' ' ' MET . 82.4 t -143.87 126.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.639 1.175 . . . . 0.0 108.025 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.0 t -103.96 97.51 11.41 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.994 0.918 . . . . 0.0 108.785 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.89 -14.0 21.53 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.882 2.388 . . . . 0.0 111.798 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -76.61 -15.93 59.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.334 1.054 . . . . 0.0 112.026 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.55 20.69 39.31 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 116.053 1.181 . . . . 0.0 116.053 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.63 13.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.312 1.045 . . . . 0.0 113.098 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -65.13 -29.56 70.42 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 109.865 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.61 118.88 20.44 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.338 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.17 64.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 110.509 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.12 -172.08 3.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.025 0.93 . . . . 0.0 110.517 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 66' ' ' HIS . 98.5 m -67.95 116.99 9.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.734 0.813 . . . . 0.0 110.635 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -107.59 156.76 37.33 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.788 0.835 . . . . 0.0 110.268 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.69 154.75 70.75 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.926 2.417 . . . . 0.0 113.869 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.48 134.99 51.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.467 1.107 . . . . 0.0 108.721 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -102.15 108.77 20.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.64 161.81 13.39 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 18.2 m -131.07 130.88 43.77 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.555 ' CE1' HG11 ' A' ' 160' ' ' VAL . 61.9 t80 -94.88 121.87 36.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -129.27 126.94 40.17 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.78 168.91 37.43 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -71.86 165.56 23.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.037 0.535 . . . . 0.0 111.843 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 36.0 mt-10 -75.02 -40.66 60.37 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.327 0.584 . . . . 0.0 111.734 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.66 -33.57 70.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.882 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.47 -42.7 18.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.107 0.563 . . . . 0.0 111.0 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 24.5 ptt180 -60.58 -32.01 71.12 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.196 0.599 . . . . 0.0 111.342 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.52 -49.0 62.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.935 0.894 . . . . 0.0 110.334 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.55 -35.35 77.3 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 0.0 111.525 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 122' ' ' ILE . 66.1 t -67.38 -51.9 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.665 0.786 . . . . 0.0 110.36 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.8 t -61.03 -42.46 98.51 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.98 0.8 . . . . 0.0 109.381 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.05 -41.2 82.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.671 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -63.81 -40.0 95.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 110.81 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 93.5 mt -67.36 -36.75 82.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.917 0.887 . . . . 0.0 112.246 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -26.94 34.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.357 0.263 . . . . 0.0 111.086 173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -59.5 -37.69 78.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.238 0.615 . . . . 0.0 110.883 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -100.17 -28.41 13.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.842 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.76 16.56 80.58 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.486 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 48.0 m-85 -110.29 127.35 54.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.749 0.819 . . . . 0.0 110.162 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 12.3 mmmm -135.52 114.98 12.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.443 1.097 . . . . 0.0 110.13 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . 53.4 tp . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 26.4 p -64.66 -23.09 67.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.064 0.946 . . . . 0.0 112.817 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.3 -44.28 95.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.03 0.932 . . . . 0.0 110.57 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -85.49 -18.76 32.57 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.012 0.925 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 6.7 tp10 -80.54 0.31 34.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.674 1.189 . . . . 0.0 111.992 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.0 -17.96 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.134 0.574 . . . . 0.0 112.265 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -102.84 127.92 49.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.84 0.856 . . . . 0.0 109.973 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -78.64 118.32 20.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.73 165.86 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.426 0.69 . . . . 0.0 111.106 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.66 108.03 3.7 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.944 0.498 . . . . 0.0 110.845 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 70.8 t80 -76.2 -40.39 52.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 109.687 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.31 -161.21 33.36 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.723 -0.487 . . . . 0.0 111.97 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.5 p -137.72 141.85 41.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 0.0 110.39 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -111.46 102.41 10.77 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.017 0.927 . . . . 0.0 110.022 -174.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -86.82 81.9 8.01 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.106 0.955 . . . . 0.0 110.707 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.89 -158.74 32.3 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.341 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -132.63 127.59 35.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 111.951 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 146' ' ' LEU . 89.2 t -96.07 124.93 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.999 0.919 . . . . 0.0 109.95 173.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.7 m -109.91 0.2 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.904 0.882 . . . . 0.0 110.599 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -67.09 -15.64 65.49 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 115.209 0.843 . . . . 0.0 115.209 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 45.0 mt -61.81 -42.21 98.73 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.876 0.871 . . . . 0.0 111.706 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 2.89 26.95 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.369 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -65.49 -69.84 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.82 -75.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.1 p -128.18 -45.95 1.37 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 66.99 8.68 50.66 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.87 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.05 127.44 35.04 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 CA-C-N 117.155 0.477 . . . . 0.0 110.186 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.89 -179.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.895 0.878 . . . . 0.0 111.11 -170.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.03 148.84 50.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.594 0.757 . . . . 0.0 110.609 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 20.4 m120 -68.37 -28.41 67.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.867 0.467 . . . . 0.0 111.99 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -117.66 51.69 1.03 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.29 136.04 57.43 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.303 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 7.4 ttt -110.62 114.55 28.02 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.2 m -103.77 169.41 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.115 0.566 . . . . 0.0 110.894 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.76 22.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.992 0.917 . . . . 0.0 109.049 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.51 134.3 34.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.392 0.677 . . . . 0.0 109.532 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -124.6 126.54 45.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.86 159.31 30.69 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -41.96 125.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.489 1.116 . . . . 0.0 113.439 -166.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -88.84 -15.75 2.53 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.077 1.852 . . . . 0.0 113.305 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -162.48 24.86 0.1 Allowed 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -167.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 15.2 m120 -109.13 96.76 22.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.341 171.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.27 -40.07 85.18 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.582 . . . . 0.0 113.406 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -90.54 -43.82 9.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.29 0.636 . . . . 0.0 111.548 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.3 m-20 -87.77 78.9 8.31 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.128 0.49 . . . . 0.0 112.111 -168.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -23.15 64.64 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 170.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.83 -16.98 61.13 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.016 0.926 . . . . 0.0 111.4 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.76 9.03 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.619 HD13 ' SD ' ' A' ' 123' ' ' MET . 79.1 mt -101.44 125.54 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.58 118.2 35.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.457 1.103 . . . . 0.0 108.418 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.68 134.09 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.567 0.747 . . . . 0.0 111.671 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 3.1 m-20 -107.69 174.23 5.97 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.702 1.201 . . . . 0.0 109.563 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 32.9 p30 -106.81 176.1 5.28 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.175 0.59 . . . . 0.0 111.093 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.28 -21.61 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.64 0.776 . . . . 0.0 112.329 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -85.26 -21.33 29.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.15 0.58 . . . . 0.0 110.842 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 119.61 -20.82 9.34 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.55 139.64 47.65 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.097 0.949 . . . . 0.0 111.417 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.3 pt20 -68.31 123.28 20.3 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.312 0.577 . . . . 0.0 111.023 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.16 -40.79 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.772 0.829 . . . . 0.0 109.529 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 162.84 -149.55 17.51 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.741 -174.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -118.82 150.48 39.75 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 110.923 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 171' ' ' LEU . 9.9 tp -78.74 159.67 27.82 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.844 1.258 . . . . 0.0 108.252 171.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -69.09 110.12 4.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -45.34 -35.32 3.47 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.335 1.454 . . . . 0.0 113.906 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.545 ' HB2' HD22 ' A' ' 115' ' ' LEU . 15.1 mm-40 -62.17 -58.33 8.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.874 0.87 . . . . 0.0 110.443 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 114' ' ' GLU . 2.9 mm? -70.83 -39.6 72.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.782 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -22.19 64.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.911 1.684 . . . . 0.0 112.081 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.5 -42.43 89.91 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 124.101 0.876 . . . . 0.0 113.687 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.96 -44.99 21.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.53 0.332 . . . . 0.0 110.311 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.81 -26.82 67.59 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.199 0.6 . . . . 0.0 111.845 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.65 67.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.723 0.809 . . . . 0.0 111.394 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.1 -41.01 67.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.214 0.605 . . . . 0.0 111.825 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 127' ' ' LEU . 3.8 mp -68.44 -38.55 79.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-O 120.884 0.373 . . . . 0.0 110.262 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.619 ' SD ' HD13 ' A' ' 98' ' ' ILE . 71.7 mtp -73.45 -48.63 32.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.865 0.866 . . . . 0.0 111.287 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.46 -45.5 68.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.53 0.732 . . . . 0.0 111.084 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -84.67 -1.76 56.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.963 0.505 . . . . 0.0 111.872 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.09 39.98 25.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 0.0 111.714 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 122' ' ' ILE . 95.3 mt -64.77 -40.66 95.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.684 0.794 . . . . 0.0 110.275 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.96 164.74 33.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.639 . . . . 0.0 110.694 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -91.28 128.97 37.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.804 1.241 . . . . 0.0 110.021 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' A' ' 123' ' ' MET . 2.3 mp -115.57 124.04 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -141.93 131.56 24.04 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -100.49 172.65 24.22 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 -173.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 5.1 p -161.54 119.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.91 1.284 . . . . 0.0 108.33 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.88 108.89 62.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 110.191 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.88 -11.14 19.95 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.677 2.251 . . . . 0.0 111.2 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 10.7 t80 -75.37 -30.82 60.29 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.157 0.583 . . . . 0.0 109.547 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.27 22.89 61.5 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.21 38.92 16.37 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.266 1.026 . . . . 0.0 112.229 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.73 -4.09 18.23 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.644 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.587 HD21 ' HB2' ' A' ' 142' ' ' PHE . 49.6 t30 -128.27 143.66 51.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.057 1.343 . . . . 0.0 108.603 173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.05 -27.71 48.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.236 0.615 . . . . 0.0 111.005 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 140' ' ' ASN . 87.4 m-85 -77.94 -165.69 0.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.1 m -70.44 149.79 46.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 136' ' ' PHE . 25.4 ptt? -143.77 160.28 50.86 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.755 0.822 . . . . 0.0 109.811 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.31 144.7 51.88 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.181 1.921 . . . . 0.0 112.827 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 67' ' ' VAL . 23.0 tp -123.15 120.03 32.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.867 1.267 . . . . 0.0 108.599 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -93.6 106.27 18.25 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 66.3 mtm -102.14 162.78 12.65 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.73 0.812 . . . . 0.0 109.195 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 m -136.01 128.98 31.33 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -96.72 116.31 28.92 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.932 1.293 . . . . 0.0 109.292 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -116.44 128.37 55.42 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.46 165.96 36.99 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -69.04 153.74 43.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.639 0.776 . . . . 0.0 110.711 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 7.4 mm-40 -61.14 -46.32 91.04 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.371 1.069 . . . . 0.0 111.166 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.31 -14.21 62.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.2 0.6 . . . . 0.0 111.409 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.23 -28.29 13.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.032 0.533 . . . . 0.0 111.324 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 29.2 ptt180 -64.08 -33.14 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.017 0.527 . . . . 0.0 111.49 -167.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -74.62 -37.11 62.91 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.354 0.662 . . . . 0.0 110.055 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.52 79.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.205 0.602 . . . . 0.0 111.132 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 42.2 t -64.03 -51.22 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.623 1.169 . . . . 0.0 110.2 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -51.1 71.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.374 1.047 . . . . 0.0 109.925 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 34.8 t70 -57.37 -36.98 71.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.325 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -67.23 -40.2 86.34 Favored 'General case' 0 C--O 1.25 1.124 0 C-N-CA 124.157 0.983 . . . . 0.0 111.146 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 170' ' ' LYS . 91.9 mt -60.53 -50.51 73.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.453 0.701 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -24.23 55.75 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.435 0.694 . . . . 0.0 112.074 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 24.3 ttmm -57.54 -54.28 48.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.486 0.715 . . . . 0.0 110.308 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -85.05 -19.88 31.28 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.799 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.22 79.81 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.175 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 54.1 m-85 -116.52 130.12 56.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.146 0.979 . . . . 0.0 110.254 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 9.9 ptmm? -167.82 139.48 3.0 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.286 1.034 . . . . 0.0 108.341 166.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 111' ' ' LEU . 2.9 tp . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -58.56 -36.04 73.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.127 0.971 . . . . 0.0 112.917 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.89 -35.94 82.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.087 0.555 . . . . 0.0 111.186 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -76.26 -31.77 58.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.814 0.845 . . . . 0.0 110.659 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -96.57 17.23 16.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.477 1.111 . . . . 0.0 111.978 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.58 -24.8 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.666 0.386 . . . . 0.0 111.029 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.49 102.26 2.18 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.263 0.625 . . . . 0.0 109.717 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.6 m -85.91 131.32 34.32 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.829 0.852 . . . . 0.0 109.804 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 m -97.57 157.93 3.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.356 1.062 . . . . 0.0 110.55 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 tp -88.14 126.22 35.01 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.568 0.747 . . . . 0.0 109.286 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -86.66 -44.21 12.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.89 -161.92 29.8 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.592 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -123.76 150.32 44.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.205 1.002 . . . . 0.0 110.889 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.6 mp -107.91 167.25 10.12 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 108.621 175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.57 102.67 3.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.0 0.905 . . . . 0.0 108.98 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.7 -171.03 13.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -134.39 118.08 17.05 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.573 0.749 . . . . 0.0 109.858 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 143' ' ' THR . 96.8 t -78.13 123.24 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.187 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 112' ' ' LYS . 33.9 m -94.55 -29.97 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.685 0.794 . . . . 0.0 110.447 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.61 -13.89 80.01 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.971 -1.013 . . . . 0.0 115.14 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.571 HD22 ' HG3' ' A' ' 144' ' ' MET . 3.1 pp -50.72 -40.27 53.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.772 0.829 . . . . 0.0 113.032 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.37 1.04 5.42 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.35 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -59.54 -66.01 0.58 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.991 0.516 . . . . 0.0 111.05 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -103.77 -72.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.533 ' HB ' HG22 ' A' ' 76' ' ' VAL . 33.7 p -127.44 -47.54 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.491 0.662 . . . . 0.0 110.411 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.4 -21.66 4.25 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.082 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 74' ' ' THR . 35.6 m -78.48 133.06 31.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-O 121.544 0.688 . . . . 0.0 110.71 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 138' ' ' ALA . 25.8 m -138.51 -174.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.976 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -68.59 154.24 42.25 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.868 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -54.11 -42.04 68.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.245 1.018 . . . . 0.0 112.244 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.4 61.41 0.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 9.1 tp10 -80.37 152.8 28.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mtp -112.14 135.27 53.01 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 108' ' ' VAL . 22.6 m -123.71 -176.6 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.522 1.129 . . . . 0.0 109.472 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.98 138.7 19.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 0.0 109.629 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 100' ' ' VAL . 8.1 mp -94.36 137.7 33.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.255 0.55 . . . . 0.0 110.028 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.06 150.73 33.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.345 -1.298 . . . . 0.0 107.612 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 137.89 54.95 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.81 117.13 38.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 63.6 Cg_endo -75.58 -11.4 20.44 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.422 2.748 . . . . 0.0 112.902 -172.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -79.16 -22.93 44.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.98 0.512 . . . . 0.0 110.358 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 6.2 m-20 -108.04 95.61 15.62 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.462 0.705 . . . . 0.0 109.864 175.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.27 -34.0 3.07 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.464 2.11 . . . . 0.0 112.453 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -80.09 -32.85 39.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.487 1.115 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 25.2 t70 -102.76 93.37 5.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.259 0.552 . . . . 0.0 109.725 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.44 -15.17 60.91 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.917 0.887 . . . . 0.0 110.857 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -8.93 58.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.404 0.682 . . . . 0.0 111.032 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.87 128.12 33.47 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 168.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -134.91 123.34 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.014 0.926 . . . . 0.0 108.846 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.532 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 19.6 ttmm -100.73 149.42 23.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.365 0.666 . . . . 0.0 110.332 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.543 HG22 ' HG ' ' A' ' 85' ' ' LEU . 88.7 t -108.08 123.14 63.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.346 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -125.32 144.89 50.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.3 0.64 . . . . 0.0 110.331 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.2 154.9 40.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.869 1.268 . . . . 0.0 108.718 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.21 -23.59 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.162 0.585 . . . . 0.0 110.642 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.56 -31.37 66.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.829 1.252 . . . . 0.0 111.311 170.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.96 -2.95 24.24 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 113.734 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -75.12 143.26 43.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.366 0.666 . . . . 0.0 110.694 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.87 109.68 7.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.136 0.574 . . . . 0.0 109.645 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 83' ' ' VAL . 16.0 t -98.48 -20.51 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.034 0.934 . . . . 0.0 110.622 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.25 34.46 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 116.183 1.233 . . . . 0.0 116.183 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -176.65 136.25 0.24 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.974 1.71 . . . . 0.0 107.507 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mp -78.71 137.55 37.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 110.487 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' VAL . 13.4 mmmm -68.02 154.47 41.56 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 167.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -52.37 -27.21 14.72 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.315 1.046 . . . . 0.0 112.638 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 115' ' ' LEU . 10.0 mm-40 -64.27 -57.06 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.336 0.655 . . . . 0.0 110.231 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.1 mm? -70.57 -44.72 66.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.93 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 0.0 111.596 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.06 -21.83 59.7 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.037 0.211 . . . . 0.0 113.441 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.25 -59.6 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 110.223 171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -63.62 -18.89 64.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.268 1.027 . . . . 0.0 113.513 -170.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.0 70.15 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 111.612 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -77.39 -31.66 54.37 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.883 0.873 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 160' ' ' VAL . 2.1 mp -72.33 -34.51 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.732 0.813 . . . . 0.0 109.208 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.1 tpp -75.79 -38.98 57.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.303 . . . . 0.0 110.125 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.8 -57.01 4.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 18.3 m120 -80.3 -5.33 56.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.163 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 58.29 35.0 24.58 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.183 0.993 . . . . 0.0 110.755 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 95.3 mt -58.55 -40.44 83.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.158 0.983 . . . . 0.0 111.315 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.42 129.47 14.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.012 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.45 113.55 6.85 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -89.93 97.4 7.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -98.28 114.92 27.37 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.88 149.26 19.86 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.99 117.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 77' ' ' VAL . 2.0 p -107.17 96.58 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.54 -9.93 15.98 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.309 2.673 . . . . 0.0 111.781 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' A' ' 138' ' ' ALA . 32.8 t80 -68.02 -32.68 73.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.644 0.777 . . . . 0.0 110.487 175.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.97 -17.63 49.75 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.39 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . 60.66 24.12 13.92 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.453 1.101 . . . . 0.0 113.024 175.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -66.91 -32.17 73.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.885 0.874 . . . . 0.0 111.045 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.449 HD21 ' HB2' ' A' ' 142' ' ' PHE . 42.0 t30 -67.71 133.58 49.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.55 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.98 60.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.871 0.869 . . . . 0.0 111.236 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' ASN . 98.3 m-85 -80.78 -179.82 7.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.18 0.592 . . . . 0.0 110.987 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' VAL . 89.7 m -69.05 123.27 20.6 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.567 0.747 . . . . 0.0 110.354 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.571 ' HG3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -116.99 154.61 49.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.732 0.813 . . . . 0.0 110.33 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.89 148.32 35.65 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.488 2.125 . . . . 0.0 113.386 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 65.9 tp -125.28 143.16 51.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.141 1.377 . . . . 0.0 107.804 175.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -110.35 113.39 26.01 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -100.79 164.29 11.92 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 m -142.46 124.88 15.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.447 ' HE2' HD11 ' A' ' 164' ' ' LEU . 3.0 m-30 -95.18 127.22 41.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.657 0.783 . . . . 0.0 111.21 -176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -126.34 149.53 49.12 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.376 1.07 . . . . 0.0 109.449 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.39 -135.11 3.72 Favored Glycine 0 C--O 1.211 -1.328 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.61 175.67 8.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.313 1.056 . . . . 0.0 111.731 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 49.1 mt-10 -76.57 -38.53 54.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.87 0.868 . . . . 0.0 113.221 -167.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG2' HD22 ' A' ' 156' ' ' ASN . 3.7 pm0 -64.84 -29.31 70.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.869 0.468 . . . . 0.0 110.293 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.57 HD22 ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -80.74 -35.53 33.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.51 0.724 . . . . 0.0 110.868 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 160' ' ' VAL . 6.7 ppt_? -69.82 -29.87 67.25 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -176.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.8 -49.96 72.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.909 0.884 . . . . 0.0 110.43 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.75 70.93 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.009 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 14.8 p -68.67 -39.08 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.549 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.1 t -61.65 -49.5 76.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -55.03 -41.09 70.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.998 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.24 0.616 . . . . 0.0 111.779 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD11 ' HE2' ' A' ' 150' ' ' PHE . 88.2 mt -64.09 -49.16 73.33 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.946 0.898 . . . . 0.0 111.512 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -27.23 57.48 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.605 0.362 . . . . 0.0 111.554 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -67.85 -42.93 80.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.173 0.589 . . . . 0.0 111.136 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 169' ' ' PHE . 20.9 m170 -89.5 -39.13 13.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.999 0.519 . . . . 0.0 110.718 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.96 38.59 40.54 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.43 -0.35 . . . . 0.0 113.102 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.695 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 74.1 m-85 -133.84 130.04 37.32 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.367 0.667 . . . . 0.0 110.778 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.89 119.55 11.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.074 0.95 . . . . 0.0 110.11 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 C--O 1.246 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 108.481 174.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.6 p -75.23 -16.55 60.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.704 0.802 . . . . 0.0 112.038 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -80.7 -30.71 36.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.005 0.922 . . . . 0.0 110.697 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.46 -55.12 4.04 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.855 0.862 . . . . 0.0 109.251 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -89.28 63.72 6.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.897 1.279 . . . . 0.0 108.821 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.29 -38.0 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.267 0.627 . . . . 0.0 111.097 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -121.48 142.39 50.09 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.934 0.893 . . . . 0.0 108.824 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 m -64.4 136.52 57.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.601 0.76 . . . . 0.0 110.703 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.27 155.73 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.717 . . . . 0.0 109.908 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.75 105.04 2.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 161' ' ' SER . 35.7 t80 -71.52 -35.27 70.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.799 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.89 34.57 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 123.569 0.543 . . . . 0.0 112.754 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 22.2 p -151.41 136.57 17.5 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.257 1.023 . . . . 0.0 110.211 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.2 mt -103.95 -178.06 3.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.881 0.872 . . . . 0.0 111.507 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 157.55 30.16 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.522 169.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -177.24 -165.79 33.06 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -121.32 117.61 27.42 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.829 0.814 . . . . 0.0 110.84 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.9 t -91.48 142.07 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 143' ' ' THR . 12.8 m -107.29 -16.55 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.089 1.356 . . . . 0.0 109.763 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -59.41 -12.6 18.89 Favored Glycine 0 C--O 1.204 -1.743 0 C-N-CA 125.596 1.57 . . . . 0.0 116.071 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 70' ' ' LEU . 4.7 mp -45.03 -50.68 10.64 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.061 0.931 . . . . 0.0 111.421 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 142' ' ' PHE . 18.9 ptp180 -75.59 6.24 5.02 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -70.17 -55.2 9.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 0.0 110.687 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -115.68 -69.85 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.488 ' HB ' HG22 ' A' ' 76' ' ' VAL . 23.5 p -124.77 -47.26 1.82 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.753 0.421 . . . . 0.0 111.38 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.35 69.58 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.029 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 74' ' ' THR . 31.5 m -136.16 128.45 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.52 -174.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.693 1.197 . . . . 0.0 110.042 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.59 151.66 40.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.535 0.734 . . . . 0.0 110.832 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.13 -30.62 68.27 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.287 1.035 . . . . 0.0 112.645 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -124.69 37.26 4.44 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.466 1.106 . . . . 0.0 109.51 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.73 112.51 1.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.159 0.984 . . . . 0.0 113.09 -172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 103' ' ' VAL . 62.5 mtt -77.31 124.84 28.41 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 35.5 m -117.36 170.3 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.855 0.862 . . . . 0.0 110.609 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 133.97 39.29 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.929 0.892 . . . . 0.0 109.804 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.87 109.51 17.06 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -110.35 126.99 54.82 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.786 0.834 . . . . 0.0 109.13 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.562 ' HB3' ' SD ' ' A' ' 123' ' ' MET . 51.3 ptt85 -57.87 142.5 45.76 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.981 0.513 . . . . 0.0 110.04 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.83 111.41 4.79 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.191 0.597 . . . . 0.0 111.282 -169.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -86.29 -8.54 7.5 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.282 2.655 . . . . 0.0 113.176 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -95.6 -35.04 11.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.897 0.879 . . . . 0.0 110.553 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -103.17 104.76 42.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.917 0.887 . . . . 0.0 110.532 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.47 -36.16 12.09 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.671 2.248 . . . . 0.0 112.267 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -82.48 -34.19 28.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.572 0.749 . . . . 0.0 111.091 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.83 59.85 0.74 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.817 0.818 . . . . 0.0 109.551 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.47 -22.82 65.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.024 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.47 -15.39 62.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.853 0.861 . . . . 0.0 111.202 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.79 46.25 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.982 0.513 . . . . 0.0 109.739 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.94 132.44 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -104.61 126.11 51.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.404 1.082 . . . . 0.0 108.648 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.67 119.03 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.778 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -119.8 130.15 54.79 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.106 0.962 . . . . 0.0 108.935 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.7 p-10 -75.9 -176.42 3.4 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.151 0.58 . . . . 0.0 110.666 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 29.7 m -64.22 -23.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 118.654 0.661 . . . . 0.0 112.091 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.24 -24.06 63.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.293 0.637 . . . . 0.0 110.16 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.16 9.66 61.83 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.693 0.663 . . . . 0.0 112.598 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.96 135.16 34.98 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.33 1.052 . . . . 0.0 109.602 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -76.12 65.49 2.13 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.375 1.47 . . . . 0.0 111.898 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.88 -31.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.138 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . -132.72 -179.29 16.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.839 -0.619 . . . . 0.0 114.31 -171.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.655 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 37.3 t60 -162.34 124.42 2.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 107.685 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 171' ' ' LEU . 3.3 tp -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.793 1.237 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -61.63 120.85 11.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.1 ptmt -60.26 -21.36 61.79 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.229 1.012 . . . . 0.0 113.41 -172.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.37 -47.26 86.12 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.679 0.752 . . . . 0.0 109.961 172.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 169' ' ' PHE . 3.2 mm? -80.95 -41.11 23.4 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.712 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -61.76 -33.39 73.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.295 1.038 . . . . 0.0 111.937 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.02 -27.52 67.31 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.661 0.601 . . . . 0.0 112.681 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 167' ' ' HIS . . . -73.56 -50.75 19.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.163 0.985 . . . . 0.0 110.895 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 171' ' ' LEU . 2.9 mm? -68.01 -22.21 64.99 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.42 0.688 . . . . 0.0 110.627 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.96 -33.53 67.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.096 0.959 . . . . 0.0 111.185 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -65.82 -43.81 87.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.903 0.481 . . . . 0.0 111.008 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.95 -38.75 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 12.5 ptp -81.76 -29.89 32.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.44 -49.58 21.82 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.16 0.505 . . . . 0.0 110.121 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -79.68 -0.98 36.28 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.418 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 56.55 36.67 27.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.993 1.317 . . . . 0.0 112.186 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.96 -41.25 87.21 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -161.85 153.73 19.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 111.156 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -84.17 114.37 21.74 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.655 1.182 . . . . 0.0 108.872 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 130' ' ' ILE . 1.7 mp -90.61 98.94 8.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.74 165.13 24.59 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.746 0.818 . . . . 0.0 108.975 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -142.42 162.83 27.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.94 127.33 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 123.871 0.868 . . . . 0.0 109.131 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.38 105.14 16.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.071 1.349 . . . . 0.0 108.202 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.54 -9.74 16.0 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.267 1.978 . . . . 0.0 112.113 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.22 -17.49 25.96 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.166 0.986 . . . . 0.0 111.751 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.33 69.14 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 123.413 0.445 . . . . 0.0 114.041 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 56.07 71.5 0.55 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.684 1.194 . . . . 0.0 110.158 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -91.45 17.91 7.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.215 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.69 174.08 13.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.925 0.49 . . . . 0.0 111.368 -172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -103.43 -21.08 13.85 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 111.392 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HA ' HH21 ' A' ' 71' ' ' ARG . 33.5 p90 -79.82 -169.29 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.941 0.497 . . . . 0.0 110.411 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 HG12 ' A' ' 68' ' ' VAL . 61.5 p -72.8 141.14 48.05 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.288 0.235 . . . . 0.0 111.524 -175.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' HD11 ' A' ' 70' ' ' LEU . 26.1 ptt? -124.43 144.7 46.72 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 123.674 0.789 . . . . 0.0 109.281 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 26.7 Cg_exo -66.02 128.56 19.93 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.294 1.996 . . . . 0.0 112.448 167.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 148' ' ' MET . 56.5 tp -108.04 148.44 29.76 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.016 0.927 . . . . 0.0 108.912 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -112.7 117.12 31.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.68 0.792 . . . . 0.0 109.036 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.1 mpt? -103.33 163.73 12.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.896 0.878 . . . . 0.0 109.376 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 38.3 m -143.05 134.82 26.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.046 0.538 . . . . 0.0 110.242 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -95.49 121.76 37.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 0.0 110.437 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -117.02 127.18 53.91 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 162.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.77 162.72 36.51 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -81.79 155.44 25.44 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.97 0.508 . . . . 0.0 110.461 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.92 -24.3 66.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.654 0.781 . . . . 0.0 112.837 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.27 -40.85 90.41 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.853 0.358 . . . . 0.0 110.822 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 160' ' ' VAL . 14.0 m120 -90.98 -16.94 27.15 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 118.871 -0.585 . . . . 0.0 112.402 -172.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.15 -28.48 67.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.519 0.512 . . . . 0.0 111.229 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.12 -54.17 45.04 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.839 0.855 . . . . 0.0 110.18 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.73 69.1 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.915 0.76 . . . . 0.0 112.095 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 156' ' ' ASN . 68.0 t -62.21 -60.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 60' ' ' PHE . 23.1 t -59.89 -53.13 61.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.22 0.95 . . . . 0.0 111.198 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.32 -49.32 17.76 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.981 1.313 . . . . 0.0 111.764 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -69.91 -37.75 76.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.537 ' HA ' ' CE1' ' A' ' 167' ' ' HIS . 78.5 mt -59.07 -49.78 76.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.275 0.63 . . . . 0.0 111.743 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -67.49 -32.77 73.82 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.717 0.636 . . . . 0.0 110.567 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.06 -54.6 42.8 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.822 0.849 . . . . 0.0 111.471 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 164' ' ' LEU . 2.2 p80 -81.43 -28.44 34.26 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.358 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.35 -0.03 60.87 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 75.0 m-85 -112.28 146.46 38.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.507 1.123 . . . . 0.0 109.571 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -169.7 156.1 6.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.275 1.03 . . . . 0.0 110.212 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.541 ' H ' HD21 ' A' ' 119' ' ' LEU . 22.7 tp . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 CA-C-O 119.585 -0.564 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 55' ' ' VAL . 21.7 m -57.23 -40.39 77.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.319 1.048 . . . . 0.0 113.262 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.78 -32.94 60.75 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.154 0.582 . . . . 0.0 111.979 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.25 -7.55 24.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.416 1.087 . . . . 0.0 110.853 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 39.9 tt0 -108.84 -9.76 15.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.014 0.925 . . . . 0.0 111.769 -174.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' SER . 15.6 m -81.0 20.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -98.68 146.17 26.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.884 0.874 . . . . 0.0 109.366 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -67.36 119.68 12.6 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.079 0.552 . . . . 0.0 110.579 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -110.79 167.67 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.018 0.927 . . . . 0.0 110.166 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.41 120.93 29.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.345 0.658 . . . . 0.0 111.057 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.6 ' HA ' HH11 ' A' ' 157' ' ' ARG . 24.7 t80 -80.46 -43.67 20.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.62 -161.19 28.91 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -118.26 148.13 42.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.0 mp -99.31 170.34 8.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -153.84 30.77 0.45 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.717 0.407 . . . . 0.0 111.275 -170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -70.07 158.66 53.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.33 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' THR . 25.7 p-80 -100.13 109.6 21.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.39 0.676 . . . . 0.0 111.457 -171.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.9 m -76.0 122.35 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.468 0.652 . . . . 0.0 111.753 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.68 -1.34 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.422 1.089 . . . . 0.0 110.827 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 72' ' ' TYR . . . -69.66 -18.44 73.94 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.875 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 144' ' ' MET . 57.5 mt -59.1 -24.95 63.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 6.33 3.57 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.533 0.733 . . . . 0.0 112.455 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 6.5 t80 -62.18 -70.24 0.21 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.399 0.68 . . . . 0.0 109.977 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -118.34 -68.29 0.93 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.769 0.427 . . . . 0.0 109.912 168.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -122.45 -44.5 2.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.111 0.564 . . . . 0.0 110.587 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.77 66.74 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.367 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.61 136.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.184 0.594 . . . . 0.0 110.977 -173.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 134' ' ' VAL . 14.9 m -142.84 -179.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.011 0.924 . . . . 0.0 110.644 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.14 154.57 41.76 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.016 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -47.36 -50.81 21.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.922 1.289 . . . . 0.0 111.782 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.14 57.69 1.06 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.82 148.82 50.55 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.348 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.18 132.66 44.34 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.7 m -126.94 165.54 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.108 0.963 . . . . 0.0 109.205 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.68 116.35 15.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.496 0.718 . . . . 0.0 109.573 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 130' ' ' ILE . 6.9 mp -73.16 107.28 5.4 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 89' ' ' PRO . 29.0 tt0 -109.74 143.96 38.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 108.519 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -65.37 -164.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.799 0.84 . . . . 0.0 111.161 173.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -39.63 110.42 0.63 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.28 1.032 . . . . 0.0 111.863 169.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.445 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . 92.0 Cg_endo -82.99 -39.47 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.557 2.171 . . . . 0.0 113.133 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -169.2 17.98 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.563 0.745 . . . . 0.0 110.506 -172.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 17.9 m120 -104.79 98.78 16.04 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 123.792 0.837 . . . . 0.0 109.457 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.67 -44.59 25.47 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.457 2.771 . . . . 0.0 114.189 -166.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.77 -21.85 26.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.179 0.592 . . . . 0.0 111.026 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 28.0 m-20 -93.93 64.77 3.43 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 109.761 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.35 -24.94 63.06 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.575 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -89.44 -11.23 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.245 0.618 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -69.59 104.82 2.47 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 123.357 0.411 . . . . 0.0 110.606 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 108.83 18.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -103.28 121.16 42.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.056 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 83' ' ' VAL . 21.7 t -94.14 117.73 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.403 0.681 . . . . 0.0 109.977 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -110.6 129.37 55.82 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.054 0.942 . . . . 0.0 109.14 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 23.7 p-10 -78.38 165.96 23.21 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.16 0.436 . . . . 0.0 109.938 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -64.81 -20.13 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -72.02 -29.87 64.63 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.246 0.618 . . . . 0.0 110.453 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 108.76 39.01 1.8 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.246 -0.433 . . . . 0.0 113.241 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -119.07 127.74 53.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.949 0.9 . . . . 0.0 108.99 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.59 75.0 5.11 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.052 0.93 . . . . 0.0 109.158 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.21 -35.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.656 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.16 166.55 13.42 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -172.09 123.85 0.51 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 108.969 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.3 mp -70.22 136.12 49.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.57 171.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -63.86 147.55 51.59 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -29.42 11.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.643 0.777 . . . . 0.0 112.526 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.569 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.9 mt-10 -62.03 -49.74 74.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 110.235 -175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 1.5 mm? -87.16 -43.2 12.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.82 -33.88 64.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.045 1.338 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.98 -38.06 92.32 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 124.021 0.825 . . . . 0.0 113.544 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.66 20.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.16 0.584 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 170' ' ' LYS . 3.7 mm? -67.54 -20.98 65.48 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 0.0 111.246 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.03 74.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.623 0.769 . . . . 0.0 110.998 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -65.51 -41.23 93.41 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.064 0.546 . . . . 0.0 110.824 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 127' ' ' LEU . 2.5 mp -68.83 -45.58 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.834 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 46.2 ttm -73.62 -25.83 60.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.074 0.549 . . . . 0.0 111.224 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.82 -55.23 10.37 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 0.0 109.675 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 1.9 m-20 -76.92 -7.25 55.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.655 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 62.2 31.92 17.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.464 1.106 . . . . 0.0 111.027 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 125' ' ' ASN . 96.3 mt -57.49 -58.74 6.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.713 0.805 . . . . 0.0 111.608 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.67 138.27 42.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.846 0.459 . . . . 0.0 110.405 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -75.82 116.07 16.15 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.246 1.019 . . . . 0.0 109.496 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 85' ' ' LEU . 2.4 mp -91.64 100.71 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 12.0 tp10 -69.19 161.0 30.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.275 1.03 . . . . 0.0 109.426 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.16 136.65 6.44 Favored Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -146.6 129.02 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.203 1.401 . . . . 0.0 108.157 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 137' ' ' GLY . 1.9 p -107.67 106.46 58.51 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.098 0.559 . . . . 0.0 109.618 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.57 -11.51 15.59 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.561 2.174 . . . . 0.0 112.486 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.423 ' HE2' ' H ' ' A' ' 140' ' ' ASN . 69.0 t80 -75.93 -23.0 55.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 67.63 13.56 63.54 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.83 47.28 20.57 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.156 0.982 . . . . 0.0 111.765 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -63.98 -28.17 69.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.961 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' H ' ' HE2' ' A' ' 136' ' ' PHE . 90.9 m-20 -112.72 131.15 55.79 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.143 0.977 . . . . 0.0 108.62 171.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.17 -15.58 62.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.611 0.764 . . . . 0.0 110.328 170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -64.6 178.78 0.71 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.144 0.978 . . . . 0.0 111.186 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 66' ' ' HIS . 51.3 m -69.85 117.61 11.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.239 0.616 . . . . 0.0 110.214 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 70' ' ' LEU . 25.6 ptt? -116.88 150.99 46.82 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 123.426 0.69 . . . . 0.0 109.631 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.53 129.31 17.6 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.295 1.997 . . . . 0.0 111.587 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.471 HD23 ' HE3' ' A' ' 148' ' ' MET . 51.1 tp -110.88 141.48 44.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -101.39 109.71 21.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.747 0.419 . . . . 0.0 109.998 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.35 164.14 11.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 131' ' ' GLU . 16.5 m -137.6 132.69 33.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.005 0.366 . . . . 0.0 110.237 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -95.06 116.2 28.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.981 0.912 . . . . 0.0 110.252 178.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -116.17 128.98 56.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.619 1.168 . . . . 0.0 108.193 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.35 160.36 27.14 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.462 ' HE3' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -74.27 162.4 28.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.608 0.763 . . . . 0.0 109.335 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.8 -37.52 73.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.462 0.705 . . . . 0.0 112.49 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.13 -37.08 43.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.172 0.989 . . . . 0.0 110.951 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.462 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 13.9 m120 -86.46 -50.06 7.15 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.6 HH11 ' HA ' ' A' ' 60' ' ' PHE . 36.4 mtm180 -51.96 -49.55 62.97 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.532 1.145 . . . . 0.0 112.375 -166.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -60.15 -39.1 85.19 Favored 'General case' 0 CA--C 1.553 1.083 0 O-C-N 123.528 0.517 . . . . 0.0 111.389 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.07 60.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.409 0.684 . . . . 0.0 111.764 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 68.2 t -62.58 -53.72 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.964 0.906 . . . . 0.0 110.203 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.0 m -56.79 -49.95 73.79 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.562 1.164 . . . . 0.0 110.21 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 166' ' ' LYS . 34.2 t70 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.102 0.876 . . . . 0.0 110.701 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.86 -34.88 73.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.481 1.112 . . . . 0.0 111.732 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 92.7 mt -68.94 -33.16 73.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -31.8 39.59 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.834 0.288 . . . . 0.0 111.479 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 28.2 mtpp -60.85 -53.0 62.65 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -87.49 -37.42 16.95 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.909 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.66 -4.96 49.34 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 113.549 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.762 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 67.1 m-85 -89.01 107.13 18.87 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 123.86 0.864 . . . . 0.0 109.554 -175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.569 ' HD3' ' HB3' ' A' ' 164' ' ' LEU . 36.7 mtmm -134.01 139.04 45.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 110.206 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.685 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 4.9 tt . . . . . 0 C--O 1.25 1.088 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' GLU . 41.1 p -54.34 -25.34 23.52 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.36 1.064 . . . . 0.0 113.698 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.37 -55.4 35.21 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.209 1.003 . . . . 0.0 111.305 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -5.47 48.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.108 0.563 . . . . 0.0 111.415 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 51' ' ' SER . 28.6 tt0 -90.96 21.81 3.99 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.517 0.727 . . . . 0.0 110.878 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.34 -4.09 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.792 0.837 . . . . 0.0 112.222 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.1 109.12 1.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.763 0.825 . . . . 0.0 111.589 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -105.15 117.71 34.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.494 1.118 . . . . 0.0 108.767 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.86 153.22 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.561 0.744 . . . . 0.0 110.278 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -88.21 113.0 23.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 150' ' ' PHE . 78.8 t80 -72.77 -50.95 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.476 1.11 . . . . 0.0 110.796 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.06 -161.29 29.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.419 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.6 p -133.33 144.71 49.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.158 0.583 . . . . 0.0 110.709 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 3.2 mp -104.9 174.07 6.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 0.0 109.633 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -139.67 153.99 47.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.71 -167.19 35.48 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 123.15 0.281 . . . . 0.0 112.458 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -143.33 117.18 9.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.999 0.92 . . . . 0.0 110.132 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.9 t -83.89 113.06 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.054 0.542 . . . . 0.0 109.597 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' HH21 ' A' ' 71' ' ' ARG . 27.8 m -85.87 -13.65 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -65.07 -17.15 63.08 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.749 -1.114 . . . . 0.0 115.779 -166.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 144' ' ' MET . 55.7 mt -52.44 -33.43 44.06 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 68' ' ' VAL . 8.9 ptt85 -74.31 6.67 3.41 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.916 0.887 . . . . 0.0 112.98 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -75.73 -66.83 0.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.775 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' HB2' HE22 ' A' ' 107' ' ' GLN . 47.2 t80 -112.62 -70.29 0.82 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.47 0.308 . . . . 0.0 110.926 -172.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 p -126.73 -47.51 1.54 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.59 0.756 . . . . 0.0 110.92 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.22 6.73 88.81 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.82 -1.082 . . . . 0.0 114.71 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.19 128.04 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.198 0.523 . . . . 0.0 109.723 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG13 HD22 ' A' ' 102' ' ' ASN . 13.3 t -138.89 161.85 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 22.7 t-20 -76.1 156.29 33.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.462 0.574 . . . . 0.0 110.706 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 26.8 t-20 -60.71 -30.7 70.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -168.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -129.98 30.98 4.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.075 0.55 . . . . 0.0 110.12 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 9.0 tp10 -74.62 152.19 39.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.145 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.572 ' HG3' HG22 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -91.53 143.95 26.06 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.144 170.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.04 171.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 123.774 0.83 . . . . 0.0 109.166 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.3 110.2 10.92 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.73 115.55 14.43 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -122.17 118.56 28.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -62.59 168.01 4.01 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -34.45 107.01 0.3 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 125.006 1.323 . . . . 0.0 114.037 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -104.31 4.27 0.31 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.749 2.966 . . . . 0.0 113.516 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -158.28 -44.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -58.5 103.02 0.33 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 124.648 1.179 . . . . 0.0 111.451 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.56 -44.85 12.8 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.154 2.569 . . . . 0.0 113.902 -163.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -89.25 -44.88 9.95 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.181 0.593 . . . . 0.0 110.89 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.05 85.25 6.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 -168.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -75.6 -14.8 60.4 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.295 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.8 -0.25 56.07 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.726 0.411 . . . . 0.0 112.062 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.09 106.66 2.04 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.893 0.477 . . . . 0.0 110.541 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.2 mt -99.28 113.39 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -95.81 133.88 39.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 0.0 110.656 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.68 115.23 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 71.2 m-20 -103.44 171.88 7.12 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.15 0.98 . . . . 0.0 110.368 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 81' ' ' GLU . 27.5 t-20 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 82' ' ' MET . 35.0 m -64.34 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.348 0.659 . . . . 0.0 112.753 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -87.36 9.02 21.91 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.019 0.528 . . . . 0.0 110.078 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.47 -22.93 7.91 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.8 -0.444 . . . . 0.0 113.565 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.44 111.11 1.0 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 0.0 110.328 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 5.0 pp0? -65.38 127.35 31.43 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 123.6 0.562 . . . . 0.0 109.965 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.49 -0.79 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.183 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 147.44 -150.35 22.58 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.221 0.326 . . . . 0.0 113.456 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.39 172.12 13.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.738 0.815 . . . . 0.0 110.298 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 tp -87.96 160.69 17.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.233 1.013 . . . . 0.0 109.742 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' HD23 ' A' ' 115' ' ' LEU . 11.8 mmmm -82.08 141.87 32.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.805 0.442 . . . . 0.0 110.345 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -62.09 -27.92 69.25 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.938 0.895 . . . . 0.0 113.037 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' HD22 ' A' ' 115' ' ' LEU . 28.1 mp0 -63.44 -54.09 42.02 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.486 0.66 . . . . 0.0 109.286 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 2.7 mm? -72.36 -41.88 65.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.253 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.92 -25.63 68.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.295 1.038 . . . . 0.0 111.266 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.77 -34.38 82.14 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.512 0.507 . . . . 0.0 112.862 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.48 -60.61 2.08 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.954 0.501 . . . . 0.0 110.344 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.619 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.9 mp -65.26 -20.18 66.3 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -169.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.09 65.61 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.106 0.562 . . . . 0.0 111.84 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -64.45 -37.27 86.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.338 0.655 . . . . 0.0 110.9 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 119' ' ' LEU . 2.3 mp -73.97 -39.98 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.025 0.93 . . . . 0.0 110.112 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.479 ' SD ' HD13 ' A' ' 130' ' ' ILE . 91.3 mmm -70.81 -39.86 72.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.543 1.137 . . . . 0.0 111.074 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.55 -51.09 11.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.812 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.0 -1.97 55.73 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.312 0.645 . . . . 0.0 112.308 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm 61.97 35.04 16.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.093 0.957 . . . . 0.0 111.96 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 87.8 mt -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.75 154.23 22.04 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.446 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -99.16 118.67 36.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.653 1.181 . . . . 0.0 108.683 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.479 HD13 ' SD ' ' A' ' 123' ' ' MET . 3.6 mp -94.3 98.25 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.48 117.4 30.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.357 0.663 . . . . 0.0 109.245 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -115.53 133.7 11.07 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 120.09 -0.283 . . . . 0.0 113.765 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 82' ' ' MET . 87.3 t -113.54 135.83 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.585 1.154 . . . . 0.0 108.113 168.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.6 p -93.04 100.46 4.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 171.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.07 -12.37 10.69 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.32 2.014 . . . . 0.0 112.749 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.44 -31.03 53.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 89.32 -5.78 83.85 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.724 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . 57.98 44.39 19.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.754 0.822 . . . . 0.0 110.936 -175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.8 -25.93 68.12 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.267 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -95.87 148.39 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.175 0.99 . . . . 0.0 110.16 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.77 -24.12 52.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.418 0.687 . . . . 0.0 109.824 171.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 70' ' ' LEU . 65.7 t80 -69.65 173.37 6.19 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.9 1.28 . . . . 0.0 109.987 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.8 m -66.92 135.4 53.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.074 0.95 . . . . 0.0 111.149 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -124.64 158.71 61.16 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.988 0.915 . . . . 0.0 110.55 -178.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.04 142.94 52.58 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.686 2.258 . . . . 0.0 112.281 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 148' ' ' MET . 40.5 tp -121.63 141.45 51.1 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -108.21 133.53 52.32 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.519 ' HE3' ' HB3' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -122.73 164.58 18.04 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -133.73 144.28 49.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.064 0.946 . . . . 0.0 108.652 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -109.48 111.45 22.98 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.958 -169.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -114.58 146.13 41.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.884 0.873 . . . . 0.0 108.922 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.57 38.88 Favored Glycine 0 N--CA 1.466 0.647 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.351 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -76.39 162.68 27.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.995 0.518 . . . . 0.0 111.404 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 42.4 mt-10 -75.19 -37.4 61.21 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.363 0.665 . . . . 0.0 111.712 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.9 -36.36 75.34 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.874 174.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.3 -38.55 68.7 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.121 0.568 . . . . 0.0 110.912 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -62.08 -27.37 68.86 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 123.332 0.395 . . . . 0.0 111.405 -170.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -69.94 -51.05 36.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.321 1.048 . . . . 0.0 111.024 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.2 -33.95 68.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.534 0.734 . . . . 0.0 111.774 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 122' ' ' ILE . 11.8 p -77.49 -33.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.034 0.534 . . . . 0.0 110.492 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.7 t -60.41 -47.88 84.16 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.89 -42.27 71.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.44 -39.83 94.6 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.828 0.851 . . . . 0.0 111.364 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.06 -40.46 95.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.362 0.665 . . . . 0.0 111.069 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -35.32 62.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.598 0.359 . . . . 0.0 111.839 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.22 -38.84 90.71 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.23 0.612 . . . . 0.0 111.527 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 73.0 m80 -97.85 -27.38 14.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.816 0.446 . . . . 0.0 111.512 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.98 37.67 92.27 Favored Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.325 0.39 . . . . 0.0 113.754 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 34.9 m-85 -126.61 136.03 51.99 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.252 0.621 . . . . 0.0 111.515 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -140.73 120.15 13.12 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.623 1.169 . . . . 0.0 109.276 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 171.178 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 p -74.56 -12.83 60.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.036 0.935 . . . . 0.0 111.844 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.17 -28.84 69.08 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.196 0.599 . . . . 0.0 111.049 174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -68.4 -16.37 63.89 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 0.0 111.527 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 49.0 mt-10 -109.22 16.1 22.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.35 1.06 . . . . 0.0 111.727 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.85 0.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.95 129.44 56.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.109 0.964 . . . . 0.0 108.822 169.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -76.48 116.11 16.86 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.14 147.49 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.773 0.829 . . . . 0.0 110.017 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.47 132.85 48.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.992 0.517 . . . . 0.0 109.823 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 161' ' ' SER . 79.0 t80 -92.85 -44.59 8.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.79 -164.11 25.95 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.244 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.7 p -132.56 131.43 41.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.964 0.906 . . . . 0.0 110.772 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 85.7 mt -90.12 157.13 17.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.561 1.144 . . . . 0.0 108.963 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -162.09 35.91 0.12 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -162.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.75 -157.79 17.16 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 120.045 -0.308 . . . . 0.0 113.184 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.546 ' HB3' HG22 ' A' ' 143' ' ' THR . 39.1 m-70 -124.95 138.67 54.23 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 146' ' ' LEU . 53.0 t -100.42 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.099 0.96 . . . . 0.0 110.357 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.47 -3.28 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.517 0.727 . . . . 0.0 110.362 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -63.22 -14.93 55.68 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.243 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 144' ' ' MET . 98.5 mt -53.85 -37.59 63.8 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.712 0.756 . . . . 0.0 112.424 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -88.94 9.1 26.2 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.377 0.671 . . . . 0.0 112.179 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -66.19 -69.74 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.166 0.586 . . . . 0.0 110.7 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.38 -68.96 0.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.115 0.483 . . . . 0.0 110.137 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -125.16 -43.04 1.97 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.8 0.84 . . . . 0.0 109.986 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.53 57.63 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.622 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.33 127.5 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.044 0.538 . . . . 0.0 109.96 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.36 134.42 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.913 0.885 . . . . 0.0 109.672 -170.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -72.37 152.3 42.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.18 0.992 . . . . 0.0 109.877 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -59.13 -34.88 72.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.909 0.483 . . . . 0.0 111.398 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.93 44.08 2.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.186 0.994 . . . . 0.0 109.313 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.28 147.96 49.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.62 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 133' ' ' VAL . 89.5 mtp -117.42 129.3 55.76 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 166.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.95 166.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.799 0.84 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.1 116.17 14.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.142 0.977 . . . . 0.0 108.617 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 130' ' ' ILE . 7.8 mp -80.12 109.44 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -118.61 137.49 53.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.223 1.009 . . . . 0.0 109.814 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -62.22 116.37 4.95 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 166.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.57 118.37 25.05 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.583 1.153 . . . . 0.0 111.242 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -85.16 -6.81 9.27 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 123.645 2.897 . . . . 0.0 112.85 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.0 -32.22 30.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.306 0.643 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -98.66 105.58 31.36 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.629 0.771 . . . . 0.0 109.353 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -48.72 4.64 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.816 2.344 . . . . 0.0 113.193 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -78.72 -31.61 46.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.466 0.706 . . . . 0.0 111.987 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -80.25 79.95 6.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.261 0.553 . . . . 0.0 110.176 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.6 -21.07 60.43 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.309 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 28.8 p-10 -84.55 -6.62 59.38 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 111.575 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.89 106.02 3.47 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.71 112.63 41.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 4.7 tmmm? -107.5 142.48 37.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.354 1.061 . . . . 0.0 108.868 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.69 122.85 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.521 1.128 . . . . 0.0 110.402 -168.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -120.68 143.92 48.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.19 0.996 . . . . 0.0 109.098 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -85.32 -169.33 2.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.745 0.418 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.43 -33.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.731 0.813 . . . . 0.0 112.241 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -74.33 -21.54 59.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.147 0.979 . . . . 0.0 111.01 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.71 -2.16 66.72 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.909 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.09 140.59 47.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.995 0.918 . . . . 0.0 110.159 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 1.3 mp0 -68.7 106.6 2.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.153 0.581 . . . . 0.0 110.521 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.67 -34.56 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.657 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 164.09 -149.82 17.44 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.582 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -139.25 139.39 37.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 171' ' ' LEU . 8.0 tp -68.46 144.87 54.52 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.321 1.049 . . . . 0.0 109.651 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.6 mtpt -68.98 129.43 39.9 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -58.23 -29.03 65.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.93 1.292 . . . . 0.0 113.146 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.8 mp0 -65.66 -37.05 85.43 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.736 0.779 . . . . 0.0 110.165 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 112' ' ' LYS . 1.8 mm? -95.87 -39.48 9.79 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.35 68.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.833 1.253 . . . . 0.0 111.686 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.45 98.46 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.957 0.786 . . . . 0.0 112.517 173.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -49.96 34.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.162 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 122' ' ' ILE . 10.9 mp -62.54 -20.61 64.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.901 0.88 . . . . 0.0 112.237 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -60.19 -35.4 75.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 111.762 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -69.54 -39.67 77.33 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.6 mp -68.74 -35.27 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.516 0.726 . . . . 0.0 109.553 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.44 -30.37 57.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.474 1.11 . . . . 0.0 110.714 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.2 -58.6 3.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.998 0.919 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.444 ' ND2' HD21 ' A' ' 127' ' ' LEU . 63.2 t30 -79.05 -13.57 59.69 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.634 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 64.4 53.03 1.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.7 1.2 . . . . 0.0 111.181 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.444 HD21 ' ND2' ' A' ' 125' ' ' ASN . 98.4 mt -79.84 -26.09 40.55 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.792 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 150' ' ' PHE . . . -156.45 146.96 21.59 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.822 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 150' ' ' PHE . 15.8 mm100 -93.39 105.82 17.85 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.492 1.117 . . . . 0.0 108.822 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HD22 ' A' ' 85' ' ' LEU . 3.3 mp -85.95 100.71 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.67 122.72 31.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.975 0.91 . . . . 0.0 108.947 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.67 150.32 17.92 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 82' ' ' MET . 71.1 t -147.43 129.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.643 1.577 . . . . 0.0 107.308 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 137' ' ' GLY . 15.3 t -104.29 100.98 24.15 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 -16.36 16.45 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.706 2.271 . . . . 0.0 112.254 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.76 -28.1 55.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.098 0.959 . . . . 0.0 111.139 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 65.2 27.61 72.57 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.12 23.83 10.58 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.366 1.066 . . . . 0.0 112.57 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -64.89 -25.48 67.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.67 0.788 . . . . 0.0 110.994 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.49 125.19 29.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.183 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -26.93 63.64 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.292 0.568 . . . . 0.0 109.93 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -85.56 -178.95 6.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.844 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 66' ' ' HIS . 40.8 m -71.2 112.17 7.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.542 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.576 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -93.72 153.97 41.05 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.39 0.676 . . . . 0.0 110.448 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.36 165.72 27.93 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.806 2.337 . . . . 0.0 113.043 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 148' ' ' MET . 46.0 tp -128.53 126.9 41.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.184 0.994 . . . . 0.0 108.72 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -85.53 107.12 17.32 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 24.3 mtm -120.98 160.57 23.25 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.016 0.527 . . . . 0.0 109.875 178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -147.88 146.86 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.001 1.321 . . . . 0.0 107.903 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' ' HB1' ' A' ' 128' ' ' ALA . 42.4 p90 -133.89 130.77 38.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.23 0.538 . . . . 0.0 111.536 -174.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -118.17 137.55 52.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.746 1.218 . . . . 0.0 110.368 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 -174.87 32.68 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 29.1 mtmm -85.41 -177.11 6.37 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.083 0.441 . . . . 0.0 109.967 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.54 -27.43 55.94 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.798 0.439 . . . . 0.0 112.019 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.08 -34.77 73.57 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 127' ' ' LEU . 17.5 m120 -81.22 -22.64 38.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.411 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -64.68 -41.91 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.507 0.67 . . . . 0.0 109.522 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -74.74 -43.29 55.75 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.52 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.57 85.71 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.717 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 14.7 p -66.8 -44.82 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.893 0.477 . . . . 0.0 110.781 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 60.7 p -63.13 -55.98 20.69 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.717 0.407 . . . . 0.0 110.737 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 111.768 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -72.73 -43.14 63.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.606 0.763 . . . . 0.0 110.871 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 170' ' ' LYS . 93.9 mt -67.62 -30.04 69.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.329 0.652 . . . . 0.0 110.882 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -70.58 -50.96 31.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 111.376 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -33.22 75.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.54 0.336 . . . . 0.0 111.454 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.84 -33.01 62.09 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.521 0.328 . . . . 0.0 110.814 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.82 71.26 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.563 0.539 . . . . 0.0 113.284 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -139.69 134.43 31.95 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.54 1.136 . . . . 0.0 109.015 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 164' ' ' LEU . 61.1 pttt -167.32 136.33 2.69 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.918 0.761 . . . . 0.0 110.992 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 111' ' ' LEU . 3.8 tt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -63.14 -28.28 69.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.222 1.009 . . . . 0.0 111.632 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -65.71 -34.22 77.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.704 1.201 . . . . 0.0 111.399 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.08 -27.96 27.9 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.896 0.878 . . . . 0.0 110.075 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -91.94 17.48 9.2 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.657 -174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.03 -32.52 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.67 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 100.9 4.38 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.4 m -73.1 136.2 44.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.577 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -100.13 168.0 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.876 0.871 . . . . 0.0 110.487 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.0 tp -84.64 127.29 34.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.142 0.577 . . . . 0.0 110.726 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.522 ' HE2' HG21 ' A' ' 160' ' ' VAL . 12.2 m-30 -87.42 -48.94 7.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.497 0.719 . . . . 0.0 109.301 172.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.12 -163.15 35.39 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.51 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 55.9 p -124.45 132.87 53.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 109.974 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 58.5 mt -86.06 156.29 20.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.631 1.173 . . . . 0.0 109.018 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -149.07 34.65 0.74 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.108 0.48 . . . . 0.0 111.432 -166.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . -79.52 -150.28 5.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.539 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -133.98 142.86 47.83 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.581 0.752 . . . . 0.0 111.942 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 ' HB2' ' A' ' 146' ' ' LEU . 62.0 t -91.98 117.77 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.904 0.882 . . . . 0.0 109.639 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' HD3' ' A' ' 112' ' ' LYS . 35.5 m -102.3 -2.49 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.69 0.796 . . . . 0.0 111.578 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.92 -18.02 77.35 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 144' ' ' MET . 69.7 mt -60.68 -38.44 84.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.716 0.806 . . . . 0.0 112.767 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -77.22 6.25 6.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.857 0.863 . . . . 0.0 112.677 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.67 -69.28 0.35 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.98 0.512 . . . . 0.0 110.405 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -115.81 -70.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.077 0.151 . . . . 0.0 111.171 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.4 p -125.06 -46.34 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.963 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.26 40.59 15.69 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.391 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 m -91.84 128.04 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 122.672 0.389 . . . . 0.0 110.965 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 134' ' ' VAL . 21.7 m -140.6 167.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.289 1.036 . . . . 0.0 110.097 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.5 158.27 36.37 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.398 0.679 . . . . 0.0 111.0 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -55.88 -33.72 64.86 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.091 0.956 . . . . 0.0 112.52 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -130.93 42.52 3.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.008 0.923 . . . . 0.0 109.568 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 77' ' ' VAL . 11.8 tp10 -59.86 110.13 1.1 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.795 -173.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.559 ' HG2' HG22 ' A' ' 133' ' ' VAL . 58.6 mtt -80.68 109.41 15.19 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.59 159.46 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.719 0.808 . . . . 0.0 110.896 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.57 128.66 39.69 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 109.328 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 100' ' ' VAL . 6.6 mp -80.93 151.27 28.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.743 0.817 . . . . 0.0 110.696 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -141.75 141.38 33.23 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -70.66 -174.23 0.87 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 122.505 0.322 . . . . 0.0 110.426 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -53.28 117.8 12.62 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.51 0.724 . . . . 0.0 112.174 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -86.14 3.58 6.88 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.694 2.263 . . . . 0.0 112.906 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -160.81 -50.51 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.497 0.719 . . . . 0.0 111.069 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -46.73 100.57 0.24 Allowed Pre-proline 0 N--CA 1.495 1.788 0 C-N-CA 125.041 1.336 . . . . 0.0 113.4 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.3 -34.5 27.1 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.44 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.74 -45.68 10.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.93 80.1 8.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -71.76 -14.66 62.06 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -96.62 7.74 45.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.228 1.011 . . . . 0.0 111.43 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.93 102.97 10.45 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.5 mt -97.65 117.69 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 5.3 tmmm? -98.82 128.18 44.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 174.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 85' ' ' LEU . 65.5 t -106.4 136.79 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.705 0.802 . . . . 0.0 110.147 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -115.07 164.4 14.24 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.225 1.01 . . . . 0.0 108.289 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.55 -174.87 2.64 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.86 -31.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 122.605 0.362 . . . . 0.0 111.814 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.72 -16.01 60.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.574 0.749 . . . . 0.0 110.72 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.73 2.97 58.41 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.737 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -79.5 125.46 29.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.654 0.782 . . . . 0.0 109.686 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 8.8 pt20 -72.27 89.22 1.19 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.914 0.864 . . . . 0.0 110.417 173.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.53 -11.23 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.151 -171.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.06 153.98 16.58 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.314 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.02 149.45 34.14 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.51 1.124 . . . . 0.0 108.365 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -108.27 131.56 54.57 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD3' HG11 ' A' ' 68' ' ' VAL . 32.5 mmmt -61.53 119.76 9.22 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.4 ptmm? -54.08 -24.64 18.21 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.553 1.141 . . . . 0.0 113.674 -172.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.82 -50.35 62.88 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.412 0.625 . . . . 0.0 110.08 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 169' ' ' PHE . 3.4 mm? -69.2 -42.55 75.63 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.581 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 111' ' ' LEU . . . -67.49 -19.44 65.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.47 1.508 . . . . 0.0 112.025 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.56 56.64 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.394 0.088 . . . . 0.0 113.087 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 164' ' ' LEU . . . -87.72 -53.32 4.83 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.673 0.789 . . . . 0.0 110.559 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.13 -34.34 76.17 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.836 0.854 . . . . 0.0 112.653 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.32 59.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.754 0.822 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.92 -48.35 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 127' ' ' LEU . 1.9 mp -61.89 -43.03 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.199 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.47 -41.77 98.61 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.338 0.655 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.28 -34.23 70.48 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.382 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -97.06 0.65 48.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.43 0.692 . . . . 0.0 111.119 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? 53.76 36.97 25.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.097 1.359 . . . . 0.0 111.856 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 122' ' ' ILE . 83.7 mt -68.72 -40.88 79.73 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.219 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.09 156.31 30.77 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.136 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -91.57 128.0 37.24 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.863 1.265 . . . . 0.0 109.869 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.41 102.14 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HE1' ' A' ' 151' ' ' TRP . 44.3 tt0 -90.61 124.05 34.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.544 0.738 . . . . 0.0 109.926 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.682 ' HA2' ' HG2' ' A' ' 148' ' ' MET . . . -102.69 138.27 13.84 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.102 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.2 t -139.34 135.68 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 124.338 1.055 . . . . 0.0 108.523 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 77' ' ' VAL . 93.4 t -106.24 104.47 50.15 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.693 0.797 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.4 -13.93 8.37 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.637 2.225 . . . . 0.0 112.941 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.99 -26.88 33.5 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.566 0.746 . . . . 0.0 110.881 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 71.05 4.6 56.16 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.559 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.94 74.29 0.33 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.122 -176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.46 -16.11 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.583 0.753 . . . . 0.0 111.152 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -144.73 151.22 38.56 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.26 -16.54 63.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.879 0.872 . . . . 0.0 111.72 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -70.79 176.29 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.116 0.484 . . . . 0.0 111.155 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -71.33 137.3 48.35 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.465 0.706 . . . . 0.0 111.364 -171.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 70' ' ' LEU . 24.4 ptt? -126.38 161.21 53.71 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.954 0.902 . . . . 0.0 110.163 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.29 154.52 56.4 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.331 2.021 . . . . 0.0 112.477 170.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HB2' HG23 ' A' ' 67' ' ' VAL . 62.6 tp -135.74 120.59 18.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.515 1.126 . . . . 0.0 108.945 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -91.53 103.63 16.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' ' HA2' ' A' ' 132' ' ' GLY . 67.8 mtm -107.66 164.56 12.13 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.887 0.875 . . . . 0.0 108.972 173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 86.0 m -137.07 118.94 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.905 0.882 . . . . 0.0 108.702 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.39 117.51 30.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.376 1.07 . . . . 0.0 108.717 -175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.544 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 48.1 p-90 -145.06 133.91 22.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.901 0.48 . . . . 0.0 109.878 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.89 4.78 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 155' ' ' GLU . 4.0 mptp? -92.18 146.28 23.84 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.542 0.737 . . . . 0.0 111.361 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.21 -21.7 60.6 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.201 0.6 . . . . 0.0 111.809 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 153' ' ' LYS . 10.2 pt-20 -65.58 -32.91 74.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.543 0.687 . . . . 0.0 109.806 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 88.2 m-20 -96.13 -15.46 22.12 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.033 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -57.61 -33.35 68.13 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.028 0.531 . . . . 0.0 110.717 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -68.48 -55.15 12.75 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.932 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.589 0.756 . . . . 0.0 112.363 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.522 HG21 ' HE2' ' A' ' 60' ' ' PHE . 45.8 t -67.74 -60.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.376 1.07 . . . . 0.0 110.322 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.8 t -58.31 -45.32 88.25 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.179 0.924 . . . . 0.0 110.436 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.48 -43.39 88.94 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.814 1.246 . . . . 0.0 111.297 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -65.85 -41.15 92.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.875 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.539 HD13 ' HE3' ' A' ' 170' ' ' LYS . 97.4 mt -61.26 -40.11 92.87 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.574 0.749 . . . . 0.0 111.67 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -40.64 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.56 -40.44 95.56 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.17 -23.38 47.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 66.06 34.64 88.95 Favored Glycine 0 C--N 1.357 1.743 0 O-C-N 123.751 0.657 . . . . 0.0 113.326 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.749 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 43.9 m-85 -148.51 126.42 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.076 0.951 . . . . 0.0 109.614 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.539 ' HE3' HD13 ' A' ' 164' ' ' LEU . 52.9 mtpt -136.03 118.17 15.47 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.071 0.948 . . . . 0.0 109.207 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 163.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.0 m -74.72 1.76 11.61 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.581 0.752 . . . . 0.0 112.548 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.6 -36.33 18.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.8 -60.06 1.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 111.83 -172.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -85.7 15.79 4.46 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -162.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.15 -26.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.572 0.349 . . . . 0.0 111.085 172.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -87.15 109.14 19.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.51 0.724 . . . . 0.0 109.898 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.3 m -74.66 123.56 25.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -97.08 130.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.199 0.6 . . . . 0.0 109.434 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.58 105.95 4.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.32 -47.04 72.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.575 1.15 . . . . 0.0 110.293 174.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.81 -161.74 31.22 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.853 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.5 p -111.91 133.32 54.17 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.272 1.029 . . . . 0.0 109.014 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 92.4 mt -117.6 -178.97 3.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.106 0.962 . . . . 0.0 109.811 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -148.48 148.35 30.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.064 0.459 . . . . 0.0 111.45 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.72 -148.42 5.12 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.805 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -160.25 105.23 1.49 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.246 0.618 . . . . 0.0 110.582 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 171' ' ' LEU . 20.4 t -71.71 113.66 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.437 0.695 . . . . 0.0 110.663 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -91.45 -22.06 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.779 0.832 . . . . 0.0 111.355 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -71.23 -12.62 72.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.196 0.903 . . . . 0.0 115.167 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 144' ' ' MET . 26.7 mt -50.93 -40.91 58.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.434 1.094 . . . . 0.0 112.799 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 3.7 41.92 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.537 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -69.86 -69.72 0.33 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.979 0.512 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -116.43 -69.51 0.85 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.648 0.261 . . . . 0.0 111.18 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.603 ' HB ' HG23 ' A' ' 76' ' ' VAL . 23.1 p -125.87 -46.65 1.69 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.53 0.732 . . . . 0.0 110.572 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 63.69 21.91 65.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.474 -0.784 . . . . 0.0 113.977 -176.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 74' ' ' THR . 99.3 t -74.97 128.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 121.368 0.604 . . . . 0.0 109.555 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.73 140.29 16.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.319 -1.309 . . . . 0.0 107.552 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 65.1 t30 -69.71 162.62 27.39 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.98 0.512 . . . . 0.0 110.277 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 2.4 m-20 -47.12 -40.81 16.26 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.5 1.52 . . . . 0.0 113.881 -168.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -135.01 36.63 3.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.522 0.729 . . . . 0.0 110.117 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 53.7 tt0 -73.73 133.25 43.3 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.438 0.637 . . . . 0.0 110.995 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 50.0 ttm -79.95 123.38 27.75 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.475 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 22.5 m -103.61 145.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.663 0.785 . . . . 0.0 110.597 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.59 132.94 53.76 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 109.559 -171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.95 110.82 22.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.625 0.77 . . . . 0.0 109.229 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.68 140.87 49.97 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -67.56 145.1 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.93 122.31 80.33 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 122.563 0.345 . . . . 0.0 110.387 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.98 -19.29 13.98 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.355 2.703 . . . . 0.0 113.548 -173.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -72.96 -36.25 67.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 42.0 m-80 -102.78 98.43 11.24 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.058 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.32 -50.57 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.7 2.267 . . . . 0.0 113.267 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -87.2 -31.2 20.46 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.23 0.612 . . . . 0.0 110.832 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . 14.3 t70 -74.81 85.19 2.18 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 16.4 ptpt -74.04 -14.5 61.02 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.989 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.4 11.56 8.3 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.465 0.706 . . . . 0.0 110.899 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.21 122.68 47.83 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HB ' HD22 ' A' ' 111' ' ' LEU . 85.2 mt -133.7 125.39 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.988 0.915 . . . . 0.0 108.849 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -104.94 116.8 32.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.807 1.643 . . . . 0.0 110.367 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.61 128.64 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.619 . . . . 0.0 110.76 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -121.84 121.67 37.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.174 0.99 . . . . 0.0 108.88 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.6 p-10 -65.0 164.42 12.79 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.093 0.557 . . . . 0.0 110.324 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -64.34 -14.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -167.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.7 t-20 -72.07 -17.38 62.01 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.806 0.843 . . . . 0.0 111.656 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.1 10.56 51.55 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 123.988 0.804 . . . . 0.0 113.023 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.34 145.66 26.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.435 1.094 . . . . 0.0 109.441 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -72.56 103.12 3.44 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.45 -30.93 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.012 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.28 178.18 42.02 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.453 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 63.2 t-80 -142.63 150.41 40.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 171' ' ' LEU . 10.1 mp -78.96 156.02 28.68 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.131 0.491 . . . . 0.0 111.954 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.572 ' HB2' HD23 ' A' ' 115' ' ' LEU . 32.2 mmmt -73.69 142.5 46.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 159.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.47 -21.33 64.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.073 0.549 . . . . 0.0 112.362 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HG3' HD22 ' A' ' 115' ' ' LEU . 8.1 pt-20 -68.6 -44.91 73.33 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 117.67 0.214 . . . . 0.0 111.011 172.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 ' HG3' ' A' ' 114' ' ' GLU . 3.3 mm? -66.66 -51.25 58.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 110.252 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.41 -20.23 64.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.955 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.3 75.47 Favored Glycine 0 C--N 1.353 1.503 0 O-C-N 123.6 0.562 . . . . 0.0 113.229 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.84 -50.63 5.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.419 0.688 . . . . 0.0 109.66 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 tp -62.42 -20.91 64.97 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.994 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -48.46 -54.92 12.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.587 1.155 . . . . 0.0 110.546 170.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -62.3 -25.31 67.79 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.046 0.939 . . . . 0.0 112.146 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.667 HG13 HG23 ' A' ' 160' ' ' VAL . 1.9 mp -74.77 -59.57 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 122.546 0.338 . . . . 0.0 110.425 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.1 mtm -75.25 -22.4 57.86 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.81 -59.96 2.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.163 0.585 . . . . 0.0 110.112 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.01 -1.68 33.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.511 0.724 . . . . 0.0 111.486 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 63.85 38.51 8.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.409 1.084 . . . . 0.0 111.15 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 160' ' ' VAL . 99.2 mt -65.95 -45.45 81.73 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.982 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -168.78 163.03 11.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.151 0.5 . . . . 0.0 111.137 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -90.87 136.05 33.33 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.346 1.059 . . . . 0.0 109.68 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -106.59 146.76 12.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.94 116.58 12.95 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.98 150.48 21.51 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.0 t -140.13 124.56 19.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 137' ' ' GLY . 61.0 t -90.15 107.92 22.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.99 -13.5 12.78 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.224 1.949 . . . . 0.0 112.232 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.78 -27.9 36.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.235 0.614 . . . . 0.0 111.689 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 59.27 46.67 93.47 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 61.52 30.5 18.78 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.33 1.052 . . . . 0.0 112.046 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.29 -26.17 66.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.179 0.592 . . . . 0.0 110.779 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -130.87 139.24 50.11 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.89 -23.9 26.86 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.754 0.822 . . . . 0.0 111.006 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -73.21 173.14 9.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.374 0.67 . . . . 0.0 109.826 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.2 m -68.81 113.33 6.15 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.694 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' HD11 ' A' ' 70' ' ' LEU . 20.3 ptt? -117.82 150.39 47.0 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.012 0.925 . . . . 0.0 109.288 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.7 159.59 6.59 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.211 2.607 . . . . 0.0 114.491 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.5 tp -130.6 141.01 50.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.281 1.032 . . . . 0.0 108.518 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -93.93 145.78 24.39 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.543 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 44.4 mtt -132.78 161.07 35.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.258 0.623 . . . . 0.0 109.79 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.08 137.87 44.92 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' HG21 ' A' ' 160' ' ' VAL . 24.1 t80 -135.34 125.04 25.29 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -164.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -145.97 149.31 33.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.932 0.493 . . . . 0.0 110.911 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.92 -125.04 0.78 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -123.62 162.26 23.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.206 1.002 . . . . 0.0 109.796 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -69.4 -41.54 76.28 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.492 0.717 . . . . 0.0 110.761 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.54 -26.26 68.62 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.372 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.0 -33.16 15.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.507 0.723 . . . . 0.0 111.567 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -64.2 -29.09 70.21 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.009 0.524 . . . . 0.0 112.249 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 158' ' ' LYS . 32.7 ttpt -74.12 -43.36 57.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.74 0.816 . . . . 0.0 110.949 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.11 84.06 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 122' ' ' ILE . 14.4 p -78.34 -36.55 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.691 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.9 p -60.85 -49.67 76.52 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.32 -45.35 65.56 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.341 1.026 . . . . 0.0 110.418 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -62.35 -38.08 88.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.55 1.14 . . . . 0.0 111.794 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.25 -36.38 69.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.612 0.765 . . . . 0.0 111.566 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.83 36.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 117.861 0.301 . . . . 0.0 110.969 174.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -61.67 -51.84 66.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.966 0.907 . . . . 0.0 110.473 -176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -90.55 -38.78 12.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.108 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.54 33.06 64.09 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.235 0.334 . . . . 0.0 112.546 -172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 57.2 m-85 -135.0 135.4 41.37 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.955 0.902 . . . . 0.0 110.943 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.553 ' H ' HD12 ' A' ' 115' ' ' LEU . 22.6 pttm -175.38 150.63 1.14 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.329 1.452 . . . . 0.0 109.21 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 1.2 tt . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -71.68 -25.05 61.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.967 0.907 . . . . 0.0 111.504 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.4 -29.95 69.59 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.453 0.701 . . . . 0.0 112.103 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.47 -16.17 61.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.475 0.71 . . . . 0.0 111.813 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 48.7 mt-10 -95.2 48.75 1.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.632 0.773 . . . . 0.0 110.545 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.92 -13.94 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.669 0.388 . . . . 0.0 111.494 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -107.77 129.35 55.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.302 1.041 . . . . 0.0 109.766 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -82.73 132.5 35.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.63 HG23 HH11 ' A' ' 157' ' ' ARG . 28.9 m -97.27 144.1 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.014 0.435 . . . . 0.0 110.4 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.68 120.08 18.78 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.862 0.865 . . . . 0.0 111.605 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -80.56 -43.29 20.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.899 . . . . 0.0 109.991 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.11 -159.75 28.7 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.6 p -131.08 130.89 43.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.114 0.565 . . . . 0.0 109.654 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HB3' ' OXT' ' A' ' 171' ' ' LEU . 6.0 mp -74.08 168.49 19.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.526 1.131 . . . . 0.0 110.159 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -143.83 27.42 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -158.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -87.17 -166.9 43.11 Favored Glycine 0 C--O 1.215 -1.075 0 N-CA-C 113.865 0.306 . . . . 0.0 113.865 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.515 ' HB3' HG22 ' A' ' 143' ' ' THR . 26.3 m-70 -116.33 144.16 44.61 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 146' ' ' LEU . 32.0 t -93.4 98.98 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.089 0.955 . . . . 0.0 109.94 175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -80.75 8.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.947 0.499 . . . . 0.0 111.404 172.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 109' ' ' GLY . . . -78.6 -15.3 81.04 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.421 1.01 . . . . 0.0 115.374 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' SD ' ' A' ' 144' ' ' MET . 89.3 mt -55.01 -32.13 61.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.256 0.622 . . . . 0.0 112.305 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -89.4 -3.43 58.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.937 0.895 . . . . 0.0 112.737 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -73.99 -69.58 0.43 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.807 0.276 . . . . 0.0 110.956 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -115.77 -72.38 0.69 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 120.657 0.265 . . . . 0.0 110.766 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.5 p -127.35 -44.45 1.56 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.098 0.959 . . . . 0.0 109.232 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' LEU . . . 76.57 8.13 85.9 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 114.594 -1.185 . . . . 0.0 113.351 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.95 128.85 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HB ' ' A' ' 134' ' ' VAL . 41.6 t -138.45 148.35 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.655 1.182 . . . . 0.0 108.2 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 18.8 t-20 -78.43 159.01 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -43.93 -48.02 8.5 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -167.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.58 36.63 4.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.299 0.64 . . . . 0.0 109.84 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.7 tt0 -76.19 140.93 41.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.67 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 133' ' ' VAL . 81.8 mtp -87.42 163.17 16.89 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.883 0.849 . . . . 0.0 111.375 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 31.5 m -129.96 175.98 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.08 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 132.2 17.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.01 0.924 . . . . 0.0 108.52 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.2 mp -89.33 140.17 29.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 122.958 0.503 . . . . 0.0 110.297 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -145.26 148.03 33.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.2 1.4 . . . . 0.0 107.878 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -70.38 149.08 47.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.51 128.16 93.08 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 122.263 0.225 . . . . 0.0 111.165 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 -17.76 13.62 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.204 2.602 . . . . 0.0 113.381 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -78.78 -41.83 29.48 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -107.53 99.49 29.02 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.022 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.65 -31.3 2.03 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.358 2.039 . . . . 0.0 112.951 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.97 -41.81 41.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.293 0.637 . . . . 0.0 110.222 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.32 95.89 9.36 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.695 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.9 ptpt -76.2 -17.3 59.59 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.238 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -66.7 -24.62 66.28 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.071 0.549 . . . . 0.0 110.416 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.6 109.67 5.68 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.48 127.08 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.79 129.86 55.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.552 0.741 . . . . 0.0 110.56 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' A' ' 85' ' ' LEU . 61.6 t -98.36 132.81 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.717 0.807 . . . . 0.0 109.434 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -126.64 140.39 52.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.34 1.056 . . . . 0.0 108.513 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 31.4 p-10 -80.56 -176.1 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.091 0.405 . . . . 0.0 110.833 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.95 -27.21 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 123.464 0.705 . . . . 0.0 112.608 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -82.54 -14.03 55.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.044 0.538 . . . . 0.0 111.093 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.64 11.36 62.24 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.37 -0.377 . . . . 0.0 113.183 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -82.75 129.79 35.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.589 0.756 . . . . 0.0 108.97 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.11 88.39 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.984 0.897 . . . . 0.0 109.601 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.42 -24.07 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.464 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.698 ' HA3' ' HA3' ' A' ' 69' ' ' GLY . . . 170.71 -152.49 18.79 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 114.319 0.488 . . . . 0.0 114.319 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -139.81 155.59 47.19 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 109.775 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 116' ' ' ALA . 3.6 tt -80.09 136.65 36.59 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HB2' HD23 ' A' ' 115' ' ' LEU . 27.9 mtpt -68.66 126.18 28.88 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.393 0.542 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 22.3 ptmt -61.61 -21.07 64.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -170.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -43.48 81.85 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.641 0.734 . . . . 0.0 109.758 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.5 mm? -81.43 -40.06 23.95 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.732 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -62.24 -15.94 50.28 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 124.795 1.238 . . . . 0.0 111.656 175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.27 -30.87 26.01 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.426 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.24 -47.97 7.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.596 0.759 . . . . 0.0 110.455 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.543 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.6 mm? -62.53 -18.2 61.47 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' A' ' 95' ' ' LYS . . . -59.06 -41.63 88.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.585 1.154 . . . . 0.0 110.658 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -69.25 -29.42 67.33 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.853 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.596 HG21 HD11 ' A' ' 130' ' ' ILE . 1.5 mp -68.03 -39.53 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.6 -45.48 52.83 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.49 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.22 -34.02 59.24 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.456 -170.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 127' ' ' LEU . 8.3 m120 -106.03 -1.38 23.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.099 0.56 . . . . 0.0 110.345 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.31 42.83 17.64 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.758 1.223 . . . . 0.0 110.192 175.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 122' ' ' ILE . 97.9 mt -71.04 -33.01 69.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.19 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.24 169.22 25.26 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.813 0.816 . . . . 0.0 113.118 -171.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -117.77 107.87 14.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 107.485 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.596 HD11 HG21 ' A' ' 122' ' ' ILE . 7.4 mt -106.88 101.48 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.87 177.29 7.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.02 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -151.54 152.88 24.58 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' MET . 96.6 t -145.21 126.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 107.804 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 137' ' ' GLY . 22.7 t -104.76 95.28 8.6 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.84 -10.86 15.42 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.903 2.402 . . . . 0.0 112.659 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -82.63 -25.48 33.11 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.709 0.803 . . . . 0.0 110.246 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 134' ' ' VAL . . . 56.07 37.01 69.65 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.187 0.835 . . . . 0.0 115.187 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 58.31 21.2 8.0 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.953 0.901 . . . . 0.0 113.135 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.237 0.615 . . . . 0.0 109.968 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.63 120.52 26.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.308 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.37 65.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.32 158.92 29.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.651 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 66' ' ' HIS . 70.7 m -69.69 113.55 7.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.352 0.596 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -101.61 158.71 31.25 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.342 1.057 . . . . 0.0 110.751 -172.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.75 164.72 11.14 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.127 2.552 . . . . 0.0 114.284 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 67' ' ' VAL . 66.6 tp -144.5 131.44 20.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.288 1.435 . . . . 0.0 109.097 -173.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -97.27 107.03 19.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 85' ' ' LEU . 71.8 mtm -113.95 112.34 23.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.661 0.384 . . . . 0.0 110.837 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -88.28 115.09 25.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.407 -167.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -95.29 120.33 35.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.29 1.436 . . . . 0.0 110.195 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -121.78 155.69 34.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.317 1.047 . . . . 0.0 109.151 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.23 157.79 23.82 Favored Glycine 0 N--CA 1.469 0.839 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.356 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 9.5 mtmp? -75.99 158.92 31.38 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.752 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.79 -43.75 73.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 123.549 0.74 . . . . 0.0 112.992 -171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 156' ' ' ASN . 18.4 pt-20 -65.7 -39.96 91.79 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.081 0.467 . . . . 0.0 110.285 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 155' ' ' GLU . 16.2 m120 -70.78 -32.92 70.2 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.487 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.63 HH11 HG23 ' A' ' 58' ' ' VAL . 42.0 mmm-85 -62.04 -40.57 96.18 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 110.818 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -63.86 -54.38 35.77 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.889 0.743 . . . . 0.0 109.427 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.11 93.41 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -173.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.02 -37.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.987 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.2 t -62.53 -53.02 60.95 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.78 -31.9 68.82 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.707 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -71.52 -46.78 58.71 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.415 0.686 . . . . 0.0 111.252 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 170' ' ' LYS . 94.6 mt -64.49 -36.18 83.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.406 0.682 . . . . 0.0 110.493 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -72.29 -36.86 69.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.528 1.131 . . . . 0.0 111.297 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -66.28 -51.96 52.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.981 0.912 . . . . 0.0 110.802 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.95 -34.32 62.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.134 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.24 79.12 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.184 -0.917 . . . . 0.0 114.228 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 70.5 m-85 -135.51 96.0 3.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.33 0.652 . . . . 0.0 110.336 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.538 ' HG2' HD22 ' A' ' 164' ' ' LEU . 33.9 mtmm -108.78 150.77 27.14 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 65' ' ' GLY . 16.7 tp . . . . . 0 C--O 1.255 1.363 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.2 p -55.1 -48.11 74.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.678 1.191 . . . . 0.0 113.14 -171.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.38 -21.89 55.5 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 0.0 112.081 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.43 -43.61 17.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.371 0.669 . . . . 0.0 111.161 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.75 28.63 1.29 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.304 0.642 . . . . 0.0 111.89 -171.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.14 -21.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.218 0.607 . . . . 0.0 110.465 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.87 125.57 29.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.381 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -77.05 148.11 36.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.91 132.05 42.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.0 112.08 12.07 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HA ' HH21 ' A' ' 157' ' ' ARG . 59.8 t80 -78.72 -42.63 27.77 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.985 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.92 -160.39 30.71 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.756 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.5 p -120.72 162.97 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 110.423 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' MET . 4.5 mp -120.64 166.9 13.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 30.59 0.74 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.331 0.653 . . . . 0.0 110.727 -171.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 171' ' ' LEU . . . -67.78 168.59 39.72 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.456 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HB3' HG22 ' A' ' 143' ' ' THR . 35.0 m-70 -112.57 105.29 13.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.584 0.753 . . . . 0.0 110.303 -170.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.39 125.92 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.768 0.827 . . . . 0.0 110.085 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -90.61 -27.09 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.518 0.727 . . . . 0.0 110.87 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA3' ' H ' ' A' ' 110' ' ' HIS . . . -72.3 -16.18 77.12 Favored Glycine 0 C--O 1.209 -1.452 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.8 -165.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.531 HD13 ' HE3' ' A' ' 144' ' ' MET . 6.1 mt -43.69 -47.04 7.71 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.063 1.345 . . . . 0.0 114.035 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -73.15 7.79 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.239 1.016 . . . . 0.0 113.601 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.57 -54.28 48.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.078 0.951 . . . . 0.0 110.772 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -111.48 -68.23 0.94 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.3 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 p -123.77 -46.49 1.98 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.627 0.371 . . . . 0.0 111.626 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 35.02 63.97 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.766 -171.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.73 135.35 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.645 0.778 . . . . 0.0 110.205 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 134' ' ' VAL . 27.0 m -149.11 168.66 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 124.771 1.228 . . . . 0.0 109.195 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . 8.0 t30 -77.67 157.26 30.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.237 0.615 . . . . 0.0 110.373 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.72 -37.34 70.82 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.935 1.294 . . . . 0.0 112.429 -171.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -126.23 35.5 4.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.607 0.763 . . . . 0.0 109.828 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . 31.6 tt0 -73.79 138.07 44.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 103' ' ' VAL . 1.3 mpt? -88.02 141.59 28.46 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.381 0.61 . . . . 0.0 109.505 174.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.93 175.42 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.403 1.081 . . . . 0.0 108.624 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 137.35 26.6 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.71 107.32 18.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -111.06 141.25 44.81 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.049 1.34 . . . . 0.0 107.537 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' HG2' ' A' ' 123' ' ' MET . 13.9 ptm180 -70.71 168.06 17.39 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.237 0.471 . . . . 0.0 110.08 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.15 118.3 65.94 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.07 -14.8 18.76 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.79 2.326 . . . . 0.0 112.806 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.39 -42.99 9.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.512 0.725 . . . . 0.0 110.263 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 6.0 m-20 -84.85 107.71 12.53 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.039 0.936 . . . . 0.0 110.455 -175.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.25 -51.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.58 2.186 . . . . 0.0 113.681 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -87.81 -24.61 23.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.253 0.621 . . . . 0.0 111.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 2.7 m-20 -85.56 58.58 5.12 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.34 1.067 . . . . 0.0 108.824 168.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -77.44 -15.16 59.48 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.662 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -71.59 -12.3 61.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.276 1.031 . . . . 0.0 110.962 170.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.99 104.8 7.67 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 62.7 mt -110.99 108.34 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.709 0.766 . . . . 0.0 109.12 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 101' ' ' ASN . 60.0 tttt -77.69 116.24 18.08 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.389 1.475 . . . . 0.0 110.089 175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.65 106.74 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 121.756 0.789 . . . . 0.0 109.271 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.31 142.51 34.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.695 0.798 . . . . 0.0 110.928 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.35 173.17 9.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.801 1.24 . . . . 0.0 110.567 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 31.4 m -67.36 -12.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.487 0.715 . . . . 0.0 111.917 171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.27 -31.2 68.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.927 0.891 . . . . 0.0 110.552 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.68 -3.88 56.26 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.663 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.66 151.61 20.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.931 0.892 . . . . 0.0 108.964 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 4.7 pp0? -88.69 131.98 34.78 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.99 -38.42 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.63 -156.51 9.65 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.048 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.652 ' H ' ' HA3' ' A' ' 69' ' ' GLY . 87.7 m-70 -141.61 155.13 45.75 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.2 1.0 . . . . 0.0 109.779 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 116' ' ' ALA . 6.4 tt -89.04 144.1 26.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.727 1.211 . . . . 0.0 108.187 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HB2' HD23 ' A' ' 115' ' ' LEU . 33.8 mtpt -72.45 126.57 30.17 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.064 0.546 . . . . 0.0 110.436 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 14.6 ptmm? -57.44 -29.24 64.02 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.22 -40.99 86.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.309 0.576 . . . . 0.0 111.043 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 112' ' ' LYS . 2.7 mm? -77.87 -40.69 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.398 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.67 -20.44 65.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.028 1.331 . . . . 0.0 112.712 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.15 -34.03 65.91 Favored Glycine 0 C--N 1.347 1.181 0 O-C-N 123.604 0.565 . . . . 0.0 113.702 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.17 -49.13 13.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.01 0.524 . . . . 0.0 110.128 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 mm? -64.55 -19.97 65.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.012 0.925 . . . . 0.0 112.449 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.36 69.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.78 0.832 . . . . 0.0 111.809 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.01 -32.72 39.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.414 0.685 . . . . 0.0 111.57 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 119' ' ' LEU . 3.0 mp -70.52 -42.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 87' ' ' ARG . 50.8 tpp -65.28 -37.52 87.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.586 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.58 -64.62 0.89 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.166 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -82.64 -0.84 49.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.412 0.685 . . . . 0.0 111.765 -170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 60.57 39.4 18.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.33 1.052 . . . . 0.0 110.276 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 156' ' ' ASN . 94.9 mt -56.28 -39.64 72.97 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.137 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . . . -164.63 153.77 13.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.92 175.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -88.74 131.54 34.99 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.295 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.8 101.38 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -84.11 117.79 23.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.738 0.815 . . . . 0.0 109.523 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.01 149.09 19.2 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.1 t -147.46 124.39 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.321 1.448 . . . . 0.0 107.468 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 77' ' ' VAL . 7.9 t -88.94 106.08 12.05 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.48 -13.43 8.53 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.614 2.209 . . . . 0.0 113.12 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.85 -24.06 28.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.868 0.867 . . . . 0.0 111.454 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 79' ' ' ASN . . . 61.79 41.2 99.59 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.497 0.498 . . . . 0.0 113.337 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 60.38 70.89 0.6 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.349 1.06 . . . . 0.0 110.871 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.89 -32.11 71.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.076 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 142' ' ' PHE . 41.2 t30 -160.53 132.0 5.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 108.657 -175.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.08 -20.02 61.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.034 0.533 . . . . 0.0 111.606 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.516 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . 49.4 t80 -67.48 -169.56 0.11 Allowed 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.901 0.88 . . . . 0.0 109.398 171.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 66' ' ' HIS . 32.7 m -65.92 120.69 13.54 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.54 -0.725 . . . . 0.0 111.136 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.531 ' HE3' HD13 ' A' ' 70' ' ' LEU . 13.0 ttm -120.98 141.71 33.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.773 1.229 . . . . 0.0 109.702 -172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.29 127.15 16.9 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.816 1.678 . . . . 0.0 110.351 166.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.458 HD23 ' HE3' ' A' ' 148' ' ' MET . 64.3 tp -110.47 145.05 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.57 109.55 21.38 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.555 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.2 mpt? -101.49 162.87 12.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 m -139.49 115.47 10.26 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 160' ' ' VAL . 6.3 t80 -97.05 118.49 33.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.445 1.098 . . . . 0.0 110.29 -171.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -148.54 143.42 26.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.542 0.737 . . . . 0.0 110.265 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.24 -130.26 1.29 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.88 144.63 26.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.372 0.586 . . . . 0.0 110.177 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.87 -37.31 84.18 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.671 0.788 . . . . 0.0 112.688 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 156' ' ' ASN . 10.3 pt-20 -63.78 -30.88 71.92 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.554 0.742 . . . . 0.0 110.791 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 127' ' ' LEU . 15.9 m-20 -88.61 -34.06 17.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.153 0.981 . . . . 0.0 111.644 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -64.88 -33.47 76.09 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.767 0.427 . . . . 0.0 110.928 -171.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -69.65 -43.95 71.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.29 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.54 99.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.06 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.604 HG11 ' CZ ' ' A' ' 150' ' ' PHE . 81.1 t -67.72 -42.79 86.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.673 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 25.1 t -49.93 -54.64 18.48 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.12 0.888 . . . . 0.0 109.681 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.51 -55.81 25.28 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.25 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -68.3 -23.85 64.78 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 170' ' ' LYS . 60.9 mt -69.91 -50.23 44.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.263 0.483 . . . . 0.0 110.408 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -26.14 54.11 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.73 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -78.36 -45.14 23.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.646 0.779 . . . . 0.0 110.62 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 169' ' ' PHE . 42.4 t60 -71.76 -29.86 64.95 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.93 78.13 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.936 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' A' ' 115' ' ' LEU . 96.9 m-85 -142.04 128.08 19.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.752 0.821 . . . . 0.0 109.187 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HB3' HD22 ' A' ' 164' ' ' LEU . 25.3 pttm -159.45 153.55 23.5 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.713 0.633 . . . . 0.0 110.095 172.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.507 HD22 ' HG ' ' A' ' 111' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.065 . . . . . . . . 1 1 . 1 stop_ save_